Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1997 Jan;10(1):86–124. doi: 10.1128/cmr.10.1.86

Infections in solid-organ transplant recipients.

R Patel 1, C V Paya 1
PMCID: PMC172945  PMID: 8993860

Abstract

Solid-organ transplantation is a therapeutic option for many human diseases. Infections are a major complication of solid-organ transplantation. All candidates should undergo a thorough infectious-disease screening prior to transplantation. There are three time frames, influenced by surgical factors, the level of immunosuppression, and environmental exposures, during which infections of specific types most frequently occur posttransplantation. Most infections during the first month are related to surgical complications. Opportunistic infections typically occur from the second to the sixth month. During the late posttransplant period (beyond 6 months), transplantation recipients suffer from the same infections seen in the general community. Opportunistic bacterial infections seen in transplant recipients include those caused by Legionella spp., Nocardia spp., Salmonella spp., and Listeria monocytogenes. Cytomegalovirus is the most common cause of viral infections. Herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and others are also significant pathogens. Fungal infections, caused by both yeasts and mycelial fungi, are associated with the highest mortality rates. Mycobacterial, pneumocystis, and parasitic diseases may also occur.

Full Text

The Full Text of this article is available as a PDF (564.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott M. R., Smith D. D. Mycobacterial infections in immunosuppressed patients. Med J Aust. 1981 Apr 4;1(7):351–353. doi: 10.5694/j.1326-5377.1981.tb135629.x. [DOI] [PubMed] [Google Scholar]
  2. Abu-Farsakh H., Cagle P. T., Buffone G. J., Bruner J. M., Weilbaecher D., Greenberg S. D. Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder. Arch Pathol Lab Med. 1992 Jan;116(1):93–95. [PubMed] [Google Scholar]
  3. Agarwal A., Gupta A., Sakhuja V., Talwar P., Joshi K., Chugh K. S. Retinitis following disseminated cryptococcosis in a renal allograft recipient. Efficacy of oral fluconazole. Acta Ophthalmol (Copenh) 1991 Jun;69(3):402–405. doi: 10.1111/j.1755-3768.1991.tb04836.x. [DOI] [PubMed] [Google Scholar]
  4. Ajello L., Georg L. K., Steigbigel R. T., Wang C. J. A case of phaeohyphomycosis caused by a new species of Phialophora. Mycologia. 1974 May-Jun;66(3):490–498. [PubMed] [Google Scholar]
  5. Albes J., Haverich A., Freihorst J., von der Hardt H., Manthey-Stiers F. Management of mycotic rupture of the ascending aorta after heart-lung transplantation. Ann Thorac Surg. 1990 Dec;50(6):982–983. doi: 10.1016/0003-4975(90)91139-3. [DOI] [PubMed] [Google Scholar]
  6. Aldape K. D., Fox H. S., Roberts J. P., Ascher N. L., Lake J. R., Rowley H. A. Cladosporium trichoides cerebral phaeohyphomycosis in a liver transplant recipient. Report of a case. Am J Clin Pathol. 1991 Apr;95(4):499–502. doi: 10.1093/ajcp/95.4.499. [DOI] [PubMed] [Google Scholar]
  7. Alexander J. A., Brouillette D. E., Chien M. C., Yoo Y. K., Tarter R. E., Gavaler J. S., Van Thiel D. H. Infectious esophagitis following liver and renal transplantation. Dig Dis Sci. 1988 Sep;33(9):1121–1126. doi: 10.1007/BF01535788. [DOI] [PubMed] [Google Scholar]
  8. Algan M., Jonon B., George J. L., Lion C., Kessler M., Burdin J. C. Listeria monocytogenes endophthalmitis in a renal-transplant patient receiving ciclosporin. Ophthalmologica. 1990;201(1):23–27. doi: 10.1159/000310120. [DOI] [PubMed] [Google Scholar]
  9. Allen K. A., Markin R. S., Rennard S. I., Shaw B. W., Jr, Thompson A. B., Wood R. P., Woods G. S., Linder J. Bronchoalveolar lavage in liver transplant patients. Acta Cytol. 1989 Jul-Aug;33(4):539–543. [PubMed] [Google Scholar]
  10. Alsip S. G., Cobbs C. G. Pseudallescheria boydii infection of the central nervous system in a cardiac transplant recipient. South Med J. 1986 Mar;79(3):383–384. doi: 10.1097/00007611-198603000-00034. [DOI] [PubMed] [Google Scholar]
  11. Ampel N. M., Wing E. J. Legionella infection in transplant patients. Semin Respir Infect. 1990 Mar;5(1):30–37. [PubMed] [Google Scholar]
  12. Anandi V., John T. J., Walter A., Shastry J. C., Lalitha M. K., Padhye A. A., Ajello L., Chandler F. W. Cerebral phaeohyphomycosis caused by Chaetomium globosum in a renal transplant recipient. J Clin Microbiol. 1989 Oct;27(10):2226–2229. doi: 10.1128/jcm.27.10.2226-2229.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Anderson D. J., Schmidt C., Goodman J., Pomeroy C. Cryptococcal disease presenting as cellulitis. Clin Infect Dis. 1992 Mar;14(3):666–672. doi: 10.1093/clinids/14.3.666. [DOI] [PubMed] [Google Scholar]
  14. Andrews W., Fyock B., Gray S., Coln D., Hendrickse W., Siegel J., Belknap B., Hogge A., Benser M., Kennard B. Pediatric liver transplantation: the Dallas experience. Transplant Proc. 1987 Aug;19(4):3267–3276. [PubMed] [Google Scholar]
  15. Arduino R. C., Johnson P. C., Miranda A. G. Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine. Clin Infect Dis. 1993 Apr;16(4):505–512. doi: 10.1093/clind/16.4.505. [DOI] [PubMed] [Google Scholar]
  16. Armes J. E., Angus P., Southey M. C., Battaglia S. E., Ross B. C., Jones R. M., Venter D. J. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. Cancer. 1994 Nov 1;74(9):2436–2441. doi: 10.1002/1097-0142(19941101)74:9<2436::aid-cncr2820740908>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  17. Arnold J. C., Nouri-Aria K. T., O'Grady J. G., Portmann B. C., Alexander G. J., Williams R. Hepatic alpha-interferon expression in cytomegalovirus-infected liver allograft recipients with and without vanishing bile duct syndrome. Clin Investig. 1993 Mar;71(3):191–196. doi: 10.1007/BF00180101. [DOI] [PubMed] [Google Scholar]
  18. Arnold J. C., Portmann B. C., O'Grady J. G., Naoumov N. V., Alexander G. J., Williams R. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology. 1992 Aug;16(2):285–292. doi: 10.1002/hep.1840160202. [DOI] [PubMed] [Google Scholar]
  19. Arnouts P. J., Ramael M. R., Ysebaert D. K., Verpooten G. A., de Broe M. E., van Marck E. A., Pattyn S. R. Legionella pneumophila peritonitis in a kidney transplant patient. Scand J Infect Dis. 1991;23(1):119–122. doi: 10.3109/00365549109023386. [DOI] [PubMed] [Google Scholar]
  20. Arnow P. M., Andersen R. L., Mainous P. D., Smith E. J. Pumonary aspergillosis during hospital renovation. Am Rev Respir Dis. 1978 Jul;118(1):49–53. doi: 10.1164/arrd.1978.118.1.49. [DOI] [PubMed] [Google Scholar]
  21. Ascher N. L., Simmons R. L., Marker S., Klugman J., Najarian J. S. Tuberculous joint disease in transplant patients. Am J Surg. 1978 Jun;135(6):853–856. doi: 10.1016/0002-9610(78)90180-0. [DOI] [PubMed] [Google Scholar]
  22. Ascher N. L., Simmons R. L., Marker S., Najarian J. S. Listeria infection in transplant patients. Five cases and a review of the literature. Arch Surg. 1978 Jan;113(1):90–94. doi: 10.1001/archsurg.1978.01370130092018. [DOI] [PubMed] [Google Scholar]
  23. Avery R. K. Infections and immunizations in organ transplant recipients: a preventive approach. Cleve Clin J Med. 1994 Sep-Oct;61(5):386–392. doi: 10.3949/ccjm.61.5.386. [DOI] [PubMed] [Google Scholar]
  24. Azadian B. S., Beck A., Curtis J. R., Cherrington L. E., Gower P. E., Phillips M., Eastwood J. B., Nicholls J. Disseminated infection with mycobacterium chelonei in a haemodialysis patient. Tubercle. 1981 Dec;62(4):281–284. doi: 10.1016/s0041-3879(81)80009-8. [DOI] [PubMed] [Google Scholar]
  25. Bach M. C., Adler J. L., Breman J., P'eng F. K., Sahyoun A., Schlesinger R. M., Madras P., Monaco A. P. Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients. Lancet. 1973 Jan 27;1(7796):180–184. doi: 10.1016/s0140-6736(73)90007-x. [DOI] [PubMed] [Google Scholar]
  26. Badger I. L., Crosby H. A., Kong K. L., Baker J. P., Hutchings P., Elliott T. S., McMaster P., Bion J. F., Buckels J. A. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplant Proc. 1991 Feb;23(1 Pt 2):1460–1461. [PubMed] [Google Scholar]
  27. Bailey T. C., Ettinger N. A., Storch G. A., Trulock E. P., Hanto D. W., Dunagan W. C., Jendrisak M. D., McCullough C. S., Kenzora J. L., Powderly W. G. Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants. Am J Med. 1993 Sep;95(3):273–278. doi: 10.1016/0002-9343(93)90279-x. [DOI] [PubMed] [Google Scholar]
  28. Balfour H. H., Jr, Chace B. A., Stapleton J. T., Simmons R. L., Fryd D. S. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med. 1989 May 25;320(21):1381–1387. doi: 10.1056/NEJM198905253202105. [DOI] [PubMed] [Google Scholar]
  29. Balfour H. H., Jr, Sachs G. W., Welo P., Gehrz R. C., Simmons R. L., Najarian J. S. Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial. Birth Defects Orig Artic Ser. 1984;20(1):289–304. [PubMed] [Google Scholar]
  30. Balk A. H., Weimar W., Rothbarth P. H., Meeter K., Metselaar H. J., Mochtar B., Simoons M. L. Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience. Infection. 1993 Jul-Aug;21(4):195–200. doi: 10.1007/BF01728886. [DOI] [PubMed] [Google Scholar]
  31. Ballardie F. W., Winearls C. G., Williams G. Cyclosporin and steroids in renal transplantation: risk of Pneumocystis carinii pneumonia? Lancet. 1984 Sep 15;2(8403):638–639. doi: 10.1016/s0140-6736(84)90628-7. [DOI] [PubMed] [Google Scholar]
  32. Barbara J. A., Clarkson A. R., LaBrooy J., McNeil J. D., Woodroffe A. J. Candida albicans arthritis in a renal allograft recipient with an interaction between cyclosporin and fluconazole. Nephrol Dial Transplant. 1993;8(3):263–266. [PubMed] [Google Scholar]
  33. Baringer J. R., Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med. 1973 Mar 29;288(13):648–650. doi: 10.1056/NEJM197303292881303. [DOI] [PubMed] [Google Scholar]
  34. Barkholt L. M., Ericzon B. G., Ehrnst A., Forsgren M., Andersson J. P. Cytomegalovirus infections in liver transplant patients: incidence and outcome. Transplant Proc. 1990 Feb;22(1):235–237. [PubMed] [Google Scholar]
  35. Barkholt L., Ericzon B. G., Tollemar J., Malmborg A. S., Ehrnst A., Wilczek H., Andersson J. Infections in human liver recipients: different patterns early and late after transplantation. Transpl Int. 1993 Mar;6(2):77–84. doi: 10.1007/BF00336649. [DOI] [PubMed] [Google Scholar]
  36. Barton I. K., Nicholson F. Use of pooled immunoglobulin and acyclovir as prophylaxis against cytomegalovirus disease in recipients of renal allografts. Nephrol Dial Transplant. 1991;6(7):525–526. doi: 10.1093/ndt/6.7.525. [DOI] [PubMed] [Google Scholar]
  37. Basadonna G., Feria A., Perez R., Klein H., Sturges M., Colquhoun S. Incidence of infection and acute rejection after cytomegalovirus immune globulin prophylaxis in renal transplantation. Transplant Proc. 1994 Oct;26(5 Suppl 1):52–53. [PubMed] [Google Scholar]
  38. Basgoz N., Preiksaitis J. K. Post-transplant lymphoproliferative disorder. Infect Dis Clin North Am. 1995 Dec;9(4):901–923. [PubMed] [Google Scholar]
  39. Bauling P. C., Weil R., 3rd, Schröter G. P. Legionella lung abscess after renal transplantation. J Infect. 1985 Jul;11(1):51–55. doi: 10.1016/s0163-4453(85)91010-2. [DOI] [PubMed] [Google Scholar]
  40. Bell R., Sheil A. G., McDonald J. A., McCaughan G. W. The role of CMV immune prophylaxis in patients at risk of primary CMV infection following orthotopic liver transplantation. Transplant Proc. 1989 Oct;21(5):3781–3782. [PubMed] [Google Scholar]
  41. Bell T. J., Williams G. B. Successful treatment of tuberculosis in renal transplant recipients. J R Soc Med. 1978 Apr;71(4):265–268. doi: 10.1177/014107687807100408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ben Hamida F., Achard J. M., Westeel P. F., Chandenier J., Bouzernidj M., Petit J., Carme B., Fournier A. Leg granuloma due to Neocosmospora vasinfecta in a renal graft recipient. Transplant Proc. 1993 Jun;25(3):2292–2292. [PubMed] [Google Scholar]
  43. Ben Hamida M., Bedrossian J., Pruna A., Fouqueray B., Metivier F., Idatte J. M. Fungal mycotic aneurysms and visceral infection due to Scedosporium apiospermum in a kidney transplant patient. Transplant Proc. 1993 Jun;25(3):2290–2291. [PubMed] [Google Scholar]
  44. Benedict L. M., Kusne S., Torre-Cisneros J., Hunt S. J. Primary cutaneous fungal infection after solid-organ transplantation: report of five cases and review. Clin Infect Dis. 1992 Jul;15(1):17–21. doi: 10.1093/clinids/15.1.17. [DOI] [PubMed] [Google Scholar]
  45. Bensousan T., Garo B., Islam S., Bourbigot B., Cledes J., Garre M. Possible transfer of Pneumocystis carinii between kidney transplant recipients. Lancet. 1990 Oct 27;336(8722):1066–1067. doi: 10.1016/0140-6736(90)92534-o. [DOI] [PubMed] [Google Scholar]
  46. Berenguer J., Prieto M., Mir J., Cordoba J., Rayón M. Hepatitis C viral infection after orthotopic liver transplantation. Adv Exp Med Biol. 1994;368:173–179. doi: 10.1007/978-1-4615-1989-8_19. [DOI] [PubMed] [Google Scholar]
  47. Berk M. R., Meyers A. M., Cassal W., Botha J. R., Myburgh J. A. Non-typhoid salmonella infections after renal transplantation. A serious clinical problem. Nephron. 1984;37(3):186–189. doi: 10.1159/000183241. [DOI] [PubMed] [Google Scholar]
  48. Bibashi E., Papagianni A., Kelesidis A., Antoniadou R., Papadimitriou M. Peritonitis due to Aspergillus niger in a patient on continuous ambulatory peritoneal dialysis shortly after kidney graft rejection. Nephrol Dial Transplant. 1993;8(2):185–187. [PubMed] [Google Scholar]
  49. Bisbe J., Vilardell J., Valls M., Moreno A., Brancos M., Andreu J. Transient fungemia and Candida arthritis due to Candida zeylanoides. Eur J Clin Microbiol. 1987 Dec;6(6):668–669. doi: 10.1007/BF02013067. [DOI] [PubMed] [Google Scholar]
  50. Bjøro K., Frøland S. S., Yun Z., Samdal H. H., Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med. 1994 Dec 15;331(24):1607–1611. doi: 10.1056/NEJM199412153312402. [DOI] [PubMed] [Google Scholar]
  51. Blitzer A., Lawson W., Meyers B. R., Biller H. F. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope. 1980 Apr;90(4):635–648. doi: 10.1288/00005537-198004000-00010. [DOI] [PubMed] [Google Scholar]
  52. Blohmé I., Nyberg G., Jeansson S., Svalander C. Adenovirus infection in a renal transplant patient. Transplant Proc. 1992 Feb;24(1):295–295. [PubMed] [Google Scholar]
  53. Bocchi E. A., Bellotti G., Uip D., Kalil J., de Lourdes Higuchi M., Fiorelli A., Stolf N., Jatene A., Pilleggi F. Long-term follow-up after heart transplantation in Chagas' disease. Transplant Proc. 1993 Feb;25(1 Pt 2):1329–1330. [PubMed] [Google Scholar]
  54. Bodey G. P., Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):413–437. doi: 10.1007/BF01964057. [DOI] [PubMed] [Google Scholar]
  55. Bogers A. J., van't Wout J. W., Cats V. M., Quaegebeur J. M., Huysmans H. A. Mediastinal rupture of a thoracoabdominal mycotic aneurysm caused by Salmonella typhimurium in an immunocompromised patient. Eur J Cardiothorac Surg. 1987;1(2):116–118. doi: 10.1016/1010-7940(87)90022-4. [DOI] [PubMed] [Google Scholar]
  56. Boivin G., Erice A., Crane D. D., Dunn D. L., Balfour H. H., Jr Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis. Antimicrob Agents Chemother. 1993 Feb;37(2):357–359. doi: 10.1128/aac.37.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Bolivar R., Satterwhite T. K., Floyd M. Cutaneous lesions due to Mycobacterium kansasii. Arch Dermatol. 1980 Feb;116(2):207–208. [PubMed] [Google Scholar]
  58. Boon A. P., Adams D. H., Buckels J., McMaster P. Cerebral aspergillosis in liver transplantation. J Clin Pathol. 1990 Feb;43(2):114–118. doi: 10.1136/jcp.43.2.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Boon A. P., O'Brien D., Adams D. H. 10 year review of invasive aspergillosis detected at necropsy. J Clin Pathol. 1991 Jun;44(6):452–454. doi: 10.1136/jcp.44.6.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Bortolussi R. A., MacDonald M. R., Bannatyne R. M., Arbus G. S. Treatment of Candida peritonitis by peritoneal lavage with amphotericin B. J Pediatr. 1975 Dec;87(6 Pt 1):987–988. doi: 10.1016/s0022-3476(75)80925-5. [DOI] [PubMed] [Google Scholar]
  61. Boudreaux J. P., Hayes D. H., Mizrahi S., Maggiore P., Blazek J., Dick D. Decreasing incidence of serious cytomegalovirus infection using gancyclovir prophylaxis in pediatric liver transplant patients. Transplant Proc. 1993 Apr;25(2):1872–1872. [PubMed] [Google Scholar]
  62. Bourlond A., Alexandre G. Dermal alternariasis in a kidney transplant recipient. Dermatologica. 1984;168(3):152–156. doi: 10.1159/000249690. [DOI] [PubMed] [Google Scholar]
  63. Bouscarat F., Samuel D., Simon F., Debat P., Bismuth H., Saimot A. G. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis. 1994 Nov;19(5):854–859. doi: 10.1093/clinids/19.5.854. [DOI] [PubMed] [Google Scholar]
  64. Bowen P. A., 2nd, Lobel S. A., Caruana R. J., Leffell M. S., House M. A., Rissing J. P., Humphries A. L. Transmission of human immunodeficiency virus (HIV) by transplantation: clinical aspects and time course analysis of viral antigenemia and antibody production. Ann Intern Med. 1988 Jan;108(1):46–48. doi: 10.7326/0003-4819-108-1-46. [DOI] [PubMed] [Google Scholar]
  65. Boyle E. M., Jr, Burdine J., Bolman R. M., 3rd Successful treatment of Mycoplasma mediastinitis after heart-lung transplantation. J Heart Lung Transplant. 1993 May-Jun;12(3):508–512. [PubMed] [Google Scholar]
  66. Braf Z. F., Altmann G., Ostfeld E. Fungal infections after renal transplantation. Isr J Med Sci. 1976 Jul;12(7):674–677. [PubMed] [Google Scholar]
  67. Branger B., Gouby A., Oulès R., Balducchi J. P., Mourad G., Fourcade J., Mion C., Duntz F., Ramuz M. Mycobacterium haemophilum and mycobacterium xenopi associated infection in a renal transplant patient. Clin Nephrol. 1985 Jan;23(1):46–49. [PubMed] [Google Scholar]
  68. Brayman K. L., Dafoe D. C., Smythe W. R., Barker C. F., Perloff L. J., Naji A., Fox I. J., Grossman R. A., Jorkasky D. K., Starr S. E. Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial. Arch Surg. 1988 Dec;123(12):1502–1508. doi: 10.1001/archsurg.1988.01400360072012. [DOI] [PubMed] [Google Scholar]
  69. Brayman K. L., Stephanian E., Matas A. J., Schmidt W., Payne W. D., Sutherland D. E., Gores P. F., Najarian J. S., Dunn D. L. Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg. 1992 Jan;127(1):38–48. doi: 10.1001/archsurg.1992.01420010044007. [DOI] [PubMed] [Google Scholar]
  70. Breinig M. K., Zitelli B., Starzl T. E., Ho M. Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis. 1987 Aug;156(2):273–279. doi: 10.1093/infdis/156.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Brems J. J., Hiatt J. R., Klein A. S., Hart J., el-Khoury G., Winston D., Millis J. M., Busuttil R. W. Disseminated aspergillosis complicating orthotopic liver transplantation for fulminant hepatic failure refractory to corticosteroid therapy. Transplantation. 1988 Sep;46(3):479–481. doi: 10.1097/00007890-198809000-00038. [DOI] [PubMed] [Google Scholar]
  72. Bren A., Kandus A., Lindic J., Varl J. Fluconazole in the treatment of fungal infections in kidney-transplanted patients. Transplant Proc. 1992 Dec;24(6):2765–2766. [PubMed] [Google Scholar]
  73. Brett M. T., Kwan J. T., Bending M. R. Caecal perforation in a renal transplant patient with disseminated histoplasmosis. J Clin Pathol. 1988 Sep;41(9):992–995. doi: 10.1136/jcp.41.9.992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Britt R. H., Enzmann D. R., Remington J. S. Intracranial infection in cardiac transplant recipients. Ann Neurol. 1981 Feb;9(2):107–119. doi: 10.1002/ana.410090203. [DOI] [PubMed] [Google Scholar]
  75. Britt W., Fay J., Seals J., Kensil C. Formulation of an immunogenic human cytomegalovirus vaccine: responses in mice. J Infect Dis. 1995 Jan;171(1):18–25. doi: 10.1093/infdis/171.1.18. [DOI] [PubMed] [Google Scholar]
  76. Brooks R. G., Hofflin J. M., Jamieson S. W., Stinson E. B., Remington J. S. Infectious complications in heart-lung transplant recipients. Am J Med. 1985 Oct;79(4):412–422. doi: 10.1016/0002-9343(85)90027-0. [DOI] [PubMed] [Google Scholar]
  77. Bubak M. E., Porayko M. K., Krom R. A., Wiesner R. H. Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy. Hepatology. 1991 Dec;14(6):1063–1065. [PubMed] [Google Scholar]
  78. Buffington G. A., Dominguez J. H., Piering W. F., Hebert L. A., Kauffman H. M., Jr, Lemann J., Jr Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA. 1976 Oct 25;236(17):1958–1960. [PubMed] [Google Scholar]
  79. Buhles W. C., Jr, Mastre B. J., Tinker A. J., Strand V., Koretz S. H. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S495–S506. doi: 10.1093/clinids/10.supplement_3.s495. [DOI] [PubMed] [Google Scholar]
  80. Burdelski M., Schmidt K., Hoyer P. F., Bernsau U., Galaske R., Brodehl J., Ringe B., Lauchart W., Wonigeit K., Pichlmayr R. Liver transplantation in children: the Hannover experience. Transplant Proc. 1987 Aug;19(4):3277–3281. [PubMed] [Google Scholar]
  81. Burke E. M., Karp D. L., Wu T. C., Corio R. L. Atypical oral presentation of herpes simplex virus infection in a patient after orthotopic liver transplantation. Eur Arch Otorhinolaryngol. 1994;251(5):301–303. doi: 10.1007/BF00181890. [DOI] [PubMed] [Google Scholar]
  82. Burkhart C. G., Dvorak N., Stockard H. An unusual case of tinea versicolor in an immunosuppressed patient. Cutis. 1981;27(1):56–58. [PubMed] [Google Scholar]
  83. Butka B. J., Bennett S. R., Johnson A. C. Disseminated inoculation blastomycosis in a renal transplant recipient. Am Rev Respir Dis. 1984 Dec;130(6):1180–1183. doi: 10.1164/arrd.1984.130.6.1180. [DOI] [PubMed] [Google Scholar]
  84. Byl B., Jacobs F., Antoine M., Depierreux M., Serruys E., Primo G., Thys J. P. Mediastinitis caused by Aspergillus fumigatus with ruptured aortic pseudoaneurysm in a heart transplant recipient: case study. Heart Lung. 1993 Mar-Apr;22(2):145–147. [PubMed] [Google Scholar]
  85. Byrd B. F., 3rd, Weiner M. H., McGee Z. A. Aspergillus spinal epidural abscess. JAMA. 1982 Dec 17;248(23):3138–3139. [PubMed] [Google Scholar]
  86. Caccamo L., Colledan M., Gridelli B., Rossi G., Doglia M., Gatti S., Ghidoni P., Lucianetti A., Lunghi G., Maggi U. Hepatitis C virus infection in liver allograft recipients. Arch Virol Suppl. 1993;8:291–304. doi: 10.1007/978-3-7091-9312-9_30. [DOI] [PubMed] [Google Scholar]
  87. Cagle P. T., Buffone G., Holland V. A., Samo T., Demmler G. J., Noon G. P., Lawrence E. C. Semiquantitative measurement of cytomegalovirus DNA in lung and heart-lung transplant patients by in vitro DNA amplification. Chest. 1992 Jan;101(1):93–96. doi: 10.1378/chest.101.1.93. [DOI] [PubMed] [Google Scholar]
  88. Carbone K. M., Pennington L. R., Gimenez L. F., Burrow C. R., Watson A. J. Mucormycosis in renal transplant patients--a report of two cases and review of the literature. Q J Med. 1985 Dec;57(224):825–831. [PubMed] [Google Scholar]
  89. Carrier M., Pelletier G. B., Cartier R., Leclerc Y., Pelletier L. C. Prevention of herpes simplex virus infection by oral acyclovir after cardiac transplantation. Can J Surg. 1992 Oct;35(5):513–516. [PubMed] [Google Scholar]
  90. Carter J. M., Green W. R., Callender C. O., Peters B. Pulmonary cavitation with Nocardia and Aspergillus in a renal transplant patient. J Natl Med Assoc. 1990 Jul;82(7):527-8, 530-1. [PMC free article] [PubMed] [Google Scholar]
  91. Castaldo P., Stratta R. J., Wood R. P., Markin R. S., Patil K. D., Shaefer M. S., Langnas A. N., Reed E. C., Li S. J., Pillen T. J. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg. 1991 Feb;126(2):149–156. doi: 10.1001/archsurg.1991.01410260033005. [DOI] [PubMed] [Google Scholar]
  92. Castaldo P., Stratta R. J., Wood R. P., Markin R. S., Patil K. D., Shaefer M. S., Langnas A. N., Reed E. C., Li S., Pillen T. J. Fungal disease in liver transplant recipients: a multivariate analysis of risk factors. Transplant Proc. 1991 Feb;23(1 Pt 2):1517–1519. [PubMed] [Google Scholar]
  93. Castaldo P., Stratta R. J., Wood R. P., Markin R. S., Patil K. D., Shaefer M. S., Langnas A. N., Shaw B. W., Jr Fungal infections in liver allograft recipients. Transplant Proc. 1991 Jun;23(3):1967–1967. [PubMed] [Google Scholar]
  94. Castelli C., Benazzo F., Minoli L., Marone P., Seghezzi R., Carlizzi C. N. Aspergillus infection of the L3-L4 disc space in an immunosuppressed heart transplant patient. Spine (Phila Pa 1976) 1990 Dec;15(12):1369–1373. doi: 10.1097/00007632-199012000-00027. [DOI] [PubMed] [Google Scholar]
  95. Caya J. G., Farmer S. G., Williams G. A., Franson T. R., Komorowski R. A., Kies J. C. Bilateral Pseudallescheria boydii endophthalmitis in an immunocompromised patient. Wis Med J. 1988 Mar;87(3):11–14. [PubMed] [Google Scholar]
  96. Cerrina J., Bavoux E., Le Roy Ladurie F., Herve P., Lafont D., Simonneau G., Dartevelle P. Ganciclovir treatment of cytomegalovirus infection in heart-lung and double-lung transplant recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1174–1175. [PubMed] [Google Scholar]
  97. Chang H., Wu J. D., Cheng K. K., Tseng H. H. Epstein-Barr virus-associated lymphoproliferative disorders in oral cavity after heart transplantation: report of a case. J Formos Med Assoc. 1994 Apr;93(4):332–336. [PubMed] [Google Scholar]
  98. Chang R. S., Lewis J. P., Reynolds R. D., Sullivan M. J., Neuman J. Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts. Ann Intern Med. 1978 Jan;88(1):34–40. doi: 10.7326/0003-4819-88-1-34. [DOI] [PubMed] [Google Scholar]
  99. Chaparro C., Maurer J. R., Chamberlain D., De Hoyos A., Winton T., Westney G., Kesten S. Causes of death in lung transplant recipients. J Heart Lung Transplant. 1994 Sep-Oct;13(5):758–766. [PubMed] [Google Scholar]
  100. Chapman L. E., Folks T. M., Salomon D. R., Patterson A. P., Eggerman T. E., Noguchi P. D. Xenotransplantation and xenogeneic infections. N Engl J Med. 1995 Nov 30;333(22):1498–1501. doi: 10.1056/NEJM199511303332211. [DOI] [PubMed] [Google Scholar]
  101. Chatterjee S. N., Chang R. S. A prospective study of oropharyngeal excretion of Epstein-Barr virus in renal homograft recipients. Scand J Infect Dis. 1982;14(2):95–98. doi: 10.3109/inf.1982.14.issue-2.03. [DOI] [PubMed] [Google Scholar]
  102. Chave J. P., David S., Wauters J. P., Van Melle G., Francioli P. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS. 1991 Aug;5(8):927–932. doi: 10.1097/00002030-199108000-00002. [DOI] [PubMed] [Google Scholar]
  103. Cheeseman S. H., Rubin R. H., Stewart J. A., Tolkoff-Rubin N. E., Cosimi A. B., Cantell K., Gilbert J., Winkle S., Herrin J. T., Black P. H. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med. 1979 Jun 14;300(24):1345–1349. doi: 10.1056/NEJM197906143002401. [DOI] [PubMed] [Google Scholar]
  104. Chou S. W. Cytomegalovirus infection and reinfection transmitted by heart transplantation. J Infect Dis. 1987 May;155(5):1054–1056. doi: 10.1093/infdis/155.5.1054. [DOI] [PubMed] [Google Scholar]
  105. Chugh K. S., Sakhuja V., Jain S., Singh V., Tarafdar A., Joshi K., Gupta K. L., Minz M. Fungal infections in renal allograft recipients. Transplant Proc. 1992 Oct;24(5):1940–1942. [PubMed] [Google Scholar]
  106. Chugh K. S., Sakhuja V., Jain S., Talwar P., Minz M., Joshi K., Indudhara R. High mortality in systemic fungal infections following renal transplantation in third-world countries. Nephrol Dial Transplant. 1993;8(2):168–172. [PubMed] [Google Scholar]
  107. Cofer J. B., Morris C. A., Sutker W. L., Husberg B. S., Goldstein R. M., Gonwa T. A., Klintmalm G. B. A randomized double-blind study of the effect of prophylactic immune globulin on the incidence and severity of CMV infection in the liver transplant recipient. Transplant Proc. 1991 Feb;23(1 Pt 2):1525–1527. [PubMed] [Google Scholar]
  108. Cohen A. T., O'Grady J. G., Sutherland S., Sallie R., Tan K. C., Williams R. Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adults. J Med Virol. 1993 May;40(1):5–9. doi: 10.1002/jmv.1890400103. [DOI] [PubMed] [Google Scholar]
  109. Cohen I. M., Galgiani J. N., Potter D., Ogden D. A. Coccidioidomycosis in renal replacement therapy. Arch Intern Med. 1982 Mar;142(3):489–494. [PubMed] [Google Scholar]
  110. Cohen S. G., Greenberg M. S. Rhinomaxillary mucormycosis in a kidney transplant patient. Oral Surg Oral Med Oral Pathol. 1980 Jul;50(1):33–38. doi: 10.1016/0030-4220(80)90328-x. [DOI] [PubMed] [Google Scholar]
  111. Collins L. A., Samore M. H., Roberts M. S., Luzzati R., Jenkins R. L., Lewis W. D., Karchmer A. W. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis. 1994 Sep;170(3):644–652. [PubMed] [Google Scholar]
  112. Colombo J. L., Sammut P. H., Langnas A. N., Shaw B. W., Jr The spectrum of Pneumocystis carinii infection after liver transplantation in children. Transplantation. 1992 Oct;54(4):621–624. doi: 10.1097/00007890-199210000-00010. [DOI] [PubMed] [Google Scholar]
  113. Colonna J. O., 2nd, Winston D. J., Brill J. E., Goldstein L. I., Hoff M. P., Hiatt J. R., Quinones-Baldrich W., Ramming K. P., Busuttil R. W. Infectious complications in liver transplantation. Arch Surg. 1988 Mar;123(3):360–364. doi: 10.1001/archsurg.1988.01400270094015. [DOI] [PubMed] [Google Scholar]
  114. Conces D. J., Jr, Vix V. A., Tarver R. D. Pleural cryptococcosis. J Thorac Imaging. 1990 Apr;5(2):84–86. doi: 10.1097/00005382-199004000-00012. [DOI] [PubMed] [Google Scholar]
  115. Conti D. J., Freed B. M., Gruber S. A., Lempert N. Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin. Arch Surg. 1994 Apr;129(4):443–447. doi: 10.1001/archsurg.1994.01420280121016. [DOI] [PubMed] [Google Scholar]
  116. Conti D. J., Tolkoff-Rubin N. E., Baker G. P., Jr, Doran M., Cosimi A. B., Delmonico F., Auchincloss H., Jr, Russell P. S., Rubin R. H. Successful treatment of invasive fungal infection with fluconazole in organ transplant recipients. Transplantation. 1989 Oct;48(4):692–695. [PubMed] [Google Scholar]
  117. Cooper D. K., Novitzky D., Schlegel V., Muchmore J. S., Cucchiara A., Zuhdi N. Successful management of symptomatic cytomegalovirus disease with ganciclovir after heart transplantation. J Heart Lung Transplant. 1991 Sep-Oct;10(5 Pt 1):656–663. [PubMed] [Google Scholar]
  118. Cooper J. F., Lichtenstein M. J., Graham B. S., Schaffner W. Mycobacterium chelonae: a cause of nodular skin lesions with a proclivity for renal transplant recipients. Am J Med. 1989 Feb;86(2):173–177. doi: 10.1016/0002-9343(89)90264-7. [DOI] [PubMed] [Google Scholar]
  119. Cortet B., Richard R., Deprez X., Lucet L., Flipo R. M., Le Loët X., Duquesnoy B., Delcambre B. Aspergillus spondylodiscitis: successful conservative treatment in 9 cases. J Rheumatol. 1994 Jul;21(7):1287–1291. [PubMed] [Google Scholar]
  120. Costa J. M., Meyers A. M., Botha J. R., Conlan A. A., Myburgh A. Mycobacterial infections in recipients of kidney allografts. A seventeen-year experience. Acta Med Port. 1988 Jan-Feb;1(1):51–57. [PubMed] [Google Scholar]
  121. Coutts I. I., Jegarajah S., Stark J. E. Tuberculosis in renal transplant recipients. Br J Dis Chest. 1979 Apr;73(2):141–148. [PubMed] [Google Scholar]
  122. Cox K. L., Lawrence-Miyasaki L. S., Garcia-Kennedy R., Lennette E. T., Martinez O. M., Krams S. M., Berquist W. E., So S. K., Esquivel C. O. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation. 1995 Feb 27;59(4):524–529. [PubMed] [Google Scholar]
  123. Crompton C. H., Cheung R. K., Donjon C., Miyazaki I., Feinmesser R., Hébert D., Dosch H. M. Epstein-Barr virus surveillance after renal transplantation. Transplantation. 1994 Apr 27;57(8):1182–1189. doi: 10.1097/00007890-199404270-00008. [DOI] [PubMed] [Google Scholar]
  124. Cruz N., Ramírez-Muxó O., Bermúdez R. H., Santiago-Delpín E. A. Pulmonary infection with M. kansasii in a renal transplant patient. Nephron. 1980;26(4):187–188. doi: 10.1159/000181978. [DOI] [PubMed] [Google Scholar]
  125. Cuende E., Barbadillo C., E-Mazzucchelli R., Isasi C., Trujillo A., Andréu J. L. Candida arthritis in adult patients who are not intravenous drug addicts: report of three cases and review of the literature. Semin Arthritis Rheum. 1993 Feb;22(4):224–241. doi: 10.1016/0049-0172(93)80071-m. [DOI] [PubMed] [Google Scholar]
  126. Cuervas-Mons V., Julio Martinez A., Dekker A., Starzl T. E., Van Thiel D. H. Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology. 1986 May-Jun;6(3):495–501. doi: 10.1002/hep.1840060329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Cuervas-Mons V., Millan I., Gavaler J. S., Starzl T. E., Van Thiel D. H. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology. 1986 Sep-Oct;6(5):922–927. doi: 10.1002/hep.1840060519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. D'Alessandro A. M., Pirsch J. D., Stratta R. J., Sollinger H. W., Kalayoglu M., Belzer F. O. Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients. Transplant Proc. 1989 Jun;21(3):3560–3561. [PubMed] [Google Scholar]
  129. Da Cunha S., Ferreira E., Ramos I., Martins R., De Freitas L., Borges J. L., Côrte-Real R., Mota A., Meliço-Silvestre A., Furtado A. L. Cerebral toxoplasmosis after renal transplantation. Case report and review. Acta Med Port. 1994 Dec;7 (Suppl 1):S61–S66. [PubMed] [Google Scholar]
  130. Daman L. A., Hashimoto K., Kaplan R. J., Trent W. G. Disseminated histoplasmosis in an immunosuppressed patient. South Med J. 1977 Mar;70(3):355–356. doi: 10.1097/00007611-197703000-00031. [DOI] [PubMed] [Google Scholar]
  131. Daoud S., Garnier J. L., Chossegros P., Chevallier P., Dubernard J. M., Touraine J. L. Hepatitis C virus infection in renal transplantation. Transplant Proc. 1995 Apr;27(2):1735–1735. [PubMed] [Google Scholar]
  132. Davies S. F., Sarosi G. A., Peterson P. K., Khan M., Howard R. J., Simmons R. L., Najarian J. S. Disseminated histoplasmosis in renal transplant recipients. Am J Surg. 1979 May;137(5):686–691. doi: 10.1016/0002-9610(79)90050-3. [DOI] [PubMed] [Google Scholar]
  133. Davis B. R., Brumbach J., Sanders W. J., Wolinsky E. Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med. 1982 Nov;97(5):723–724. doi: 10.7326/0003-4819-97-5-723. [DOI] [PubMed] [Google Scholar]
  134. Davis C. L., Gretch D. R., Carithers R. L., Jr Hepatitis B and transplantation. Infect Dis Clin North Am. 1995 Dec;9(4):925–941. [PubMed] [Google Scholar]
  135. Davis C. L., Harrison K. L., McVicar J. P., Forg P. J., Bronner M. P., Marsh C. L. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder. Clin Transplant. 1995 Feb;9(1):53–59. [PubMed] [Google Scholar]
  136. Davis C. L., Springmeyer S., Gmerek B. J. Central nervous system side effects of ganciclovir. N Engl J Med. 1990 Mar 29;322(13):933–934. doi: 10.1056/NEJM199003293221315. [DOI] [PubMed] [Google Scholar]
  137. De Biase L., Venditti M., Gallo P., Macchiarelli A., Tonelli E., Scibilia G., Marino B. Herpes simplex pneumonia in a heart transplant recipient. Recenti Prog Med. 1992 Jun;83(6):341–343. [PubMed] [Google Scholar]
  138. De Vuyst D., Surmont I., Verhaegen J., Vanhaecke J. Tibial osteomyelitis due to Aspergillus flavus in a heart transplant patient. Infection. 1992 Jan-Feb;20(1):48–49. doi: 10.1007/BF01704898. [DOI] [PubMed] [Google Scholar]
  139. DeVault G. A., Jr, Brown S. T., 3rd, Montoya S. F., Jr, King J. W., Rohr M. S., McDonald J. C. Disseminated strongyloidiasis complicating acute renal allograft rejection. Prolonged thiabendazole administration and successful retransplantation. Transplantation. 1982 Oct;34(4):220–221. doi: 10.1097/00007890-198210000-00014. [DOI] [PubMed] [Google Scholar]
  140. DeVault G. A., Jr, King J. W., Rohr M. S., Landreneau M. D., Brown S. T., 3rd, McDonald J. C. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis. 1990 Jul-Aug;12(4):653–671. doi: 10.1093/clinids/12.4.653. [DOI] [PubMed] [Google Scholar]
  141. Delaney V., Sumrani N., Hong J. H., Sommer B. Mycobacterial infections in renal allograft recipients. Transplant Proc. 1993 Jun;25(3):2288–2289. [PubMed] [Google Scholar]
  142. Delgado R., Lumbreras C., Alba C., Pedraza M. A., Otero J. R., Gómez R., Moreno E., Noriega A. R., Payá C. V. Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol. 1992 Jul;30(7):1876–1878. doi: 10.1128/jcm.30.7.1876-1878.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Demetris A. J. Hepatitis B after liver transplantation: new names for unusual presentations. Gastroenterology. 1992 Oct;103(4):1355–1356. doi: 10.1016/0016-5085(92)91528-c. [DOI] [PubMed] [Google Scholar]
  144. Dennis C., Caine N., Sharples L., Smyth R., Higenbottam T., Stewart S., Wreghitt T., Large S., Wells F. C., Wallwork J. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):893–902. [PubMed] [Google Scholar]
  145. Deusch E., End A., Grimm M., Graninger W., Klepetko W., Wolner E. Early bacterial infections in lung transplant recipients. Chest. 1993 Nov;104(5):1412–1416. doi: 10.1378/chest.104.5.1412. [DOI] [PubMed] [Google Scholar]
  146. Dhar J. M., al-Khader A. A., al-Sulaiman M., al-Hasani M. K. Non-typhoid Salmonella in renal transplant recipients: a report of twenty cases and review of the literature. Q J Med. 1991 Mar;78(287):235–250. [PubMed] [Google Scholar]
  147. Dodd L. G., Nelson S. D. Disseminated coccidioidomycosis detected by percutaneous liver biopsy in a liver transplant recipient. Am J Clin Pathol. 1990 Jan;93(1):141–144. doi: 10.1093/ajcp/93.1.141. [DOI] [PubMed] [Google Scholar]
  148. Dooley D. P., Beckius M. L., Jeffery B. S., McAllister C. K., Radentz W. H., Feldman A. R., Rinaldi M. G., Bailey S. R., Keeling J. H. Phaeohyphomycotic cutaneous disease caused by Pleurophoma in a cardiac transplant patient. J Infect Dis. 1989 Mar;159(3):503–507. doi: 10.1093/infdis/159.3.503. [DOI] [PubMed] [Google Scholar]
  149. Dowling J. N., Pasculle A. W., Frola F. N., Zaphyr M. K., Yee R. B. Infections caused by Legionella micdadei and Legionella pneumophila among renal transplant recipients. J Infect Dis. 1984 May;149(5):703–713. doi: 10.1093/infdis/149.5.703. [DOI] [PubMed] [Google Scholar]
  150. Dowling R. D., Baladi N., Zenati M., Dummer J. S., Kormos R. L., Armitage J. M., Yousem S. A., Hardesty R. L., Griffith B. P. Disruption of the aortic anastomosis after heart-lung transplantation. Ann Thorac Surg. 1990 Jan;49(1):118–122. doi: 10.1016/0003-4975(90)90368-g. [DOI] [PubMed] [Google Scholar]
  151. Dreikorn K., Doerr H. W., Geursen R. G. Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG. Scand J Urol Nephrol Suppl. 1985;92:15–21. [PubMed] [Google Scholar]
  152. Dummer J. S., Armstrong J., Somers J., Kusne S., Carpenter B. J., Rosenthal J. T., Ho M. Transmission of infection with herpes simplex virus by renal transplantation. J Infect Dis. 1987 Feb;155(2):202–206. doi: 10.1093/infdis/155.2.202. [DOI] [PubMed] [Google Scholar]
  153. Dummer J. S., Erb S., Breinig M. K., Ho M., Rinaldo C. R., Jr, Gupta P., Ragni M. V., Tzakis A., Makowka L., Van Thiel D. Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation. 1989 Jan;47(1):134–140. doi: 10.1097/00007890-198901000-00030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Dummer J. S., Hardy A., Poorsattar A., Ho M. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation. 1983 Sep;36(3):259–267. doi: 10.1097/00007890-198309000-00007. [DOI] [PubMed] [Google Scholar]
  155. Dummer J. S., Montero C. G., Griffith B. P., Hardesty R. L., Paradis I. L., Ho M. Infections in heart-lung transplant recipients. Transplantation. 1986 Jun;41(6):725–729. doi: 10.1097/00007890-198606000-00012. [DOI] [PubMed] [Google Scholar]
  156. Dummer J. S. Pneumocystis carinii infections in transplant recipients. Semin Respir Infect. 1990 Mar;5(1):50–57. [PubMed] [Google Scholar]
  157. Dummer S., Kusne S. Liver transplantation and related infections. Semin Respir Infect. 1993 Sep;8(3):191–198. [PubMed] [Google Scholar]
  158. Duncan S. R., Grgurich W. F., Iacono A. T., Burckart G. J., Yousem S. A., Paradis I. L., Williams P. A., Johnson B. A., Griffith B. P. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med. 1994 Jul;150(1):146–152. doi: 10.1164/ajrccm.150.1.8025741. [DOI] [PubMed] [Google Scholar]
  159. Duncan S. R., Paradis I. L., Dauber J. H., Yousem S. A., Hardesty R. L., Griffith B. P. Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients. Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1213–1215. doi: 10.1164/ajrccm/146.5_Pt_1.1213. [DOI] [PubMed] [Google Scholar]
  160. Dunn D. L., Gillingham K. J., Kramer M. A., Schmidt W. J., Erice A., Balfour H. H., Jr, Gores P. F., Gruessner R. W., Matas A. J., Payne W. D. A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. Transplantation. 1994 Mar 27;57(6):876–884. doi: 10.1097/00007890-199403270-00019. [DOI] [PubMed] [Google Scholar]
  161. Dunn D. L., Mayoral J. L., Gillingham K. J., Loeffler C. M., Brayman K. L., Kramer M. A., Erice A., Balfour H. H., Jr, Fletcher C. V., Bolman R. M., 3rd Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation. 1991 Jan;51(1):98–106. doi: 10.1097/00007890-199101000-00015. [DOI] [PubMed] [Google Scholar]
  162. Durand F., Bernuau J., Dupont B., Sauvanet A., Belghiti J., Degott C., Benhamou J. P. Aspergillus intraabdominal abscess after liver transplantation successfully treated with itraconazole. Transplantation. 1992 Oct;54(4):734–735. [PubMed] [Google Scholar]
  163. Dussaix E., Wood C. Cytomegalovirus infection in pediatric liver recipients. A virological survey and prophylaxis with CMV immune globulin and early DHPG treatment. Transplantation. 1989 Aug;48(2):272–274. [PubMed] [Google Scholar]
  164. Duston M., McHenry M. C., Braun W. F., Fieker D. H., Gavan T. L., Novick A. C. Cryptococcal meningitis causing fever of unknown origin in renal transplant recipients: report of two cases initially diagnosed by urine cultures. Transplantation. 1981 Oct;32(4):334–336. doi: 10.1097/00007890-198110000-00015. [DOI] [PubMed] [Google Scholar]
  165. Dyall-Smith D., Trowell H., Mark A., Dyall-Smith M. Cutaneous squamous cell carcinomas and papillomaviruses in renal transplant recipients: a clinical and molecular biological study. J Dermatol Sci. 1991 May;2(3):139–146. doi: 10.1016/0923-1811(91)90059-7. [DOI] [PubMed] [Google Scholar]
  166. Einsele H., Ehninger G., Steidle M., Vallbracht A., Müller M., Schmidt H., Saal J. G., Waller H. D., Müller C. A. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet. 1991 Nov 9;338(8776):1170–1172. doi: 10.1016/0140-6736(91)92032-w. [DOI] [PubMed] [Google Scholar]
  167. Eisen H. J., Hicks D., Kant J. A., Montone K. T., Mull R., Pigott J., Tomaszewski J. E. Diagnosis of posttransplantation lymphoproliferative disorder by endomyocardial biopsy in a cardiac allograft recipient. J Heart Lung Transplant. 1994 Mar-Apr;13(2):241–245. [PubMed] [Google Scholar]
  168. Eisenmann D., Knipp H., Laube H., Stegmann T. Prevention of cytomegalovirus disease in heart transplant recipients by prophylaxis with cytomegalovirus hyperimmune globulin plus oral acyclovir. Transplant Proc. 1990 Oct;22(5):2322–2323. [PubMed] [Google Scholar]
  169. Elinder C. G., Andersson J., Bolinder G., Tydén G. Effectiveness of low-dose cotrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and/or pancreas transplantation. Transpl Int. 1992 May;5(2):81–84. doi: 10.1007/BF00339221. [DOI] [PubMed] [Google Scholar]
  170. Elkhammas E. A., Henry M. L., Tesi R. J., Mutabagani K., Bryan B. A., Ferguson R. M. Cytomegalovirus prevention in combined kidney-pancreas transplantation using acyclovir alone. Transplant Proc. 1994 Apr;26(2):436–436. [PubMed] [Google Scholar]
  171. Elkins C. C., Frist W. H., Dummer J. S., Stewart J. R., Merrill W. H., Carden K. A., Bender H. W., Jr Cytomegalovirus disease after heart transplantation: is acyclovir prophylaxis indicated? Ann Thorac Surg. 1993 Dec;56(6):1267–1273. doi: 10.1016/0003-4975(93)90664-4. [DOI] [PubMed] [Google Scholar]
  172. End A., Helbich T., Wisser W., Dekan G., Klepetko W. The pulmonary nodule after lung transplantation. Cause and outcome. Chest. 1995 May;107(5):1317–1322. doi: 10.1378/chest.107.5.1317. [DOI] [PubMed] [Google Scholar]
  173. Erice A., Holm M. A., Gill P. C., Henry S., Dirksen C. L., Dunn D. L., Hillam R. P., Balfour H. H., Jr Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Microbiol. 1992 Nov;30(11):2822–2825. doi: 10.1128/jcm.30.11.2822-2825.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Erice A., Jordan M. C., Chace B. A., Fletcher C., Chinnock B. J., Balfour H. H., Jr Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. JAMA. 1987 Jun 12;257(22):3082–3087. [PubMed] [Google Scholar]
  175. Erice A., Rhame F. S., Heussner R. C., Dunn D. L., Balfour H. H., Jr Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis. 1991 Jul-Aug;13(4):537–547. doi: 10.1093/clinids/13.4.537. [DOI] [PubMed] [Google Scholar]
  176. Erlich K. S., Mills J., Chatis P., Mertz G. J., Busch D. F., Follansbee S. E., Grant R. M., Crumpacker C. S. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1989 Feb 2;320(5):293–296. doi: 10.1056/NEJM198902023200506. [DOI] [PubMed] [Google Scholar]
  177. Esquivel C. O., Jaffe R., Gordon R. D., Iwatsuki S., Shaw B. W., Jr, Starzl T. E. Liver rejection and its differentiation from other causes of graft dysfunction. Semin Liver Dis. 1985 Nov;5(4):369–374. doi: 10.1055/s-2008-1040634. [DOI] [PubMed] [Google Scholar]
  178. Faggian G., Livi U., Bortolotti U., Mazzucco A., Stellin G., Chiominto B., Vivani M. A., Gallucci V. Itraconazole therapy for acute invasive pulmonary aspergillosis in heart transplantation. Transplant Proc. 1989 Feb;21(1 Pt 3):2506–2507. [PubMed] [Google Scholar]
  179. Fairley J. W., Hunt B. J., Glover G. W., Radley-Smith R. C., Yacoub M. H. Unusual lymphoproliferative oropharyngeal lesions in heart and heart-lung transplant recipients. J Laryngol Otol. 1990 Sep;104(9):720–724. doi: 10.1017/s002221510011374x. [DOI] [PubMed] [Google Scholar]
  180. Farr B., Beacham B. E., Atuk N. O. Cutaneous histoplasmosis after renal transplantation. South Med J. 1981 May;74(5):635–637. doi: 10.1097/00007611-198105000-00036. [DOI] [PubMed] [Google Scholar]
  181. Faulds D., Heel R. C. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs. 1990 Apr;39(4):597–638. doi: 10.2165/00003495-199039040-00008. [DOI] [PubMed] [Google Scholar]
  182. Fehir K. M., Decker W. A., Samo T., Young J. B., Lederer E., Lawrence E. C. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation. Transplant Proc. 1989 Feb;21(1 Pt 3):3107–3109. [PubMed] [Google Scholar]
  183. Ferraz A. S., Figueiredo J. F. Transmission of Chagas' disease through transplanted kidney: occurrence of the acute form of the disease in two recipients from the same donor. Rev Inst Med Trop Sao Paulo. 1993 Sep-Oct;35(5):461–463. [PubMed] [Google Scholar]
  184. Ferreiro J. A., Robert M. A., Townsend J., Vinters H. V. Neuropathologic findings after liver transplantation. Acta Neuropathol. 1992;84(1):1–14. doi: 10.1007/BF00427209. [DOI] [PubMed] [Google Scholar]
  185. Finkelstein R., Singer P., Lefler E. Catheter-related fungemia caused by trichosporon beigelii in non-neutropenic patients. Am J Med. 1989 Jan;86(1):133–133. doi: 10.1016/0002-9343(89)90247-7. [DOI] [PubMed] [Google Scholar]
  186. Finn W. F. CMV-enriched immune globulin produces consistent reliable results in renal transplant patients. Transplantation. 1993 Aug;56(2):491–491. doi: 10.1097/00007890-199308000-00052. [DOI] [PubMed] [Google Scholar]
  187. Fisher J., Tuazon C. U., Geelhoed G. W. Mucormycosis in transplant patients. Am Surg. 1980 May;46(5):315–322. [PubMed] [Google Scholar]
  188. Fishman J. A. Pneumocystis carinii and parasitic infections in transplantation. Infect Dis Clin North Am. 1995 Dec;9(4):1005–1044. [PubMed] [Google Scholar]
  189. Flume P. A., Egan T. M., Paradowski L. J., Detterbeck F. C., Thompson J. T., Yankaskas J. R. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med. 1994 Jun;149(6):1601–1607. doi: 10.1164/ajrccm.149.6.7516251. [DOI] [PubMed] [Google Scholar]
  190. Fojtasek M. F., Kelly M. T. Isolation of Mycobacterium chelonei with the lysis-centrifugation blood culture technique. J Clin Microbiol. 1982 Aug;16(2):403–405. doi: 10.1128/jcm.16.2.403-405.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Forbes G. M., Harvey F. A., Philpott-Howard J. N., O'Grady J. G., Jensen R. D., Sahathevan M., Casewell M. W., Williams R. Nocardiosis in liver transplantation: variation in presentation, diagnosis and therapy. J Infect. 1990 Jan;20(1):11–19. doi: 10.1016/s0163-4453(90)92236-e. [DOI] [PubMed] [Google Scholar]
  192. Fowler C. G., Lindsay I., Levin J., Sweny P., Fernando O. N., Moorhead J. F. Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. Br Med J (Clin Res Ed) 1982 Nov 13;285(6352):1394–1394. doi: 10.1136/bmj.285.6352.1394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Fox A. S., Tolpin M. D., Baker A. L., Broelsch C. E., Whittington P. F., Jackson T., Thistlethwaite J. R., Stuart F. P. Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis. 1988 Feb;157(2):383–385. doi: 10.1093/infdis/157.2.383. [DOI] [PubMed] [Google Scholar]
  194. Fox B. C., Sollinger H. W., Belzer F. O., Maki D. G. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med. 1990 Sep;89(3):255–274. doi: 10.1016/0002-9343(90)90337-d. [DOI] [PubMed] [Google Scholar]
  195. Fraser D. W., Buxton A. E., Naji A., Barker C. F., Rudnick M., Weinstein A. J. Disseminated mycobacterium kansasii infection presenting as cellulitis in a recipient of a renal homograft. Am Rev Respir Dis. 1975 Jul;112(1):125–129. doi: 10.1164/arrd.1975.112.1.125. [DOI] [PubMed] [Google Scholar]
  196. Freise C. E., Pons V., Lake J., Burke E., Ascher N. L., Roberts J. P. Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1498–1500. [PubMed] [Google Scholar]
  197. Frey D. J., Matas A. J., Gillingham K. J., Canafax D., Payne W. D., Dunn D. L., Sutherland D. E., Najarian J. S. Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation. 1992 Jul;54(1):50–56. doi: 10.1097/00007890-199207000-00008. [DOI] [PubMed] [Google Scholar]
  198. Frick T., Fryd D. S., Goodale R. L., Simmons R. L., Sutherland D. E., Najarian J. S. Incidence and treatment of candida esophagitis in patients undergoing renal transplantation. Data from the Minnesota prospective randomized trial of cyclosporine versus antilymphocyte globulin-azathioprine. Am J Surg. 1988 Feb;155(2):311–313. doi: 10.1016/s0002-9610(88)80722-0. [DOI] [PubMed] [Google Scholar]
  199. Féray C., Gigou M., Samuel D., Paradis V., Wilber J., David M. F., Urdea M., Reynes M., Bréchot C., Bismuth H. The course of hepatitis C virus infection after liver transplantation. Hepatology. 1994 Nov;20(5):1137–1143. doi: 10.1002/hep.1840200506. [DOI] [PubMed] [Google Scholar]
  200. Gallis H. A., Berman R. A., Cate T. R., Hamilton J. D., Gunnells J. C., Stickel D. L. Fungal infection following renal transplantation. Arch Intern Med. 1975 Sep;135(9):1163–1172. [PubMed] [Google Scholar]
  201. Gane E. J., Portmann B. C., Naoumov N. V., Smith H. M., Underhill J. A., Donaldson P. T., Maertens G., Williams R. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996 Mar 28;334(13):815–820. doi: 10.1056/NEJM199603283341302. [DOI] [PubMed] [Google Scholar]
  202. Garnier J. L., Berger F., Betuel H., Vuillaume M., Chapuis-Cellier C., Blanc N., Faure J. L., Dubernard J. M., Lenoir G., Touraine J. L. Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation. Nephrol Dial Transplant. 1989;4(9):818–823. [PubMed] [Google Scholar]
  203. Gelpi J., Chernoff A., Snydman D., Freeman R. B., Rohrer R. J., Haug C. E. Aspergillus brain abscess after liver transplantation with long-term survival. A case report. Transplantation. 1994 Jun 15;57(11):1669–1672. [PubMed] [Google Scholar]
  204. George D. L., Arnow P. M., Fox A. S., Baker A. L., Thistlethwaite J. R., Emond J. C., Whitington P. F., Broelsch C. E. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis. 1991 May-Jun;13(3):387–396. doi: 10.1093/clinids/13.3.387. [DOI] [PubMed] [Google Scholar]
  205. George D. L., Arnow P. M., Fox A., Thistlethwaite J. R., Emond J. C., Broelsch C. E., Whitington P. F. Patterns of infection after pediatric liver transplantation. Am J Dis Child. 1992 Aug;146(8):924–929. doi: 10.1001/archpedi.1992.02160200046024. [DOI] [PubMed] [Google Scholar]
  206. Gershon A. A. Immunizations for pediatric transplant patients. Kidney Int Suppl. 1993 Oct;43:S87–S90. [PubMed] [Google Scholar]
  207. Glazer J. P., Friedman H. M., Grossman R. A., Starr S. E., Barker C. F., Perloff L. J., Huang E. S., Plotkin S. A. Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial. Ann Intern Med. 1979 Nov;91(5):676–683. doi: 10.7326/0003-4819-91-5-676. [DOI] [PubMed] [Google Scholar]
  208. Glowacki L. S., Smaill F. M. Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis. Clin Transplant. 1994 Feb;8(1):10–18. [PubMed] [Google Scholar]
  209. Goffin E., Pirson Y., Cornu C., Geubel A., Squifflet J. P., van Ypersele de Strihou C. Outcome of HCV infection after renal transplantation. Kidney Int. 1994 Feb;45(2):551–555. doi: 10.1038/ki.1994.71. [DOI] [PubMed] [Google Scholar]
  210. Gombert M. E., Goldstein E. J., Corrado M. L., Stein A. J., Butt K. M. Disseminated Mycobacterium marinum infection after renal transplantation. Ann Intern Med. 1981 Apr;94(4 Pt 1):486–487. doi: 10.7326/0003-4819-94-4-486. [DOI] [PubMed] [Google Scholar]
  211. Goodman J. L. Possible transmission of herpes simplex virus by organ transplantation. Transplantation. 1989 Apr;47(4):609–613. doi: 10.1097/00007890-198904000-00009. [DOI] [PubMed] [Google Scholar]
  212. Gootenberg J. E., Stewart C. L., Vetro S. W., Bellanti J. A. Lack of graft rejection in a renal transplant recipient with AIDS. Ann Allergy. 1991 Aug;67(2 Pt 1):123–125. [PubMed] [Google Scholar]
  213. Gordon S. M., Gal A. A., Hertzler G. L., Bryan J. A., Perlino C., Kanter K. R. Diagnosis of pulmonary toxoplasmosis by bronchoalveolar lavage in cardiac transplant recipients. Diagn Cytopathol. 1993 Dec;9(6):650–654. doi: 10.1002/dc.2840090609. [DOI] [PubMed] [Google Scholar]
  214. Gorensek M. J., Carey W. D., Vogt D., Goormastic M. A multivariate analysis of risk factors for cytomegalovirus infection in liver-transplant recipients. Gastroenterology. 1990 May;98(5 Pt 1):1326–1332. doi: 10.1016/0016-5085(90)90352-2. [DOI] [PubMed] [Google Scholar]
  215. Gorensek M. J., Carey W. D., Washington J. A., 2nd, Vogt D. P., Broughan T. A., Westveer M. K. Selective bowel decontamination with quinolones and nystatin reduces gram-negative and fungal infections in orthotopic liver transplant recipients. Cleve Clin J Med. 1993 Mar-Apr;60(2):139–144. doi: 10.3949/ccjm.60.2.139. [DOI] [PubMed] [Google Scholar]
  216. Gouby A., Branger B., Oules R., Ramuz M. Two cases of Mycobacterium haemophilum infection in a renal-dialysis unit. J Med Microbiol. 1988 Apr;25(4):299–300. doi: 10.1099/00222615-25-4-299. [DOI] [PubMed] [Google Scholar]
  217. Gould F. K., Freeman R., Taylor C. E., Ashcroft T., Dark J. H., Corris P. A. Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center. J Heart Lung Transplant. 1993 Jul-Aug;12(4):695–699. [PubMed] [Google Scholar]
  218. Graham D. A., Kinyoun J. L., George D. P. Endogenous Aspergillus endophthalmitis after lung transplantation. Am J Ophthalmol. 1995 Jan;119(1):107–109. doi: 10.1016/s0002-9394(14)73829-2. [DOI] [PubMed] [Google Scholar]
  219. Granier F., Kanitakis J., Hermier C., Zhu Y. Y., Thivolet J. Localized cutaneous cryptococcosis successfully treated with ketoconazole. J Am Acad Dermatol. 1987 Jan;16(1 Pt 2):243–249. doi: 10.1016/s0190-9622(87)80073-7. [DOI] [PubMed] [Google Scholar]
  220. Grant S. M., Clissold S. P. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs. 1989 Mar;37(3):310–344. doi: 10.2165/00003495-198937030-00003. [DOI] [PubMed] [Google Scholar]
  221. Grattan M. T., Moreno-Cabral C. E., Starnes V. A., Oyer P. E., Stinson E. B., Shumway N. E. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989 Jun 23;261(24):3561–3566. [PubMed] [Google Scholar]
  222. Grauhan O., Lohmann R., Lemmens P., Schattenfroh N., Jonas S., Keck H., Raakow R., Langrehr J., Bechstein W., Blumhardt G. Mycobacterial infection after liver transplantation. Langenbecks Arch Chir. 1995;380(3):171–175. doi: 10.1007/BF00207725. [DOI] [PubMed] [Google Scholar]
  223. Grauhan O., Lohmann R., Lemmens P., Schattenfroh N., Keck H., Klein E., Raakow R., Jonas S., Langrehr J. M., Bechstein W. Fungal infections in liver transplant recipients. Langenbecks Arch Chir. 1994;379(6):372–375. doi: 10.1007/BF00191586. [DOI] [PubMed] [Google Scholar]
  224. Gray J., Wreghitt T. G., Pavel P., Smyth R. L., Parameshwar J., Stewart S., Cary N., Large S., Wallwork J. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact. J Heart Lung Transplant. 1995 Jul-Aug;14(4):640–646. [PubMed] [Google Scholar]
  225. Graybill J. R., Silva J., Jr, Fraser D. W., Lordon R., Rogers E. Disseminated mycobacteriosis due to Mycobacterium abcessus in two recipients of renal homografts. Am Rev Respir Dis. 1974 Jan;109(1):4–10. doi: 10.1164/arrd.1974.109.1.4. [DOI] [PubMed] [Google Scholar]
  226. Green M., Reyes J., Nour B., Beatty D., Kaufman M., Wilson J., Todo S., Tzakis A. Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis. Transplant Proc. 1994 Feb;26(1):173–174. [PubMed] [Google Scholar]
  227. Green M., Shlaes J. H., Barbadora K., Shlaes D. M. Bacteremia due to vancomycin-dependent Enterococcus faecium. Clin Infect Dis. 1995 Mar;20(3):712–714. doi: 10.1093/clinids/20.3.712. [DOI] [PubMed] [Google Scholar]
  228. Green M., Wald E. R., Fricker F. J., Griffith B. P., Trento A. Infections in pediatric orthotopic heart transplant recipients. Pediatr Infect Dis J. 1989 Feb;8(2):87–93. [PubMed] [Google Scholar]
  229. Green M., Wald E. R., Tzakis A., Todo S., Starzl T. E. Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review. Rev Infect Dis. 1991 Jul-Aug;13(4):653–657. doi: 10.1093/clinids/13.4.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Greene N. B., Baughman R. P., Kim C. K., Roselle G. A. Failure of ketoconazole in an immunosuppressed patient with pulmonary blastomycosis. Chest. 1985 Oct;88(4):640–641. doi: 10.1378/chest.88.4.640. [DOI] [PubMed] [Google Scholar]
  231. Grekas D., Alivanis P., Kiriazopoulou V., Dioudis C., Sioulis A., Derveniotis V., Tourkantonis A. Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol. 1993 Nov;31(11):553–556. [PubMed] [Google Scholar]
  232. Gribetz A. R., Chuang M. T., Burrows L., Teirstein A. S. Rhizopus lung abscess in renal transplant patient successfully treated by lobectomy. Chest. 1980 Jan;77(1):102–104. doi: 10.1378/chest.77.1.102. [DOI] [PubMed] [Google Scholar]
  233. Griffith B. P., Bando K., Hardesty R. L., Armitage J. M., Keenan R. J., Pham S. M., Paradis I. L., Yousem S. A., Komatsu K., Konishi H. A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. Transplantation. 1994 Mar 27;57(6):848–851. doi: 10.1097/00007890-199403270-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Grose C., Henle W., Horwitz M. S. Primary Epstein-Barr virus infection in a renal transplant recipient. South Med J. 1977 Nov;70(11):1276–1278. doi: 10.1097/00007611-197711000-00008. [DOI] [PubMed] [Google Scholar]
  235. Grossi P., De Maria R., Caroli A., Zaina M. S., Minoli L. Infections in heart transplant recipients: the experience of the Italian heart transplantation program. Italian Study Group on Infections in Heart Transplantation. J Heart Lung Transplant. 1992 Sep-Oct;11(5):847–866. [PubMed] [Google Scholar]
  236. Grossi P., Ippoliti G. B., Goggi C., Cremaschi P., Scaglia M., Minoli L. Pneumocystis carinii pneumonia in heart transplant recipients. Infection. 1993 Mar-Apr;21(2):75–79. doi: 10.1007/BF01710735. [DOI] [PubMed] [Google Scholar]
  237. Grossi P., Revello M. G., Minoli L., Percivalle E., Zavattoni M., Poma G., Martinelli L., Gerna G. Three-year experience with human cytomegalovirus infections in heart transplant recipients. J Heart Transplant. 1990 Nov-Dec;9(6):712–719. [PubMed] [Google Scholar]
  238. Grundmann R., Wienand P., Runde A., Baldamus C. A., Arns W., Burkhardt U. CMV-Hyperimmunoglobulinprophylaxe nach Nierentransplantation. Ergebnisse einer prospektiv randomisierten Studie. Dtsch Med Wochenschr. 1987 May 22;112(21):827–831. doi: 10.1055/s-2008-1068148. [DOI] [PubMed] [Google Scholar]
  239. Gryzan S., Paradis I. L., Zeevi A., Duquesnoy R. J., Dummer J. S., Griffith B. P., Hardesty R. L., Trento A., Nalesnik M. A., Dauber J. H. Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis. 1988 Jun;137(6):1268–1274. doi: 10.1164/ajrccm/137.6.1268. [DOI] [PubMed] [Google Scholar]
  240. Gudnason T., Belani K. K., Balfour H. H., Jr Ganciclovir treatment of cytomegalovirus disease in immunocompromised children. Pediatr Infect Dis J. 1989 Jul;8(7):436–440. doi: 10.1097/00006454-198907000-00006. [DOI] [PubMed] [Google Scholar]
  241. Guerin C., Pozzetto B., Broyet C., Gaudin O., Berthoux F. Ganciclovir therapy of symptomatic cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant. 1989;4(10):906–910. doi: 10.1093/ndt/4.10.906. [DOI] [PubMed] [Google Scholar]
  242. Guettier C., Hamilton-Dutoit S., Guillemain R., Farge D., Amrein C., Vulser C., Hofman P., Carpentier A., Diebold J. Primary gastrointestinal malignant lymphomas associated with Epstein-Barr virus after heart transplantation. Histopathology. 1992 Jan;20(1):21–28. doi: 10.1111/j.1365-2559.1992.tb00911.x. [DOI] [PubMed] [Google Scholar]
  243. Guillemain R., Lavarde V., Amrein C., Chevalier P., Guinvarc'h A., Glotz D. Invasive aspergillosis after transplantation. Transplant Proc. 1995 Feb;27(1):1307–1309. [PubMed] [Google Scholar]
  244. Gullberg R. M., Quintanilla A., Levin M. L., Williams J., Phair J. P. Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis. 1987 Mar-Apr;9(2):369–375. doi: 10.1093/clinids/9.2.369. [DOI] [PubMed] [Google Scholar]
  245. Gustafson T. L., Schaffner W., Lavely G. B., Stratton C. W., Johnson H. K., Hutcheson R. H., Jr Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis. 1983 Aug;148(2):230–238. doi: 10.1093/infdis/148.2.230. [DOI] [PubMed] [Google Scholar]
  246. HOPE-SIMPSON R. E. THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med. 1965 Jan;58:9–20. [PMC free article] [PubMed] [Google Scholar]
  247. Haagsma E. B., Klompmaker I. J., Grond J., Bijleveld C. M., The T. H., Schirm J., Gips C. H., Slooff M. J. Herpes virus infections after orthotopic liver transplantation. Transplant Proc. 1987 Oct;19(5):4054–4056. [PubMed] [Google Scholar]
  248. Hachisuka H., Matsumoto T., Kusuhara M., Nomura H., Nakano S., Sasai Y. Cutaneous phaeohyphomycosis caused by Exophiala jeanselmei after renal transplantation. Int J Dermatol. 1990 Apr;29(3):198–200. doi: 10.1111/j.1365-4362.1990.tb03799.x. [DOI] [PubMed] [Google Scholar]
  249. Hadley S., Samore M. H., Lewis W. D., Jenkins R. L., Karchmer A. W., Hammer S. M. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation. 1995 Mar 27;59(6):851–859. [PubMed] [Google Scholar]
  250. Haim S., Better O. S., Lichtig C., Erlik D., Barzilai A. Rhinocerebral mucormycosis following kidney transplantation. Isr J Med Sci. 1970 Sep-Oct;6(5):646–649. [PubMed] [Google Scholar]
  251. Hall J. C., Brewer J. H., Crouch T. T., Watson K. R. Cryptococcal cellulitis with multiple sites of involvement. J Am Acad Dermatol. 1987 Aug;17(2 Pt 2):329–332. doi: 10.1016/s0190-9622(87)70206-0. [DOI] [PubMed] [Google Scholar]
  252. Hall J. C., Brewer J. H., Reed W. A., Steinhaus D. M., Watson K. R. Cutaneous mucormycosis in a heart transplant patient. Cutis. 1988 Sep;42(3):183–186. [PubMed] [Google Scholar]
  253. Hall K. A., Copeland J. G., Zukoski C. F., Sethi G. K., Galgiani J. N. Markers of coccidioidomycosis before cardiac or renal transplantation and the risk of recurrent infection. Transplantation. 1993 Jun;55(6):1422–1424. doi: 10.1097/00007890-199306000-00039. [DOI] [PubMed] [Google Scholar]
  254. Hall K. A., Sethi G. K., Rosado L. J., Martinez J. D., Huston C. L., Copeland J. G. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant. 1993 May-Jun;12(3):525–526. [PubMed] [Google Scholar]
  255. Hall W. A., Martinez A. J., Dummer J. S., Griffith B. P., Hardesty R. L., Bahnson H. T., Lunsford L. D. Central nervous system infections in heart and heart-lung transplant recipients. Arch Neurol. 1989 Feb;46(2):173–177. doi: 10.1001/archneur.1989.00520380077017. [DOI] [PubMed] [Google Scholar]
  256. Hall W. A., Martinez A. J., Dummer J. S., Lunsford L. D. Nocardial brain abscess: diagnostic and therapeutic use of stereotactic aspiration. Surg Neurol. 1987 Aug;28(2):114–118. doi: 10.1016/0090-3019(87)90083-8. [DOI] [PubMed] [Google Scholar]
  257. Hamdy N. A., Andrew S. M., Shortland J. R., Boletis J., Raftery A. T., Kanis J. A., Brown C. B. Fatal cardiac zygomycosis in a renal transplant patient treated with desferrioxamine. Nephrol Dial Transplant. 1989;4(10):911–913. doi: 10.1093/ndt/4.10.911. [DOI] [PubMed] [Google Scholar]
  258. Hammer G. S., Bottone E. J., Hirschman S. Z. Mucormycosis in a transplant recipient. Am J Clin Pathol. 1975 Sep;64(3):389–398. doi: 10.1093/ajcp/64.3.389. [DOI] [PubMed] [Google Scholar]
  259. Hanto D. W. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med. 1995;46:381–394. doi: 10.1146/annurev.med.46.1.381. [DOI] [PubMed] [Google Scholar]
  260. Hanto D. W., Frizzera G., Gajl-Peczalska K. J., Sakamoto K., Purtilo D. T., Balfour H. H., Jr, Simmons R. L., Najarian J. S. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med. 1982 Apr 15;306(15):913–918. doi: 10.1056/NEJM198204153061506. [DOI] [PubMed] [Google Scholar]
  261. Hanto D. W., Frizzera G., Purtilo D. T., Sakamoto K., Sullivan J. L., Saemundsen A. K., Klein G., Simmons R. L., Najarian J. S. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res. 1981 Nov;41(11 Pt 1):4253–4261. [PubMed] [Google Scholar]
  262. Haramati L. B., Schulman L. L., Austin J. H. Lung nodules and masses after cardiac transplantation. Radiology. 1993 Aug;188(2):491–497. doi: 10.1148/radiology.188.2.8327703. [DOI] [PubMed] [Google Scholar]
  263. Harbison M. A., De Girolami P. C., Jenkins R. L., Hammer S. M. Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients. Transplantation. 1988 Jul;46(1):82–88. doi: 10.1097/00007890-198807000-00015. [DOI] [PubMed] [Google Scholar]
  264. Hardy A. M., Wajszczuk C. P., Suffredini A. F., Hakala T. R., Ho M. Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. J Infect Dis. 1984 Feb;149(2):143–147. doi: 10.1093/infdis/149.2.143. [DOI] [PubMed] [Google Scholar]
  265. Harland R. C., Vernon W. B., Bunzendahl H., Thompson J. K., Lawrence C., Bollinger R. R. Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients. Transplant Proc. 1994 Apr;26(2):432–433. [PubMed] [Google Scholar]
  266. Harris L. F., Dan B. M., Lefkowitz L. B., Jr, Alford R. H. Paecilomyces cellulitis in a renal transplant patient: successful treatment with intravenous miconazole. South Med J. 1979 Jul;72(7):897–898. doi: 10.1097/00007611-197907000-00046. [DOI] [PubMed] [Google Scholar]
  267. Havel M. P., Laczkovics A. M., Wolner E., Kurz R. W., Popow-Kraupp T. Prophylactic use of hyperimmunoglobulin for cytomegalovirus infection in heart transplantation. Clin Ther. 1989 Jul-Aug;11(4):472–478. [PubMed] [Google Scholar]
  268. Hayes M. J., Torzillo P. J., Sheil A. G., McCaughan G. W. Pneumocystis carinii pneumonia after liver transplantation in adults. Clin Transplant. 1994 Dec;8(6):499–503. [PubMed] [Google Scholar]
  269. Heaton A., Arze R. S., Ward M. K. Acyclovir for life-threatening herpes simplex virus infection after renal transplantation. Lancet. 1981 Oct 17;2(8251):875–875. doi: 10.1016/s0140-6736(81)91140-5. [DOI] [PubMed] [Google Scholar]
  270. Heironimus J. D., Winn R. E., Collins C. B. Cutaneous nonpulmonary Mycobacterium chelonei infection. Successful treatment with sulfonamides in an immunosuppressed patient. Arch Dermatol. 1984 Aug;120(8):1061–1063. doi: 10.1001/archderm.120.8.1061. [DOI] [PubMed] [Google Scholar]
  271. Hellman R. N., Hinrichs J., Sicard G., Hoover R., Golden P., Hoffsten P. Cryptococcal pyelonephritis and disseminated cryptococcosis in a renal transplant recipient. Arch Intern Med. 1981 Jan;141(1):128–130. [PubMed] [Google Scholar]
  272. Henriquez M., Levy R., Raja R. M., Kramer M. S., Rosenbaum J. L. Mucormycosis in a renal transplant recipient with successful outcome. JAMA. 1979 Sep 28;242(13):1397–1399. [PubMed] [Google Scholar]
  273. Hesse U. J., Sutherland D. E., Simmons R. L., Najarian J. S. Intra-abdominal infections in pancreas transplant recipients. Ann Surg. 1986 Feb;203(2):153–162. doi: 10.1097/00000658-198602000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  274. Hibberd P. L., Rubin R. H. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis. 1994 Aug;19 (Suppl 1):S33–S40. doi: 10.1093/clinids/19.supplement_1.s33. [DOI] [PubMed] [Google Scholar]
  275. Hibberd P. L., Tolkoff-Rubin N. E., Conti D., Stuart F., Thistlethwaite J. R., Neylan J. F., Snydman D. R., Freeman R., Lorber M. I., Rubin R. H. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995 Jul 1;123(1):18–26. doi: 10.7326/0003-4819-123-1-199507010-00002. [DOI] [PubMed] [Google Scholar]
  276. Hibberd P. L., Tolkoff-Rubin N. E., Cosimi A. B., Schooley R. T., Isaacson D., Doran M., Delvecchio A., Delmonico F. L., Auchincloss H., Jr, Rubin R. H. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation. 1992 Jan;53(1):68–72. doi: 10.1097/00007890-199201000-00013. [DOI] [PubMed] [Google Scholar]
  277. Higgins R. M., Bloom S. L., Hopkin J. M., Morris P. J. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation. 1989 Mar;47(3):558–560. [PubMed] [Google Scholar]
  278. Higgins R. M., Cahn A. P., Porter D., Richardson A. J., Mitchell R. G., Hopkin J. M., Morris P. J. Mycobacterial infections after renal transplantation. Q J Med. 1991 Feb;78(286):145–153. [PubMed] [Google Scholar]
  279. Hii J. H., Legault L., DeVeber G., Vas S. I. Successful treatment of systemic blastomycosis with high-dose ketoconazole in a renal transplant recipient. Am J Kidney Dis. 1990 Jun;15(6):595–597. doi: 10.1016/s0272-6386(12)80532-4. [DOI] [PubMed] [Google Scholar]
  280. Hirsch M. S., Schooley R. T., Cosimi A. B., Russell P. S., Delmonico F. L., Tolkoff-Rubin N. E., Herrin J. T., Cantell K., Farrell M. L., Rota T. R. Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med. 1983 Jun 23;308(25):1489–1493. doi: 10.1056/NEJM198306233082501. [DOI] [PubMed] [Google Scholar]
  281. Hirsch M. S., Schooley R. T. Resistance to antiviral drugs: the end of innocence. N Engl J Med. 1989 Feb 2;320(5):313–314. doi: 10.1056/NEJM198902023200510. [DOI] [PubMed] [Google Scholar]
  282. Hirschl M. M., Derfler K., Janata O., Heinz G., Sertl K., Balcke P. Accumulation of pneumocystis carinii pneumonia in patients after kidney transplantation. Clin Nephrol. 1992 Feb;37(2):105–105. [PubMed] [Google Scholar]
  283. Hirschmann J. V., Plorde J. J., Ochi R. F. Fever and pulmonary infiltrates in a patient with a renal transplant. West J Med. 1984 Jun;140(6):914–920. [PMC free article] [PubMed] [Google Scholar]
  284. Ho M. Advances in understanding cytomegalovirus infection after transplantation. Transplant Proc. 1994 Oct;26(5 Suppl 1):7–11. [PubMed] [Google Scholar]
  285. Hoepelman I. M., Bakker L. J., Jessurun R. F., Rozenberg-Arska M., Verhoef J. Disseminated Nocardia asteroides infection complicating renal transplantation. Neth J Med. 1987 Oct;31(3-4):175–182. [PubMed] [Google Scholar]
  286. Hofflin J. M., Potasman I., Baldwin J. C., Oyer P. E., Stinson E. B., Remington J. S. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med. 1987 Feb;106(2):209–216. doi: 10.7326/0003-4819-106-2-209. [DOI] [PubMed] [Google Scholar]
  287. Holden F. A., Kaczmer J. E., Kinahan C. C. Listerial meningitis and renal allografts: a life-threatening affinity. Postgrad Med. 1980 Dec;68(6):69–74. doi: 10.1080/00325481.1980.11715622. [DOI] [PubMed] [Google Scholar]
  288. Hoon V., Fasy T. M., Kheiri S., Theise N., Lin C. S., Klion F., Schwartz M., Miller C., Thung S. N. Case report: fatal lymphoproliferative disease seven weeks after liver transplantation. Mt Sinai J Med. 1994 Jan;61(1):72–76. [PubMed] [Google Scholar]
  289. Hopt U. T., Pfeffer F., Schareck W., Büsing M., Ming C. Ganciclovir for prophylaxis of CMV disease after pancreas/kidney transplantation. Transplant Proc. 1994 Apr;26(2):434–435. [PubMed] [Google Scholar]
  290. Hornef M. W., Bein G., Fricke L., Steinhoff J., Wagner H. J., Hinderer W., Sonneborn H. H., Kirchner H. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients. Transplantation. 1995 Sep 15;60(5):474–480. doi: 10.1097/00007890-199509000-00013. [DOI] [PubMed] [Google Scholar]
  291. Horton C. M., Freeman C. D., Nolan P. E., Jr, Copeland J. G., 3rd Cyclosporine interactions with miconazole and other azole-antimycotics: a case report and review of the literature. J Heart Lung Transplant. 1992 Nov-Dec;11(6):1127–1132. [PubMed] [Google Scholar]
  292. Horvath J., Dummer S., Loyd J., Walker B., Merrill W. H., Frist W. H. Infection in the transplanted and native lung after single lung transplantation. Chest. 1993 Sep;104(3):681–685. doi: 10.1378/chest.104.3.681. [DOI] [PubMed] [Google Scholar]
  293. Howard R. J., Simmons R. L., Najarian J. S. Fungal infections in renal transplant recipients. Ann Surg. 1978 Nov;188(5):598–605. doi: 10.1097/00000658-197811000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  294. Hoy W. E., Roberts N. J., Jr, Bryson M. F., Bowles C., Lee J. C., Rivero A. J., Ritterson A. L. Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. JAMA. 1981 Oct 23;246(17):1937–1939. [PubMed] [Google Scholar]
  295. Hrebinko R., Jordan M. L., Dummer J. S., Hickey D. P., Shapiro R., Vivas C., Starzl T. E., Simmons R. L., Hakala T. R. Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1346–1347. [PMC free article] [PubMed] [Google Scholar]
  296. Huang J. Y., Huang C. C., Lai M. K., Chu S. H., Chuang C. K. Salmonella infection in renal transplant recipients. Transplant Proc. 1994 Aug;26(4):2147–2147. [PubMed] [Google Scholar]
  297. Hubscher S. G., Buckels J. A., Elias E., McMaster P., Neuberger J. Vanishing bile-duct syndrome following liver transplantation--is it reversible? Transplantation. 1991 May;51(5):1004–1010. doi: 10.1097/00007890-199105000-00014. [DOI] [PubMed] [Google Scholar]
  298. Hubscher S. G., Williams A., Davison S. M., Young L. S., Niedobitek G. Epstein-Barr virus in inflammatory diseases of the liver and liver allografts: an in situ hybridization study. Hepatology. 1994 Oct;20(4 Pt 1):899–907. doi: 10.1002/hep.1840200419. [DOI] [PubMed] [Google Scholar]
  299. Hummel M., Schüler S., Hempel S., Rees W., Hetzer R. Obstructive bronchial aspergillosis after heart transplantation. Mycoses. 1993 Nov-Dec;36(11-12):425–428. doi: 10.1111/j.1439-0507.1993.tb00733.x. [DOI] [PubMed] [Google Scholar]
  300. Hummel M., Schüler S., Weber U., Schwertlick G., Hempel S., Theiss D., Rees W., Mueller J., Hetzer R. Aspergillosis with Aspergillus osteomyelitis and diskitis after heart transplantation: surgical and medical management. J Heart Lung Transplant. 1993 Jul-Aug;12(4):599–603. [PubMed] [Google Scholar]
  301. Hummel M., Thalmann U., Jautzke G., Staib F., Seibold M., Hetzer R. Fungal infections following heart transplantation. Mycoses. 1992 Jan-Feb;35(1-2):23–34. doi: 10.1111/j.1439-0507.1992.tb00815.x. [DOI] [PubMed] [Google Scholar]
  302. Humphreys H., Marshall R. J., Mackay I., Caul E. O. Pneumonia due to Legionella bozemanii and Chlamydia psittaci/TWAR following renal transplantation. J Infect. 1992 Jul;25(1):67–71. doi: 10.1016/0163-4453(92)93561-4. [DOI] [PubMed] [Google Scholar]
  303. Iacobellis F. W., Jacobs M. I., Cohen R. P. Primary cutaneous cryptococcosis. Arch Dermatol. 1979 Aug;115(8):984–985. [PubMed] [Google Scholar]
  304. Iberer F., Halwachs-Baumann G., Rödl S., Pleisnitzer A., Wasler A., Auer T., Petutschnigg B., Müller H., Tscheliessnigg K., Wilders-Truschnig M. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies. J Heart Lung Transplant. 1994 May-Jun;13(3):405–411. [PubMed] [Google Scholar]
  305. Icenogle T. B., Peterson E., Ray G., Minnich L., Copeland J. G. DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report. J Heart Transplant. 1987 Jul-Aug;6(4):199–203. [PubMed] [Google Scholar]
  306. Indudhara R., Singh S. K., Minz M., Yadav R. V., Chugh K. S. Tuberculous pyomyositis in a renal transplant recipient. Tuber Lung Dis. 1992 Aug;73(4):239–241. doi: 10.1016/0962-8479(92)90093-Y. [DOI] [PubMed] [Google Scholar]
  307. Ingwer I., McLeish K. R., Tight R. R., White A. C. Aspergillus fumigatus epidural abscess in a renal transplant recipient. Arch Intern Med. 1978 Jan;138(1):153–154. [PubMed] [Google Scholar]
  308. Ireton R. C., Krieger J. N., Rudd T. G., Marchioro T. L. Percutaneous endoscopic treatment of fungus ball obstruction in a renal allograft. Transplantation. 1985 Apr;39(4):453–454. [PubMed] [Google Scholar]
  309. Jaccard A., Emile J. F., Metivier F., Clauvel J. P., d'Agay M. F. Epstein-Barr virus-associated Hodgkin's disease following renal transplantation. Am J Hematol. 1994 Jul;46(3):256–257. doi: 10.1002/ajh.2830460329. [DOI] [PubMed] [Google Scholar]
  310. Jacobs F., Byl B., Bourgeois N., Coremans-Pelseneer J., Florquin S., Depré G., Van de Stadt J., Adler M., Gelin M., Thys J. P. Trichoderma viride infection in a liver transplant recipient. Mycoses. 1992 Nov-Dec;35(11-12):301–303. doi: 10.1111/j.1439-0507.1992.tb00880.x. [DOI] [PubMed] [Google Scholar]
  311. Jacobs F., Van de Stadt J., Bourgeois N., Struelens M. J., De Prez C., Adler M., Thys J. P., Gelin M. Severe infections early after liver transplantation. Transplant Proc. 1989 Feb;21(1 Pt 2):2271–2273. [PubMed] [Google Scholar]
  312. Jacobs F., Van de Stadt J., Gelin M., Nonhoff C., Gay F., Adler M., Thys J. P. Mycoplasma hominis infection of perihepatic hematomas in a liver transplant recipient. Surgery. 1992 Jan;111(1):98–100. [PubMed] [Google Scholar]
  313. Jamieson S. W., Stinson E. B., Oyer P. E., Reitz B. A., Baldwin J., Modry D., Dawkins K., Theodore J., Hunt S., Shumway N. E. Heart-lung transplantation for irreversible pulmonary hypertension. Ann Thorac Surg. 1984 Dec;38(6):554–562. doi: 10.1016/s0003-4975(10)62311-9. [DOI] [PubMed] [Google Scholar]
  314. Janner D., Bork J., Baum M., Chinnock R. Severe pneumonia after heart transplantation as a result of human parvovirus B19. J Heart Lung Transplant. 1994 Mar-Apr;13(2):336–338. [PubMed] [Google Scholar]
  315. Jennings H. S., 3rd, Bradsher R. W., McGee Z. A., Johnson H. K., Alford R. H. Acute cryptococcal cellulitis in renal transplant recipients. South Med J. 1981 Sep;74(9):1150–1153. doi: 10.1097/00007611-198109000-00036. [DOI] [PubMed] [Google Scholar]
  316. Jensen W. A., Rose R. M., Hammer S. M., Jenkins R. L., Bothe A., Jr, Benotti P. N., Dzik W. H., Costello P., Khettry U., Trey C. Pulmonary complications of orthotopic liver transplantation. Transplantation. 1986 Nov;42(5):484–490. doi: 10.1097/00007890-198611000-00008. [DOI] [PubMed] [Google Scholar]
  317. Jernigan D. B., Sanders L. I., Waites K. B., Brookings E. S., Benson R. F., Pappas P. G. Pulmonary infection due to Legionella cincinnatiensis in renal transplant recipients: two cases and implications for laboratory diagnosis. Clin Infect Dis. 1994 Mar;18(3):385–389. doi: 10.1093/clinids/18.3.385. [DOI] [PubMed] [Google Scholar]
  318. Johnson B. L. Intraocular and central nervous system lymphoma in a cardiac transplant recipient. Ophthalmology. 1992 Jun;99(6):987–992. doi: 10.1016/s0161-6420(92)31867-6. [DOI] [PubMed] [Google Scholar]
  319. Jordan M. L., Hrebinko R. L., Jr, Dummer J. S., Hickey D. P., Shapiro R., Vivas C. A., Simmons R. L., Starzl T. E., Hakala T. R. Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients. J Urol. 1992 Nov;148(5):1388–1392. doi: 10.1016/s0022-5347(17)36918-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  320. Joshi S. N., Garvin P. J., Sunwoo Y. C. Candidiasis of the duodenum and jejunum. Gastroenterology. 1981 Apr;80(4):829–833. [PubMed] [Google Scholar]
  321. Kaden J., Scholz D., Eichler C., May G. Infektionshäufigkeit mit Zytomegalieviren (CMV) nach Nierentransplantation und erste Erfahrungen mit der CMV-Gammaglobulinprophylaxe. Immun Infekt. 1985 Nov;13(6):290–295. [PubMed] [Google Scholar]
  322. Kaplan A. H., Poza-Juncal E., Shapiro R., Stapleton J. T. Cure of mucormycosis in a renal transplant patient receiving ciclosporin with maintenance of immunosuppression. Am J Nephrol. 1988;8(2):139–142. doi: 10.1159/000167573. [DOI] [PubMed] [Google Scholar]
  323. Kaplan J. E., Zoschke D., Kisch A. L. Withdrawal of immunosuppresive agents in the treatment of disseminated coccidioidomycosis. Am J Med. 1980 Apr;68(4):624–628. doi: 10.1016/0002-9343(80)90316-2. [DOI] [PubMed] [Google Scholar]
  324. Kasiske B. L., Heim-Duthoy K. L., Tortorice K. L., Ney A. L., Odland M. D., Rao K. V. Polyvalent immune globulin and cytomegalovirus infection after renal transplantation. Arch Intern Med. 1989 Dec;149(12):2733–2736. [PubMed] [Google Scholar]
  325. Katz N. M., Pierce P. F., Anzeck R. A., Visner M. S., Canter H. G., Foegh M. L., Pearle D. L., Tracy C., Rahman A. Liposomal amphotericin B for treatment of pulmonary aspergillosis in a heart transplant patient. J Heart Transplant. 1990 Jan-Feb;9(1):14–17. [PubMed] [Google Scholar]
  326. Keane W. M., Potsic W. P., Perloff L. J., Barker C. F., Grossman R. A. Aspergillus thyroiditis. Otolaryngology. 1978 Sep-Oct;86(5):ORL–761-5. doi: 10.1177/019459987808600519. [DOI] [PubMed] [Google Scholar]
  327. Keating M. R. Antiviral agents. Mayo Clin Proc. 1992 Feb;67(2):160–178. doi: 10.1016/s0025-6196(12)61319-6. [DOI] [PubMed] [Google Scholar]
  328. Keay S., Petersen E., Icenogle T., Zeluff B. J., Samo T., Busch D., Newman C. L., Buhles W. C., Jr, Merigan T. C. Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S563–S572. doi: 10.1093/clinids/10.supplement_3.s563. [DOI] [PubMed] [Google Scholar]
  329. Keenan R. J., Konishi H., Kawai A., Paradis I. L., Nunley D. R., Iacono A. T., Hardesty R. L., Weyant R. J., Griffith B. P. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg. 1995 Sep;60(3):580–585. doi: 10.1016/0003-4975(95)00407-C. [DOI] [PubMed] [Google Scholar]
  330. Kendall T. J., Wilson J. E., Radio S. J., Kandolf R., Gulizia J. M., Winters G. L., Costanzo-Nordin M. R., Malcom G. T., Thieszen S. L., Miller L. W. Cytomegalovirus and other herpesviruses: do they have a role in the development of accelerated coronary arterial disease in human heart allografts? J Heart Lung Transplant. 1992 May-Jun;11(3 Pt 2):S14–S20. [PubMed] [Google Scholar]
  331. Khawand N., Light J. A., Brems W., Aquino A., Ali A. Does intravenous immunoglobulin prevent primary cytomegalovirus disease in kidney transplant recipients? Transplant Proc. 1989 Feb;21(1 Pt 2):2072–2074. [PubMed] [Google Scholar]
  332. Kim J. H., Perfect J. R. Infection and cyclosporine. Rev Infect Dis. 1989 Sep-Oct;11(5):677–690. doi: 10.1093/clinids/11.5.677. [DOI] [PubMed] [Google Scholar]
  333. Kinder R. B., Jourdan M. H. Disseminated aspergillosis and bleeding colonic ulcers in renal transplant patient. J R Soc Med. 1985 Apr;78(4):338–339. doi: 10.1177/014107688507800414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  334. King D., Pasarell L., Dixon D. M., McGinnis M. R., Merz W. G. A phaeohyphomycotic cyst and peritonitis caused by Phialemonium species and a reevaluation of its taxonomy. J Clin Microbiol. 1993 Jul;31(7):1804–1810. doi: 10.1128/jcm.31.7.1804-1810.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  335. Kirchhoff L. V. American trypanosomiasis (Chagas' disease)--a tropical disease now in the United States. N Engl J Med. 1993 Aug 26;329(9):639–644. doi: 10.1056/NEJM199308263290909. [DOI] [PubMed] [Google Scholar]
  336. Kirklin J. K., Naftel D. C., Levine T. B., Bourge R. C., Pelletier G. B., O'Donnell J., Miller L. W., Pritzker M. R. Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. The Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1994 May-Jun;13(3):394–404. [PubMed] [Google Scholar]
  337. Kish L. S., Taylor J. S., Bergfeld W. F., Hall G. S. Petriellidium (Allescheria) boydii mycetoma in an immunosuppressed host. Cleve Clin Q. 1983 Summer;50(2):209–211. doi: 10.3949/ccjm.50.2.209. [DOI] [PubMed] [Google Scholar]
  338. Kitai I. C., King S., Gafni A. An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients. Clin Infect Dis. 1993 Sep;17(3):441–447. doi: 10.1093/clinids/17.3.441. [DOI] [PubMed] [Google Scholar]
  339. Kiyasu P. K., Ishitani M. B., McGory R. W., Gaffey M. J., Dickson R. C., Caldwell S. H., Stevenson W. S., Pruett T. L. Prevention of hepatitis B "rerecurrence" after a second liver transplant--the role of maintenance polyclonal HBIG therapy. Transplantation. 1994 Oct 27;58(8):954–956. doi: 10.1097/00007890-199410270-00018. [DOI] [PubMed] [Google Scholar]
  340. Kizilisik T. A., Preiksaitis J. K., Kneteman N. M. Cytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis. Transplant Proc. 1993 Jun;25(3):2282–2283. [PubMed] [Google Scholar]
  341. Klintmalm G., Lönnqvist B., Oberg B., Gahrton G., Lernestedt J. O., Lundgren G., Ringdén O., Robert K. H., Wahren B., Groth C. G. Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scand J Infect Dis. 1985;17(2):157–163. doi: 10.3109/inf.1985.17.issue-2.06. [DOI] [PubMed] [Google Scholar]
  342. Kochhar R., Indudhara R., Nagi B., Yadav R. V., Mehta S. K. Colonic tuberculosis due to atypical mycobacteria in a renal transplant recipient. Am J Gastroenterol. 1988 Dec;83(12):1435–1436. [PubMed] [Google Scholar]
  343. Koizumi J. H., Sommers H. M. Mycobacterium xenopi and pulmonary disease. Am J Clin Pathol. 1980 Jun;73(6):826–830. doi: 10.1093/ajcp/73.6.826. [DOI] [PubMed] [Google Scholar]
  344. Kolbeck P. C., Makhoul R. G., Bollinger R. R., Sanfilippo F. Widely disseminated Cunninghamella mucormycosis in an adult renal transplant patient: case report and review of the literature. Am J Clin Pathol. 1985 Jun;83(6):747–753. doi: 10.1093/ajcp/83.6.747. [DOI] [PubMed] [Google Scholar]
  345. Kong N. C., Shaariah W., Morad Z., Suleiman A. B., Wong Y. H. Cryptococcosis in a renal unit. Aust N Z J Med. 1990 Oct;20(5):645–649. doi: 10.1111/j.1445-5994.1990.tb00393.x. [DOI] [PubMed] [Google Scholar]
  346. Koranda F. C., Dehmel E. M., Kahn G., Penn I. Cutaneous complications in immunosuppressed renal homograft recipients. JAMA. 1974 Jul 22;229(4):419–424. [PubMed] [Google Scholar]
  347. Korvick J. A., Marsh J. W., Starzl T. E., Yu V. L. Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem. Surgery. 1991 Jan;109(1):62–68. [PMC free article] [PubMed] [Google Scholar]
  348. Korvick J., Yu V. L. Simultaneous infection with Cryptococcus neoformans and Legionella pneumophila. In vivo expression of common defects in cell-mediated immunity. Respiration. 1988;53(2):132–136. doi: 10.1159/000195405. [DOI] [PubMed] [Google Scholar]
  349. Kovacs J. A., Ng V. L., Masur H., Leoung G., Hadley W. K., Evans G., Lane H. C., Ognibene F. P., Shelhamer J., Parrillo J. E. Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med. 1988 Mar 10;318(10):589–593. doi: 10.1056/NEJM198803103181001. [DOI] [PubMed] [Google Scholar]
  350. Kovarik J., Mayer G., Pohanka E., Schwarz M., Traindl O., Graf H., Smolen J. Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections. Transplantation. 1988 Feb;45(2):402–405. doi: 10.1097/00007890-198802000-00031. [DOI] [PubMed] [Google Scholar]
  351. Kramer M. R., Denning D. W., Marshall S. E., Ross D. J., Berry G., Lewiston N. J., Stevens D. A., Theodore J. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):552–556. doi: 10.1164/ajrccm/144.3_Pt_1.552. [DOI] [PubMed] [Google Scholar]
  352. Kramer M. R., Marshall S. E., Denning D. W., Keogh A. M., Tucker R. M., Galgiani J. N., Lewiston N. J., Stevens D. A., Theodore J. Cyclosporine and itraconazole interaction in heart and lung transplant recipients. Ann Intern Med. 1990 Aug 15;113(4):327–329. doi: 10.7326/0003-4819-113-4-327. [DOI] [PubMed] [Google Scholar]
  353. Kramer M. R., Marshall S. E., Starnes V. A., Gamberg P., Amitai Z., Theodore J. Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch Intern Med. 1993 Sep 13;153(17):2010–2016. [PubMed] [Google Scholar]
  354. Kramer M. R., Stoehr C., Lewiston N. J., Starnes V. A., Theodore J. Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation--how effective and for how long? Transplantation. 1992 Mar;53(3):586–589. doi: 10.1097/00007890-199203000-00019. [DOI] [PubMed] [Google Scholar]
  355. Kramer P., Prins M. E., Kapsenberg J. G., Bornkamm G. W., Bijnen A. B., Rohol P. J., van der Heul R. O., Jeekel J., Weimar W. Persistent Epstein-Barr virus infection and a histiocytic sarcoma in a renal transplant recipient. Cancer. 1985 Feb 1;55(3):503–509. doi: 10.1002/1097-0142(19850201)55:3<503::aid-cncr2820550305>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  356. Kramer P., ten Kate F. W., Bijnen A. B., Jeekel J., Weimar W. Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet. 1984 May 5;1(8384):989–990. doi: 10.1016/s0140-6736(84)92327-4. [DOI] [PubMed] [Google Scholar]
  357. Krom R. A., Kingma L. M., Haagsma E. B., Wesenhagen H., Slooff M. J., Gips C. H. Choledochocholedochostomy, a relatively safe procedure in orthotopic liver transplantation. Surgery. 1985 May;97(5):552–556. [PubMed] [Google Scholar]
  358. Kumar P., Pearson J. E., Martin D. H., Leech S. H., Buisseret P. D., Bezbak H. C., Gonzalez F. M., Royer J. R., Streicher H. Z., Saxinger W. C. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Ann Intern Med. 1987 Feb;106(2):244–245. doi: 10.7326/0003-4819-106-2-244. [DOI] [PubMed] [Google Scholar]
  359. Kumar S., Trivedi H. L., Smith E. K. Letter: Rhinocerebral mucormycosis in a renal transplant patient. J Oral Surg. 1976 Jul;34(7):583–583. [PubMed] [Google Scholar]
  360. Kusne S., Dummer J. S., Singh N., Iwatsuki S., Makowka L., Esquivel C., Tzakis A. G., Starzl T. E., Ho M. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988 Mar;67(2):132–143. doi: 10.1097/00005792-198803000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  361. Kusne S., Schwartz M., Breinig M. K., Dummer J. S., Lee R. E., Selby R., Starzl T. E., Simmons R. L., Ho M. Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis. 1991 May;163(5):1001–1007. doi: 10.1093/infdis/163.5.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  362. Kusne S., Tobin D., Pasculle A. W., Van Thiel D. H., Ho M., Starzl T. E. Candida carriage in the alimentary tract of liver transplant candidates. Transplantation. 1994 Feb;57(3):398–402. doi: 10.1097/00007890-199402150-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  363. Kusne S., Torre-Cisneros J., Mañez R., Irish W., Martin M., Fung J., Simmons R. L., Starzl T. E. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis. 1992 Dec;166(6):1379–1383. doi: 10.1093/infdis/166.6.1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  364. Laghi F., Yeldandi V., McCabe M., Garrity E. R., Jr Common infections complicating lung transplantation. N J Med. 1993 Apr;90(4):317–319. [PubMed] [Google Scholar]
  365. Lakshiminarayan S., Sahn S. A. Tuberculosis in a patient after renal transplantation. Tubercle. 1973 Mar;54(1):72–76. doi: 10.1016/0041-3879(73)90017-2. [DOI] [PubMed] [Google Scholar]
  366. Lang P., Buisson C., Rostoker G., Ben Maadi A., Fruchaud G., Deforge L., Chopin D., Abbou C., Romano P., Fleury J. DHPG treatment of kidney transplant recipients with severe CMV infection. Transplant Proc. 1989 Feb;21(1 Pt 2):2084–2086. [PubMed] [Google Scholar]
  367. Langhoff E., Madsen S. Rapid metabolism of cyclosporin and prednisone in kidney transplant patients on tuberculostatic treatment. Lancet. 1983 Dec 3;2(8362):1303–1303. doi: 10.1016/s0140-6736(83)91174-1. [DOI] [PubMed] [Google Scholar]
  368. Langlois R. P., Flegel K. M., Meakins J. L., Morehouse D. D., Robson H. G., Guttmann R. D. Cutaneous aspergillosis with fatal dissemination in a renal transplant recipient. Can Med Assoc J. 1980 Mar 22;122(6):673–676. [PMC free article] [PubMed] [Google Scholar]
  369. Langnas A. N., Markin R. S., Cattral M. S., Naides S. J. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology. 1995 Dec;22(6):1661–1665. [PubMed] [Google Scholar]
  370. Laske A., Gallino A., Mohacsi P., Bauer E. P., Carrel T., von Segesser L. K., Turina M. I. Prophylactic treatment with ganciclovir for cytomegalovirus infection in heart transplantation. Transplant Proc. 1991 Feb;23(1 Pt 2):1170–1173. [PubMed] [Google Scholar]
  371. Lautenschlager I., Ahonen J., Eklund B., Höckerstedt K., Salmela K., Isoniemi H., Korsbäck C., Suni J., Häyry P. Hyperimmune globulin therapy of clinical CMV disease in renal allograft recipients. Transplant Proc. 1989 Feb;21(1 Pt 2):2087–2088. [PubMed] [Google Scholar]
  372. Lazarovits A. I., Tibbles L. A., Grant D. R., Ghent C. N., Wall W. J., White M. J., Joncas J. H. Anti-B cell antibodies for the treatment of monoclonal Epstein-Barr virus-induced lymphoproliferative syndrome after multivisceral transplantation. Clin Invest Med. 1994 Dec;17(6):621–625. [PubMed] [Google Scholar]
  373. Le Conte P., Blanloeil Y., Michel P., Francois T., Paineau J. Cutaneous aspergillosis in a patient with orthotopic hepatic transplantation. Transplantation. 1992 May;53(5):1153–1154. [PubMed] [Google Scholar]
  374. Le Saux N. M., Sekla L., McLeod J., Parker S., Rush D., Jeffery J. R., Brunham R. C. Epidemic of nosocomial Legionnaires' disease in renal transplant recipients: a case-control and environmental study. CMAJ. 1989 May 1;140(9):1047–1053. [PMC free article] [PubMed] [Google Scholar]
  375. Leapman S. B., Rosenberg J. B., Filo R. S., Smith E. J. Strongyloides stercoralis in chronic renal failure: safe therapy with thiabendazole. South Med J. 1980 Oct;73(10):1400–1402. doi: 10.1097/00007611-198010000-00034. [DOI] [PubMed] [Google Scholar]
  376. Lecatsas G. Papillomavirus in urine in pregnancy and following renal transplantation. Prog Clin Biol Res. 1983;105:143–148. [PubMed] [Google Scholar]
  377. Lee E. S., Locker J., Nalesnik M., Reyes J., Jaffe R., Alashari M., Nour B., Tzakis A., Dickman P. S. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med. 1995 Jan 5;332(1):19–25. doi: 10.1056/NEJM199501053320104. [DOI] [PubMed] [Google Scholar]
  378. Lee J. Y. Cytomegalovirus infection involving the skin in immunocompromised hosts. A clinicopathologic study. Am J Clin Pathol. 1989 Jul;92(1):96–100. doi: 10.1093/ajcp/92.1.96. [DOI] [PubMed] [Google Scholar]
  379. Leff R. D., Smith E. J., Aldo-Benson M. A., Aronoff G. R. Cryptococcal arthritis after renal transplantation. South Med J. 1981 Oct;74(10):1290–1290. doi: 10.1097/00007611-198110000-00046. [DOI] [PubMed] [Google Scholar]
  380. Legendre C., Ducloux D., Ferroni A., Chkoff N., Valette C., Geffrier C., Rouzioux C., Kreis H. Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: a case-controlled study. Transplant Proc. 1993 Feb;25(1 Pt 2):1431–1433. [PubMed] [Google Scholar]
  381. Leiguarda R., Roncoroni A., Taratuto A. L., Jost L., Berthier M., Nogues M., Freilij H. Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients. Neurology. 1990 May;40(5):850–851. doi: 10.1212/wnl.40.5.850. [DOI] [PubMed] [Google Scholar]
  382. Libow L. F., Beltrani V. P., Silvers D. N., Grossman M. E. Post-cardiac transplant reactivation of Chagas' disease diagnosed by skin biopsy. Cutis. 1991 Jul;48(1):37–40. [PubMed] [Google Scholar]
  383. Lichtenstein I. H., MacGregor R. R. Mycobacterial infections in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis. 1983 Mar-Apr;5(2):216–226. doi: 10.1093/clinids/5.2.216. [DOI] [PubMed] [Google Scholar]
  384. Linnemann C. C., Jr, First M. R., Schiffman G. Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med. 1981 Nov;141(12):1637–1640. [PubMed] [Google Scholar]
  385. Lipman M. C., Pillay D., Squire S. B., Sweny P., Johnson M. A. HIV infection in a long-term renal transplant recipient. Int J STD AIDS. 1995 Mar-Apr;6(2):121–122. doi: 10.1177/095646249500600212. [DOI] [PubMed] [Google Scholar]
  386. Livas I. C., Nechay P. S., Nauseef W. M. Clinical evidence of spinal and cerebral histoplasmosis twenty years after renal transplantation. Clin Infect Dis. 1995 Mar;20(3):692–695. doi: 10.1093/clinids/20.3.692. [DOI] [PubMed] [Google Scholar]
  387. Lloveras J., Peterson P. K., Simmons R. L., Najarian J. S. Mycobacterial infections in renal transplant recipients. Seven cases and a review of the literature. Arch Intern Med. 1982 May;142(5):888–892. [PubMed] [Google Scholar]
  388. Locke T. J., Odom N. J., Tapson J. S., Freeman R., McGregor C. G. Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation. J Heart Transplant. 1987 Mar-Apr;6(2):120–122. [PubMed] [Google Scholar]
  389. Lones M. A., Mishalani S., Shintaku I. P., Weiss L. M., Nichols W. S., Said J. W. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring. Hum Pathol. 1995 May;26(5):525–530. doi: 10.1016/0046-8177(95)90248-1. [DOI] [PubMed] [Google Scholar]
  390. Loria K. M., Salinger M. H., Frohlich T. G., Gendelman M. D., Cook F. V., Arentzen C. E. Primary cutaneous aspergillosis in a heart transplant recipient treated with surgical excision and oral itraconazole. J Heart Lung Transplant. 1992 Jan-Feb;11(1 Pt 1):156–159. [PubMed] [Google Scholar]
  391. Luby J. P., Ramirez-Ronda C., Rinner S., Hull A., Vergne-Marini P. A longitudinal study of varicella-zoster virus infections in renal transplant recipients. J Infect Dis. 1977 Apr;135(4):659–663. doi: 10.1093/infdis/135.4.659. [DOI] [PubMed] [Google Scholar]
  392. Lugo-Janer G. J., Pedraza R., Morales Otero L. A., González Z. A., Muñiz A., Sánchez J., Santiago-Delpín E. A. Superficial mycosis in renal transplant recipients. Transplant Proc. 1991 Apr;23(2):1787–1788. [PubMed] [Google Scholar]
  393. Lui S. F., Ali A. A., Grundy J. E., Fernando O. N., Griffiths P. D., Sweny P. Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant. 1992;7(12):1230–1237. doi: 10.1093/ndt/7.12.1230. [DOI] [PubMed] [Google Scholar]
  394. Lumbreras C., Fernandez I., Velosa J., Munn S., Sterioff S., Paya C. V. Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome. Clin Infect Dis. 1995 Mar;20(3):514–520. doi: 10.1093/clinids/20.3.514. [DOI] [PubMed] [Google Scholar]
  395. Lumbreras C., Lizasoain M., Moreno E., Aguado J. M., Gomez R., Garcia I., Gonzalez I., Loinaz C., Cisneros C., Noriega A. R. Major bacterial infections following liver transplantation: a prospective study. Hepatogastroenterology. 1992 Aug;39(4):362–365. [PubMed] [Google Scholar]
  396. Lumbreras C., Otero J. R., Herrero J. A., Gomez R., Lizasoain M., Aguado J. M., Colina F., Garcia I., Moreno E., Noriega A. R. Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies. Antimicrob Agents Chemother. 1993 Nov;37(11):2490–2492. doi: 10.1128/aac.37.11.2490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  397. Lynfield R., Herrin J. T., Rubin R. H. Varicella in pediatric renal transplant recipients. Pediatrics. 1992 Aug;90(2 Pt 1):216–220. [PubMed] [Google Scholar]
  398. MacDonald A. S., Belitsky P., Cohen A., Lee S. Cytomegalovirus disease prophylaxis in seronegative recipients of kidneys from seropositive donors by combination of cytomegalovirus-hyperimmune globulin and low-dose acyclovir. Transplant Proc. 1991 Feb;23(1 Pt 2):1355–1356. [PubMed] [Google Scholar]
  399. Mai M., Nery J., Sutker W., Husberg B., Klintmalm G., Gonwa T. DHPG (Gancyclovir) improves survival in CMV pneumonia. Transplant Proc. 1989 Feb;21(1 Pt 2):2263–2265. [PubMed] [Google Scholar]
  400. Maki D. G., Fox B. C., Kuntz J., Sollinger H. W., Belzer F. O. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine. J Lab Clin Med. 1992 Jan;119(1):11–24. [PubMed] [Google Scholar]
  401. Mancini M. C., McGinnis M. R. Dactylaria infection of a human being: pulmonary disease in a heart transplant recipient. J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 1):827–830. [PubMed] [Google Scholar]
  402. Maple P. A., McKee T., Desselberger U., Wreghitt T. G. Hepatitis C virus infections in transplant patients: serological and virological investigations. J Med Virol. 1994 Sep;44(1):43–48. doi: 10.1002/jmv.1890440109. [DOI] [PubMed] [Google Scholar]
  403. Marchevsky A. M., Bottone E. J., Geller S. A., Giger D. K. The changing spectrum of disease, etiology, and diagnosis of mucormycosis. Hum Pathol. 1980 Sep;11(5):457–464. doi: 10.1016/s0046-8177(80)80054-2. [DOI] [PubMed] [Google Scholar]
  404. Marker S. C., Simmons R. L., Balfour H. H., Jr Cytomegalovirus vaccine in renal allograft recipients. Transplant Proc. 1981 Mar;13(1 Pt 1):117–119. [PubMed] [Google Scholar]
  405. Markin R. S., Langnas A. N., Donovan J. P., Zetterman R. K., Stratta R. J. Opportunistic viral hepatitis in liver transplant recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1520–1521. [PubMed] [Google Scholar]
  406. Martin-Santos J. M., Alonso-Pulpon L., Pradas G., Cuervas-Mons V., Anguita M., Mulero-Mendoza J., Escribano E., Martinez-Beltran J., Figuera-Aymerich D. Septic arthritis by Salmonella enteritidis after heart transplantation. J Heart Transplant. 1987 May-Jun;6(3):177–179. [PubMed] [Google Scholar]
  407. Martin M., Kusne S., Alessiani M., Simmons R., Starzl T. E. Infections after liver transplantation: risk factors and prevention. Transplant Proc. 1991 Jun;23(3):1929–1930. [PMC free article] [PubMed] [Google Scholar]
  408. Martin M., Mañez R., Linden P., Estores D., Torre-Cisneros J., Kusne S., Ondick L., Ptachcinski R., Irish W., Kisor D. A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation. 1994 Oct 15;58(7):779–785. doi: 10.1097/00007890-199410150-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  409. Martineau G., Porter K. A., Corman J., Launois B., Schroter G. T., Palmer W., Putnam C. W., Groth C. G., Halgrimson C. G., Penn I. Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery. 1972 Oct;72(4):604–610. [PMC free article] [PubMed] [Google Scholar]
  410. Martinez A. J., Ahdab-Barmada M. The neuropathology of liver transplantation: comparison of main complications in children and adults. Mod Pathol. 1993 Jan;6(1):25–32. [PubMed] [Google Scholar]
  411. Marzano A., Smedile A., Abate M., Ottobrelli A., Brunetto M., Negro F., Farci P., Durazzo M., David E., Lagget M. Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence. J Hepatol. 1994 Dec;21(6):961–965. doi: 10.1016/s0168-8278(05)80602-6. [DOI] [PubMed] [Google Scholar]
  412. Mauch T. J., Crouch N. A., Freese D. K., Braunlin E. A., Dunn D. L., Kashtan C. E. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr. 1995 Dec;127(6):957–960. doi: 10.1016/s0022-3476(95)70037-4. [DOI] [PubMed] [Google Scholar]
  413. Maurer J. R., Snell G., deHoyos A., Kesten S., Winton T. Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens. Transplant Proc. 1993 Feb;25(1 Pt 2):1434–1435. [PubMed] [Google Scholar]
  414. Maurer J. R., Tullis D. E., Grossman R. F., Vellend H., Winton T. L., Patterson G. A. Infectious complications following isolated lung transplantation. Chest. 1992 Apr;101(4):1056–1059. doi: 10.1378/chest.101.4.1056. [DOI] [PubMed] [Google Scholar]
  415. Mayer J. M., Nimer L., Carroll K. Isolated pulmonary aspergillar infection in cardiac transplant recipients: case report and review. Clin Infect Dis. 1992 Oct;15(4):698–700. doi: 10.1093/clind/15.4.698. [DOI] [PubMed] [Google Scholar]
  416. Mayers D. L., Martone W. J., Mandell G. L. Cutaneous cryptococcosis mimicking gram-positive cellulitis in a renal transplant patient. South Med J. 1981 Aug;74(8):1032–1033. doi: 10.1097/00007611-198108000-00051. [DOI] [PubMed] [Google Scholar]
  417. McAllister W. A., Thompson P. J., Al-Habet S. M., Rogers H. J. Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) 1983 Mar 19;286(6369):923–925. doi: 10.1136/bmj.286.6369.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  418. McCarthy J. M., McLoughlin M. G., Shackleton C. R., Cameron E. C., Yeung C. K., Jones E. C., Keown P. A. Cytomegalovirus epididymitis following renal transplantation. J Urol. 1991 Aug;146(2):417–419. doi: 10.1016/s0022-5347(17)37811-4. [DOI] [PubMed] [Google Scholar]
  419. McCaughan G. W., McDonald J. A., Davies S., Painter D. M. Clinicopathological approach to human liver allograft dysfunction. J Gastroenterol Hepatol. 1989 Sep-Oct;4(5):467–477. doi: 10.1111/j.1440-1746.1989.tb01744.x. [DOI] [PubMed] [Google Scholar]
  420. McCormick W. F., Schochet S. S., Jr, Sarles H. E., Calverley J. R. Progressive multifocal leukoencephalopathy in renal transplant recipients. Arch Intern Med. 1976 Jul;136(7):829–834. [PubMed] [Google Scholar]
  421. McDougall J. C., Vigneswaran W. T., Peters S. G., Marshall W. T., McGregor C. G. Fungal infection of the contralateral native lung after single-lung transplantation. Ann Thorac Surg. 1993 Jul;56(1):176–178. doi: 10.1016/0003-4975(93)90433-i. [DOI] [PubMed] [Google Scholar]
  422. McGregor C. G., Daly R. C., Peters S. G., Midthun D. E., Scott J. P., Allen M. S., Tazelaar H. D., Keating M. R., Walker R. C., McDougall J. C. Evolving strategies in lung transplantation for emphysema. Ann Thorac Surg. 1994 Jun;57(6):1513–1521. doi: 10.1016/0003-4975(94)90111-2. [DOI] [PubMed] [Google Scholar]
  423. McGregor R. S., Zitelli B. J., Urbach A. H., Malatack J. J., Gartner J. C., Jr Varicella in pediatric orthotopic liver transplant recipients. Pediatrics. 1989 Feb;83(2):256–261. [PubMed] [Google Scholar]
  424. McLeish K. R., McMurray S. D., Smith E. J., Filo R. S. The transmission of Candida albicans by cadaveric allografts. J Urol. 1977 Oct;118(4):513–516. doi: 10.1016/s0022-5347(17)58089-1. [DOI] [PubMed] [Google Scholar]
  425. McNeil M. M., Brown J. M., Magruder C. H., Shearlock K. T., Saul R. A., Allred D. P., Ajello L. Disseminated Nocardia transvalensis infection: an unusual opportunistic pathogen in severely immunocompromised patients. J Infect Dis. 1992 Jan;165(1):175–178. doi: 10.1093/infdis/165.1.175. [DOI] [PubMed] [Google Scholar]
  426. Megison S. M., Andrews W. S. Combination therapy with ganciclovir and intravenous IgG for cytomegalovirus infections in pediatric liver transplant recipients. Transplantation. 1991 Jul;52(1):151–154. [PubMed] [Google Scholar]
  427. Merigan T. C., Renlund D. G., Keay S., Bristow M. R., Starnes V., O'Connell J. B., Resta S., Dunn D., Gamberg P., Ratkovec R. M. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med. 1992 Apr 30;326(18):1182–1186. doi: 10.1056/NEJM199204303261803. [DOI] [PubMed] [Google Scholar]
  428. Metselaar H. J., Balk A. H., Mochtar B., Rothbarth P. H., Weimar W. Cytomegalovirus seronegative heart transplant recipients. Prophylactic use of anti-CMV immunoglobulin. Chest. 1990 Feb;97(2):396–399. doi: 10.1378/chest.97.2.396. [DOI] [PubMed] [Google Scholar]
  429. Metselaar H. J., Rothbarth P. H., Brouwer R. M., Wenting G. J., Jeekel J., Weimar W. Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejection. Transplantation. 1989 Aug;48(2):264–266. doi: 10.1097/00007890-198908000-00016. [DOI] [PubMed] [Google Scholar]
  430. Mezo A., Jennis F., McCarthy S. W., Dawson D. J. Unusual mycobacteria in 5 cases of opportunistic infections. Pathology. 1979 Jul;11(3):377–384. doi: 10.3109/00313027909059014. [DOI] [PubMed] [Google Scholar]
  431. Michaels M. G., Wald E. R., Fricker F. J., del Nido P. J., Armitage J. Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis. 1992 Apr;14(4):847–851. doi: 10.1093/clinids/14.4.847. [DOI] [PubMed] [Google Scholar]
  432. Milbradt H., Flik J., Stangel W., Heigel R. Bedeutung der Untersuchung auf Antikörper gegen Cytomegalievirus bei Organtransplantationen. Beitr Infusionsther. 1990;26:33–36. [PubMed] [Google Scholar]
  433. Mirza S. H. Disseminated Trichosporon beigelii infection causing skin lesions in a renal transplant patient. J Infect. 1993 Jul;27(1):67–70. doi: 10.1016/0163-4453(93)93838-u. [DOI] [PubMed] [Google Scholar]
  434. Mishima T., Kobayashi Y., Ohkubo M., Marumo F., Yoshimura H. A case of renal transplant recipient complicated with cryptococcosis and amphotericin B induced acute tubular necrosis. Jpn Circ J. 1977 Sep;41(9):1009–1013. doi: 10.1253/jcj.41.1009. [DOI] [PubMed] [Google Scholar]
  435. Mocelin A. J., Brandina L., Gordan P. A., Baldy J. L., Chieffi P. P. Immunosuppression and circulating Trypanosoma cruzi in a kidney transplant recipient. Transplantation. 1977 Feb;23(2):163–163. doi: 10.1097/00007890-197702000-00011. [DOI] [PubMed] [Google Scholar]
  436. Modry D. L., Stinson E. B., Oyer P. E., Jamieson S. W., Baldwin J. C., Shumway N. E. Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rifampin. Transplantation. 1985 Mar;39(3):313–314. doi: 10.1097/00007890-198503000-00022. [DOI] [PubMed] [Google Scholar]
  437. Mollison L. C., Richards M. J., Johnson P. D., Hayes K., Munckhof W. J., Jones R. M., Dabkowski P. D., Angus P. W. High-dose oral acyclovir reduces the incidence of cytomegalovirus infection in liver transplant recipients. J Infect Dis. 1993 Sep;168(3):721–724. doi: 10.1093/infdis/168.3.721. [DOI] [PubMed] [Google Scholar]
  438. Monteforte J. S., Wood C. A. Pneumonia caused by Nocardia nova and Aspergillus fumigatus after cardiac transplantation. Eur J Clin Microbiol Infect Dis. 1993 Feb;12(2):112–114. doi: 10.1007/BF01967585. [DOI] [PubMed] [Google Scholar]
  439. Mora N. P., Cofer J. B., Solomon H., Goldstein R. M., Gonwa T. A., Husberg B. S., Klintmalm G. B. Analysis of severe infections (INF) after 180 consecutive liver transplants: the impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections. Transplant Proc. 1991 Feb;23(1 Pt 2):1528–1530. [PubMed] [Google Scholar]
  440. Mora N. P., Klintmalm G., Solomon H., Goldstein R. M., Gonwa T. A., Husberg B. S. Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant. Transplant Proc. 1992 Feb;24(1):154–155. [PubMed] [Google Scholar]
  441. Morales L. A., González Z. A., Santiago-Delpín E. A. Chromoblastomycosis in a renal transplant patient. Nephron. 1985;40(2):238–240. doi: 10.1159/000183468. [DOI] [PubMed] [Google Scholar]
  442. Morduchowicz G., Pitlik S. D., Shapira Z., Shmueli D., Yussim A., Djalovski S., Rosenfeld J. B. Infections in renal transplant recipients in Israel. Isr J Med Sci. 1985 Oct;21(10):791–797. [PubMed] [Google Scholar]
  443. Morgan J. S., Schaffner W., Stone W. J. Opportunistic strongyloidiasis in renal transplant recipients. Transplantation. 1986 Nov;42(5):518–524. doi: 10.1097/00007890-198611000-00016. [DOI] [PubMed] [Google Scholar]
  444. Moulsdale M., Harper J. M., Thatcher G. N. Unusual mycobacterium infection in a renal transplant recipient. Med J Aust. 1980 Oct 18;2(8):450–451. doi: 10.5694/j.1326-5377.1980.tb131920.x. [DOI] [PubMed] [Google Scholar]
  445. Mourad G., Soulillou J. P., Chong G., Pouliquen M., Hourmant M., Mion C. Transmission of Mycobacterium tuberculosis with renal allografts. Nephron. 1985;41(1):82–85. doi: 10.1159/000183552. [DOI] [PubMed] [Google Scholar]
  446. Mulligan D. C., Goldstein R. M., Crippin J. S., Abouljoud M. S., Levy M. F., Husberg B. S., Gonwa T. A., Foster B. R., Tillery G. W., Klintmalm G. B. Use of anti-hepatitis C virus seropositive organs in liver transplantation. Transplant Proc. 1995 Feb;27(1):1204–1205. [PubMed] [Google Scholar]
  447. Murdoch M. E., Leigh I. M. Sporotrichoid spread of cutaneous Mycobacterium chelonei infection. Clin Exp Dermatol. 1989 Jul;14(4):309–312. doi: 10.1111/j.1365-2230.1989.tb01990.x. [DOI] [PubMed] [Google Scholar]
  448. Murray-Leisure K. A., Aber R. C., Rowley L. J., Applebaum P. C., Wisman C. B., Pennock J. L., Pierce W. S. Disseminated Trichosporon beigelii (cutaneum) infection in an artificial heart recipient. JAMA. 1986 Dec 5;256(21):2995–2998. [PubMed] [Google Scholar]
  449. Murray H. W., Moore J. O., Luff R. D. Disseminated aspergillosis in a renal transplant patient: Diagnostic difficulties re-emphasized. Johns Hopkins Med J. 1975 Nov;137(5):235–237. [PubMed] [Google Scholar]
  450. Nadasdy T., Park C. S., Peiper S. C., Wenzl J. E., Oates J., Silva F. G. Epstein-Barr virus infection-associated renal disease: diagnostic use of molecular hybridization technology in patients with negative serology. J Am Soc Nephrol. 1992 Jun;2(12):1734–1742. doi: 10.1681/ASN.V2121734. [DOI] [PubMed] [Google Scholar]
  451. Naidoff M. A., Green W. R. Endogenous Aspergillus endophthalmitis occurring after kidney transplant. Am J Ophthalmol. 1975 Mar;79(3):502–509. doi: 10.1016/0002-9394(75)90628-5. [DOI] [PubMed] [Google Scholar]
  452. Nakazato P. Z., Burns W., Moore P., Garcia-Kennedy R., Cox K., Esquivel C. Viral prophylaxis in hepatic transplantation: preliminary report of a randomized trial of acyclovir and gancyclovir. Transplant Proc. 1993 Apr;25(2):1935–1937. [PubMed] [Google Scholar]
  453. Nalesnik M. A., Jaffe R., Starzl T. E., Demetris A. J., Porter K., Burnham J. A., Makowka L., Ho M., Locker J. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. 1988 Oct;133(1):173–192. [PMC free article] [PubMed] [Google Scholar]
  454. Nathan S. D., Ross D. J., Zakowski P., Kass R. M., Koerner S. K. Utility of inhaled pentamidine prophylaxis in lung transplant recipients. Chest. 1994 Feb;105(2):417–420. doi: 10.1378/chest.105.2.417. [DOI] [PubMed] [Google Scholar]
  455. Natås O. B., Willassen Y. Lung infection caused by Nocardia asteroides in a renal-transplant patient. Scand J Infect Dis. 1983;15(3):317–320. doi: 10.3109/inf.1983.15.issue-3.14. [DOI] [PubMed] [Google Scholar]
  456. Neeley S. P., Denning D. W. Cutaneous Mycobacterium thermoresistibile infection in a heart transplant recipient. Rev Infect Dis. 1989 Jul-Aug;11(4):608–611. doi: 10.1093/clinids/11.4.608. [DOI] [PubMed] [Google Scholar]
  457. Nemec D. K., Lederer E. D., Samo T. Candidal splenic abscess in a renal transplant patient. Am J Kidney Dis. 1989 Nov;14(5):408–411. doi: 10.1016/s0272-6386(89)80175-1. [DOI] [PubMed] [Google Scholar]
  458. Ness M. J., Markin R. S., Wood R. P., Shaw B. W., Jr, Woods G. L. Disseminated Trichosporon beigelii infection after orthotopic liver transplantation. Am J Clin Pathol. 1989 Jul;92(1):119–123. doi: 10.1093/ajcp/92.1.119. [DOI] [PubMed] [Google Scholar]
  459. Nicholson M. L., Veitch P. S., Donnelly P. K., Bell P. R. Systemic candidiasis caused by a renal transplant ureteric stent. Br J Urol. 1992 Oct;70(4):448–449. doi: 10.1111/j.1464-410x.1992.tb15810.x. [DOI] [PubMed] [Google Scholar]
  460. Nicholson M. L., Veitch P. S., Donnelly P. K., Flower A. J., Bell P. R. Treatment of renal transplant-associated cytomegalovirus infection with ganciclovir. Transplant Proc. 1990 Aug;22(4):1811–1812. [PubMed] [Google Scholar]
  461. Nicol D. L., MacDonald A. S., Belitsky P., Lee S., Cohen A. D., Bitter-Suermann H., Lowen J., Whalen A. Reduction by combination prophylactic therapy with CMV hyperimmune globulin and acyclovir of the risk of primary CMV disease in renal transplant recipients. Transplantation. 1993 Apr;55(4):841–846. doi: 10.1097/00007890-199304000-00030. [DOI] [PubMed] [Google Scholar]
  462. Niklasson P. M., Hambraeus A., Lundgren G., Magnusson G., Sundelin P., Groth C. G. Listeria encephalitis in five renal transplant recipients. Acta Med Scand. 1978;203(3):181–185. doi: 10.1111/j.0954-6820.1978.tb14853.x. [DOI] [PubMed] [Google Scholar]
  463. Nordén G., Björck S., Persson H., Svalander C., Li X. G., Edebo L. Cure of zygomycosis caused by a lipase-producing Rhizopus rhizopodiformis strain in a renal transplant patient. Scand J Infect Dis. 1991;23(3):377–382. doi: 10.3109/00365549109024326. [DOI] [PubMed] [Google Scholar]
  464. Novick R. J., Moreno-Cabral C. E., Stinson E. B., Oyer P. E., Starnes V. A., Hunt S. A., Shumway N. E. Nontuberculous mycobacterial infections in heart transplant recipients: a seventeen-year experience. J Heart Transplant. 1990 Jul-Aug;9(4):357–363. [PubMed] [Google Scholar]
  465. O'Grady J. G., Alexander G. J., Sutherland S., Donaldson P. T., Harvey F., Portmann B., Calne R. Y., Williams R. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet. 1988 Aug 6;2(8606):302–305. doi: 10.1016/s0140-6736(88)92356-2. [DOI] [PubMed] [Google Scholar]
  466. O'Hair D. P., Johnson C. P., Roza A. M., Adams M. B. Treatment of transplant rejection in the presence of cytomegalovirus viremia. Transplant Proc. 1990 Aug;22(4):1815–1817. [PubMed] [Google Scholar]
  467. Oaks T. E., Pae W. E., Pennock J. L., Myers J. L., Pierce W. S. Aortic rupture caused by fungal aortitis: successful management after heart transplantation. J Heart Transplant. 1988 Mar-Apr;7(2):162–164. [PubMed] [Google Scholar]
  468. Offermann G., Keller F., Molzahn M. Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment. Am J Nephrol. 1985;5(5):385–387. doi: 10.1159/000166968. [DOI] [PubMed] [Google Scholar]
  469. Ogunbiyi O. A., Scholefield J. H., Raftery A. T., Smith J. H., Duffy S., Sharp F., Rogers K. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg. 1994 Mar;81(3):365–367. doi: 10.1002/bjs.1800810313. [DOI] [PubMed] [Google Scholar]
  470. Oliver W. A. Tuberculosis in renal transplant patients. Med J Aust. 1976 May 29;1(22):828–829. doi: 10.5694/j.1326-5377.1976.tb141091.x. [DOI] [PubMed] [Google Scholar]
  471. Orr K. E., Gould F. K., Short G., Dark J. H., Hilton C. J., Corris P. A., Freeman R. Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. J Infect. 1994 Nov;29(3):249–253. doi: 10.1016/s0163-4453(94)91082-0. [DOI] [PubMed] [Google Scholar]
  472. Owens N. J., Nightingale C. H., Schweizer R. T., Schauer P. K., Dekker P. T., Quintiliani R. Prophylaxis of oral candidiasis with clotrimazole troches. Arch Intern Med. 1984 Feb;144(2):290–293. [PubMed] [Google Scholar]
  473. Palazzo J. P., Lundquist K., Mitchell D., Mittal K. R., Hann H. W., Munoz S., Moritz M. J., Jacobs J. M., Martin P. Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis. Am J Gastroenterol. 1993 Jan;88(1):102–104. [PubMed] [Google Scholar]
  474. Palestine A. G. Clinical aspects of cytomegalovirus retinitis. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S515–S521. doi: 10.1093/clinids/10.supplement_3.s515. [DOI] [PubMed] [Google Scholar]
  475. Palmer B. F., Hernandez J., Sagalowsky A., Dawidson I., Helderman J. H. Documentation of fungal pyelonephritis of the renal allograft by fine needle aspiration cytology. Transplant Proc. 1989 Aug;21(4):3598–3599. [PubMed] [Google Scholar]
  476. Pan S. H., Rosenthal P., Howard T. K., Podesta L. G., Sher L., Makowka L. Evaluation of three cytomegalovirus infection prophylactic regimens in liver transplant recipients. Transplant Proc. 1992 Aug;24(4):1466–1467. [PubMed] [Google Scholar]
  477. Paradis I. L., Williams P. Infection after lung transplantation. Semin Respir Infect. 1993 Sep;8(3):207–215. [PubMed] [Google Scholar]
  478. Pass R. F., Long W. K., Whitley R. J., Soong S. J., Diethelm A. G., Reynolds D. W., Alford C. A., Jr Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: role of source of kidney. J Infect Dis. 1978 May;137(5):556–563. doi: 10.1093/infdis/137.5.556. [DOI] [PubMed] [Google Scholar]
  479. Pass R. F., Whitley R. J., Whelchel J. D., Diethelm A. G., Reynolds D. W., Alford C. A. Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J Infect Dis. 1979 Oct;140(4):487–492. doi: 10.1093/infdis/140.4.487. [DOI] [PubMed] [Google Scholar]
  480. Patel R., Cockerill F. R., Porayko M. K., Osmon D. R., Ilstrup D. M., Keating M. R. Lactobacillemia in liver transplant patients. Clin Infect Dis. 1994 Feb;18(2):207–212. doi: 10.1093/clinids/18.2.207. [DOI] [PubMed] [Google Scholar]
  481. Patel R., Gustaferro C. A., Krom R. A., Wiesner R. H., Roberts G. D., Paya C. V. Phaeohyphomycosis due to Scopulariopsis brumptii in a liver transplant recipient. Clin Infect Dis. 1994 Jul;19(1):198–200. doi: 10.1093/clinids/19.1.198. [DOI] [PubMed] [Google Scholar]
  482. Patel R., Klein D. W., Espy M. J., Harmsen W. S., Ilstrup D. M., Paya C. V., Smith T. F. Optimization of detection of cytomegalovirus viremia in transplantation recipients by shell vial assay. J Clin Microbiol. 1995 Nov;33(11):2984–2986. doi: 10.1128/jcm.33.11.2984-2986.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  483. Patel R., Roberts G. D., Keating M. R., Paya C. V. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis. 1994 Aug;19(2):263–273. doi: 10.1093/clinids/19.2.263. [DOI] [PubMed] [Google Scholar]
  484. Patel R., Smith T. F., Espy M., Portela D., Wiesner R. H., Krom R. A., Paya C. V. A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis. 1995 Apr;171(4):1010–1014. doi: 10.1093/infdis/171.4.1010. [DOI] [PubMed] [Google Scholar]
  485. Patel R., Smith T. F., Espy M., Wiesner R. H., Krom R. A., Portela D., Paya C. V. Detection of cytomegalovirus DNA in sera of liver transplant recipients. J Clin Microbiol. 1994 Jun;32(6):1431–1434. doi: 10.1128/jcm.32.6.1431-1434.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  486. Patel S. R., Kirby T. J., McCarthy P. M., Meeker D. P., Stillwell P., Rice T. W., Kavuru M. S., Mehta A. C. Lung transplantation: the Cleveland Clinic experience. Cleve Clin J Med. 1993 Jul-Aug;60(4):303–319. doi: 10.3949/ccjm.60.4.303. [DOI] [PubMed] [Google Scholar]
  487. Patterson J. W., Broecker A. H., Kornstein M. J., Mills A. S. Cutaneous cytomegalovirus infection in a liver transplant patient. Diagnosis by in situ DNA hybridization. Am J Dermatopathol. 1988 Dec;10(6):524–530. doi: 10.1097/00000372-198812000-00009. [DOI] [PubMed] [Google Scholar]
  488. Patterson T. F., Andriole V. T., Zervos M. J., Therasse D., Kauffman C. A. The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses. 1990 Jun;33(6):297–302. [PubMed] [Google Scholar]
  489. Paya C. V. Fungal infections in solid-organ transplantation. Clin Infect Dis. 1993 May;16(5):677–688. doi: 10.1093/clind/16.5.677. [DOI] [PubMed] [Google Scholar]
  490. Paya C. V., Hermans P. E. Bacterial infections after liver transplantation. Eur J Clin Microbiol Infect Dis. 1989 Jun;8(6):499–504. doi: 10.1007/BF01967467. [DOI] [PubMed] [Google Scholar]
  491. Paya C. V., Hermans P. E., Smith T. F., Rakela J., Wiesner R. H., Krom R. A., Torres V. E., Sterioff S., Wilkowske C. J. Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection. Transplantation. 1988 Aug;46(2):229–234. doi: 10.1097/00007890-198808000-00008. [DOI] [PubMed] [Google Scholar]
  492. Paya C. V., Hermans P. E., Washington J. A., 2nd, Smith T. F., Anhalt J. P., Wiesner R. H., Krom R. A. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc. 1989 May;64(5):555–564. doi: 10.1016/s0025-6196(12)65561-x. [DOI] [PubMed] [Google Scholar]
  493. Paya C. V., Hermans P. E., Wiesner R. H., Ludwig J., Smith T. F., Rakela J., Krom R. A. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis. 1989 Nov;160(5):752–758. doi: 10.1093/infdis/160.5.752. [DOI] [PubMed] [Google Scholar]
  494. Paya C. V., Marin E., Keating M., Dickson R., Porayko M., Wiesner R. Solid organ transplantation: results and implications of acyclovir use in liver transplants. J Med Virol. 1993;Suppl 1:123–127. doi: 10.1002/jmv.1890410524. [DOI] [PubMed] [Google Scholar]
  495. Paya C. V., Smith T. F., Ludwig J., Hermans P. E. Rapid shell vial culture and tissue histology compared with serology for the rapid diagnosis of cytomegalovirus infection in liver transplantation. Mayo Clin Proc. 1989 Jun;64(6):670–675. doi: 10.1016/s0025-6196(12)65346-4. [DOI] [PubMed] [Google Scholar]
  496. Paya C. V., Wiesner R. H., Hermans P. E., Larson-Keller J. J., Ilstrup D. M., Krom R. A., Moore S. B., Ludwig J., Smith T. F. Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation. Hepatology. 1992 Jul;16(1):66–70. doi: 10.1002/hep.1840160113. [DOI] [PubMed] [Google Scholar]
  497. Paya C. V., Wiesner R. H., Hermans P. E., Larson-Keller J. J., Ilstrup D. M., Krom R. A., Rettke S., Smith T. F. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. J Hepatol. 1993 Jun;18(2):185–195. doi: 10.1016/s0168-8278(05)80245-4. [DOI] [PubMed] [Google Scholar]
  498. Pehlivanoğlu E., Ament M. E., Spolidoro J. V., Vargas J., Busuttil R., Berquist W. E. Severe cytomegalovirus infection and immunosuppressive therapy in pediatric liver transplantation. Turk J Pediatr. 1990 Jan-Mar;32(1):3–11. [PubMed] [Google Scholar]
  499. Perandones C. E., Roncoroni A. J., Frega N. S., Bianchini H. M., Hübscher O. Mycobacterium gastri arthritis: septic arthritis due to Mycobacterium gastri in a patient with a renal transplant. J Rheumatol. 1991 May;18(5):777–778. [PubMed] [Google Scholar]
  500. Pereira B. J. Hepatitis C in organ transplantation: its significance and influence on transplantation policies. Curr Opin Nephrol Hypertens. 1993 Nov;2(6):912–922. doi: 10.1097/00041552-199311000-00009. [DOI] [PubMed] [Google Scholar]
  501. Pereira B. J., Milford E. L., Kirkman R. L., Levey A. S. Transmission of hepatitis C virus by organ transplantation. N Engl J Med. 1991 Aug 15;325(7):454–460. doi: 10.1056/NEJM199108153250702. [DOI] [PubMed] [Google Scholar]
  502. Perfect J. R., Durack D. T., Gallis H. A. Cryptococcemia. Medicine (Baltimore) 1983 Mar;62(2):98–109. doi: 10.1097/00005792-198303000-00003. [DOI] [PubMed] [Google Scholar]
  503. Perschak H., Gubler J., Speich R., Russi E. Pulmonary nocardiosis concurrent with Pneumocystis carinii pneumonia in two patients undergoing immunosuppressive therapy. J Infect. 1991 Sep;23(2):183–185. doi: 10.1016/0163-4453(91)92219-u. [DOI] [PubMed] [Google Scholar]
  504. Peters C., Peterson P., Marabella P., Simmons R. L., Najarian J. S. Continuous sulfa prophylaxis for urinary tract infection in renal transplant recipients. Am J Surg. 1983 Nov;146(5):589–593. doi: 10.1016/0002-9610(83)90294-5. [DOI] [PubMed] [Google Scholar]
  505. Peterson P. K., Dahl M. V., Howard R. J., Simmons R. L., Najarian J. S. Mucormycosis and cutaneous histoplasmosis in a renal transplant recipient. Arch Dermatol. 1982 Apr;118(4):275–277. [PubMed] [Google Scholar]
  506. Pettersson E., Hovi T., Ahonen J., Fiddian A. P., Salmela K., Höckerstedt K., Eklund B., von Willebrand E., Häyry P. Prophylactic oral acyclovir after renal transplantation. Transplantation. 1985 Mar;39(3):279–281. doi: 10.1097/00007890-198503000-00014. [DOI] [PubMed] [Google Scholar]
  507. Pirsch J. D., Armbrust M. J., Stratta R. J., D'Alessandro A. M., Sollinger H. W., Belzer F. O., Kalayoglu M., Maki D. G. Perioperative infection in liver transplant recipients under a quadruple immunosuppressive protocol. Transplant Proc. 1989 Jun;21(3):3559–3559. [PubMed] [Google Scholar]
  508. Plotkin S. A., Huang E. S. Cytomegalovirus vaccine virus (Towne strain) does not induce latency. J Infect Dis. 1985 Aug;152(2):395–397. doi: 10.1093/infdis/152.2.395. [DOI] [PubMed] [Google Scholar]
  509. Plotkin S. A., Smiley M. L., Friedman H. M., Starr S. E., Fleisher G. R., Wlodaver C., Dafoe D. C., Friedman A. D., Grossman R. A., Barker C. F. Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet. 1984 Mar 10;1(8376):528–530. doi: 10.1016/s0140-6736(84)90930-9. [DOI] [PubMed] [Google Scholar]
  510. Plotkin S. A., Starr S. E., Friedman H. M., Brayman K., Harris S., Jackson S., Tustin N. B., Grossman R., Dafoe D., Barker C. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann Intern Med. 1991 Apr 1;114(7):525–531. doi: 10.7326/0003-4819-114-7-525. [DOI] [PubMed] [Google Scholar]
  511. Pluemecke G., Williams J., Elliott D., Paul L. C. Renal transplant artery rupture secondary to candida infection. Nephron. 1992;61(1):98–101. doi: 10.1159/000186843. [DOI] [PubMed] [Google Scholar]
  512. Plá M. P., Berenguer J., Arzuaga J. A., Bañares R., Polo J. R., Bouza E. Surgical wound infection by Aspergillus fumigatus in liver transplant recipients. Diagn Microbiol Infect Dis. 1992 Nov-Dec;15(8):703–706. doi: 10.1016/0732-8893(92)90074-4. [DOI] [PubMed] [Google Scholar]
  513. Polo J. M., Fábrega E., Casafont F., Fariñas M. C., Salesa R., Vázquez A., Berciano J. Treatment of cerebral aspergillosis after liver transplantation. Neurology. 1992 Sep;42(9):1817–1819. doi: 10.1212/wnl.42.9.1817. [DOI] [PubMed] [Google Scholar]
  514. Portela D., Patel R., Larson-Keller J. J., Ilstrup D. M., Wiesner R. H., Steers J. L., Krom R. A., Paya C. V. OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation. J Infect Dis. 1995 Apr;171(4):1014–1018. doi: 10.1093/infdis/171.4.1014. [DOI] [PubMed] [Google Scholar]
  515. Power C., Poland S. D., Kassim K. H., Kaufmann J. C., Rice G. P. Encephalopathy in liver transplantation: neuropathology and CMV infection. Can J Neurol Sci. 1990 Nov;17(4):378–381. doi: 10.1017/s0317167100030912. [DOI] [PubMed] [Google Scholar]
  516. Prayson R. A., Estes M. L. The neuropathology of cardiac allograft transplantation. An autopsy series of 18 patients. Arch Pathol Lab Med. 1995 Jan;119(1):59–63. [PubMed] [Google Scholar]
  517. Preiksaitis J. K., Diaz-Mitoma F., Mirzayans F., Roberts S., Tyrrell D. L. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. J Infect Dis. 1992 Nov;166(5):986–994. doi: 10.1093/infdis/166.5.986. [DOI] [PubMed] [Google Scholar]
  518. Prian G. W., Koep L. J. Elimination of cytomegalovirus disease in liver transplant patients treated prophylactically with combination cytomegalovirus hyperimmune globulin and ganciclovir. Transplant Proc. 1994 Oct;26(5 Suppl 1):54–55. [PubMed] [Google Scholar]
  519. Proca E., Popescu A. Tuberculous cerebral abscess 8 years after renal transplantation. Br J Urol. 1991 Aug;68(2):205–205. doi: 10.1111/j.1464-410x.1991.tb15298.x. [DOI] [PubMed] [Google Scholar]
  520. Prodinger W. M., Bonatti H., Allerberger F., Wewalka G., Harrison T. G., Aichberger C., Dierich M. P., Margreiter R., Tiefenbrunner F. Legionella pneumonia in transplant recipients: a cluster of cases of eight years' duration. J Hosp Infect. 1994 Mar;26(3):191–202. doi: 10.1016/0195-6701(94)90042-6. [DOI] [PubMed] [Google Scholar]
  521. Prokurat S., Drabik E., Grenda R., Vogt E. Ganciclovir in cytomegalovirus prophylaxis in high-risk pediatric renal transplant recipients. Transplant Proc. 1993 Aug;25(4):2577–2577. [PubMed] [Google Scholar]
  522. Qadri S. M., Al Dayel F., Strampfer M. J., Cunha B. A. Urinary tract infection caused by Hansenula anomala. Mycopathologia. 1988 Nov;104(2):99–101. doi: 10.1007/BF00436934. [DOI] [PubMed] [Google Scholar]
  523. Qunibi W. Y., al-Sibai M. B., Taher S., Harder E. J., de Vol E., al-Furayh O., Ginn H. E. Mycobacterial infection after renal transplantation--report of 14 cases and review of the literature. Q J Med. 1990 Oct;77(282):1039–1060. doi: 10.1093/qjmed/77.1.1039. [DOI] [PubMed] [Google Scholar]
  524. Raakow R., Steffen R., Lefèbre B., Bechstein W. O., Blumhardt G., Neuhaus P. Selective bowel decontamination effectively prevents gram-negative bacterial infections after liver transplantation. Transplant Proc. 1990 Aug;22(4):1556–1557. [PubMed] [Google Scholar]
  525. Raby N., Forbes G., Williams R. Nocardia infection in patients with liver transplants or chronic liver disease: radiologic findings. Radiology. 1990 Mar;174(3 Pt 1):713–716. doi: 10.1148/radiology.174.3.2406779. [DOI] [PubMed] [Google Scholar]
  526. Rakela J., Wiesner R. H., Taswell H. F., Hermans P. E., Smith T. F., Perkins J. D., Krom R. A. Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation. Transplant Proc. 1987 Feb;19(1 Pt 3):2399–2402. [PubMed] [Google Scholar]
  527. Ralph E. D., Barber K. R., Grant C. W. Liposomal amphotericin B: an effective, nontoxic preparation for the treatment of urinary tract infections caused by Candida albicans. Am J Nephrol. 1991;11(2):118–122. doi: 10.1159/000168286. [DOI] [PubMed] [Google Scholar]
  528. Ramirez J. C., Patterson G. A., Winton T. L., de Hoyos A. L., Miller J. D., Maurer J. R. Bilateral lung transplantation for cystic fibrosis. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg. 1992 Feb;103(2):287–294. [PubMed] [Google Scholar]
  529. Ramon Y., Oberman M., Horowitz I., Freedman A. Extensive maxillary sequestration resulting from rhinocerebral mucormyocosis. J Oral Surg. 1977 Dec;35(12):989–991. [PubMed] [Google Scholar]
  530. Rancewicz Z., Halama G., Smogorzewski M., Durlik M., Rowinska D., Lao M., Juskowa J., Wyzgal J. The usefulness of hyperimmune globulin for treatment of overt cytomegalovirus infection in allograft recipients. Transplant Proc. 1990 Aug;22(4):1818–1819. [PubMed] [Google Scholar]
  531. Randhawa P. S., Yousem S. A. Epstein-Barr virus-associated lymphoproliferative disease in a heart-lung allograft. Demonstration of host origin by restriction fragment-length polymorphism analysis. Transplantation. 1990 Jan;49(1):126–130. doi: 10.1097/00007890-199001000-00028. [DOI] [PubMed] [Google Scholar]
  532. Randhawa P. S., Yousem S. A., Paradis I. L., Dauber J. A., Griffith B. P., Locker J. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol. 1989 Aug;92(2):177–185. doi: 10.1093/ajcp/92.2.177. [DOI] [PubMed] [Google Scholar]
  533. Rao K. V., O'Brien T. J., Andersen R. C. Septic arthritis due to Nocardia asteroides after successful kidney transplantation. Arthritis Rheum. 1981 Jan;24(1):99–101. doi: 10.1002/art.1780240117. [DOI] [PubMed] [Google Scholar]
  534. Rappaport D. C., Weisbrod G. L., Herman S. J. Cyclosporine-induced lymphoma following a unilateral lung transplant. The Toronto Lung Transplant Group. Can Assoc Radiol J. 1989 Apr;40(2):110–111. [PubMed] [Google Scholar]
  535. Rattazzi L. C., Simmons R. L., Spanos P. K., Bradford D. S., Najarian J. S. Successful management of miliary tuberculosis after renal transplantation. Am J Surg. 1975 Sep;130(3):359–361. doi: 10.1016/0002-9610(75)90402-x. [DOI] [PubMed] [Google Scholar]
  536. Reed E. C., Wolford J. L., Kopecky K. J., Lilleby K. E., Dandliker P. S., Todaro J. L., McDonald G. B., Meyers J. D. Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial. Ann Intern Med. 1990 Apr 1;112(7):505–510. doi: 10.7326/0003-4819-112-7-505. [DOI] [PubMed] [Google Scholar]
  537. Rees W., Schüler S., Hummel M., Hempel S., Möller J., Hetzer R. Primary cutaneous Nocardia farcinica infection after heart transplantation: a case report. J Thorac Cardiovasc Surg. 1995 Jan;109(1):181–183. doi: 10.1016/S0022-5223(95)70436-1. [DOI] [PubMed] [Google Scholar]
  538. Rela M., Heaton N. D., Vougas V., Rolando N., Wade J., Portmann B., Williams R., Tan K. C. Gangrene of the anterior abdominal wall after orthotopic liver transplantation: invasive cutaneous candidiasis. Postgrad Med J. 1993 Jun;69(812):494–496. doi: 10.1136/pgmj.69.812.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  539. Renoult E., Aymard B., Grégoire M. J., Bellou A., Hubert J., Hestin D., Audouin J., Lederlin P., Kessler M. Epstein-Barr virus lymphoproliferative disease of donor origin after kidney transplantation: a case report. Am J Kidney Dis. 1995 Jul;26(1):84–87. doi: 10.1016/0272-6386(95)90159-0. [DOI] [PubMed] [Google Scholar]
  540. Renoult E., Kessler M., Jonon B., Schmit J. L. Significance of seroconversion against Legionella after renal transplantation: report of five cases. Clin Nephrol. 1990 Apr;33(4):209–209. [PubMed] [Google Scholar]
  541. Reyes J., Abu-Elmagd K., Tzakis A., Nour B., Casavilla A., Kusne S., Green M., Alessiani M., Jain A., Fung J. J. Infectious complications after human small bowel transplantation. Transplant Proc. 1992 Jun;24(3):1249–1250. [PMC free article] [PubMed] [Google Scholar]
  542. Reznik M., Halleux J., Urbain E., Mouchette R., Castermans P., Beaujean M. Two cases of progressive multifocal leukoencephalopathy after renal transplantation. Acta Neuropathol Suppl. 1981;7:189–191. doi: 10.1007/978-3-642-81553-9_57. [DOI] [PubMed] [Google Scholar]
  543. Ribot S., Eslami H. H. HIV infection in kidney transplant recipients. N J Med. 1992 Aug;89(8):597–599. [PubMed] [Google Scholar]
  544. Richardson W. P., Colvin R. B., Cheeseman S. H., Tolkoff-Rubin N. E., Herrin J. T., Cosimi A. B., Collins A. B., Hirsch M. S., McCluskey R. T., Russell P. S. Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med. 1981 Jul 9;305(2):57–63. doi: 10.1056/NEJM198107093050201. [DOI] [PubMed] [Google Scholar]
  545. Riddler S. A., Breinig M. C., McKnight J. L. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood. 1994 Aug 1;84(3):972–984. [PubMed] [Google Scholar]
  546. Rifkind D., Marchioro T. L., Schneck S. A., Hill R. B., Jr Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med. 1967 Jul;43(1):28–38. doi: 10.1016/0002-9343(67)90146-5. [DOI] [PubMed] [Google Scholar]
  547. Ringdén O., Lönnqvist B., Paulin T., Ahlmén J., Klintmalm G., Wahren B., Lernestedt J. O. Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. J Antimicrob Chemother. 1986 Mar;17(3):373–387. doi: 10.1093/jac/17.3.373. [DOI] [PubMed] [Google Scholar]
  548. Riska H., Kuhlbäck B. Tuberculosis and kidney transplantation. Acta Med Scand. 1979;205(7):637–640. doi: 10.1111/j.0954-6820.1979.tb06118.x. [DOI] [PubMed] [Google Scholar]
  549. Rondeau E., Bourgeon B., Peraldi M. N., Lang P., Buisson C., Schulte K. M., Weill B., Sraer J. D. Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant. 1993;8(9):858–862. [PubMed] [Google Scholar]
  550. Rondeau E., Farquet C., Ruedin P., Fries D., Sraer J. D. Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients. Transplant Proc. 1990 Aug;22(4):1813–1814. [PubMed] [Google Scholar]
  551. Rook A. H. Interactions of cytomegalovirus with the human immune system. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S460–S467. doi: 10.1093/clinids/10.supplement_3.s460. [DOI] [PubMed] [Google Scholar]
  552. Rosen T. Cutaneous Mycobacterium kansasii infection presenting as cellulitis. Cutis. 1983 Jan;31(1):87–89. [PubMed] [Google Scholar]
  553. Rosman C., Klompmaker I. J., Bonsel G. J., Bleichrodt R. P., Arends J. P., Slooff M. J. The efficacy of selective bowel decontamination as infection prevention after liver transplantation. Transplant Proc. 1990 Aug;22(4):1554–1555. [PubMed] [Google Scholar]
  554. Ross C. N., Beynon H. L., Savill J. S., Watkins R. P., Cohen J., Pusey C. D., Rees A. J. Ganciclovir treatment for cytomegalovirus infection in immunocompromised patients with renal disease. Q J Med. 1991 Nov;81(295):929–936. [PubMed] [Google Scholar]
  555. Rossaint R., Raakow R., Lewandowski K., Slama K., Steffen R., Blumhardt G., Lütgebrune R., Neuhaus P., Falke K. Strategy for prevention of infection after orthotopic liver transplantation. Transplant Proc. 1991 Jun;23(3):1965–1966. [PubMed] [Google Scholar]
  556. Roth D., Zucker K., Cirocco R., DeMattos A., Burke G. W., Nery J., Esquenazi V., Babischkin S., Miller J. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int. 1994 Jan;45(1):238–244. doi: 10.1038/ki.1994.29. [DOI] [PubMed] [Google Scholar]
  557. Rubin R. H. Infectious disease complications of renal transplantation. Kidney Int. 1993 Jul;44(1):221–236. doi: 10.1038/ki.1993.234. [DOI] [PubMed] [Google Scholar]
  558. Rubin R. H., Tolkoff-Rubin N. E. Antimicrobial strategies in the care of organ transplant recipients. Antimicrob Agents Chemother. 1993 Apr;37(4):619–624. doi: 10.1128/aac.37.4.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  559. Rubin R. H., Wolfson J. S., Cosimi A. B., Tolkoff-Rubin N. E. Infection in the renal transplant recipient. Am J Med. 1981 Feb;70(2):405–411. doi: 10.1016/0002-9343(81)90780-4. [DOI] [PubMed] [Google Scholar]
  560. Ruskin J. D., Wood R. P., Bailey M. R., Whitmore C. K., Shaw B. W. Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients. Oral Surg Oral Med Oral Pathol. 1992 Nov;74(5):567–571. doi: 10.1016/0030-4220(92)90345-q. [DOI] [PubMed] [Google Scholar]
  561. Ryan C. G., Dwyer B. W. New characteristics of Mycobacterium haemophilum. J Clin Microbiol. 1983 Oct;18(4):976–977. doi: 10.1128/jcm.18.4.976-977.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  562. Sack K., Schwieder G., Marre R., Hoyer J. Nocardial infection in a renal transplant recipient--a case report. Scand J Urol Nephrol Suppl. 1985;92:59–66. [PubMed] [Google Scholar]
  563. Saigenji H., Kaneko M., Rhenmen B., Williams R. J., Vasu M. A., Icenogle T. B., Copeland J. G. Pneumocystis carinii pneumonia after heart transplantation. Ann Thorac Surg. 1991 Jul;52(1):107–111. doi: 10.1016/0003-4975(91)91429-y. [DOI] [PubMed] [Google Scholar]
  564. Saliba F., Arulnaden J. L., Gugenheim J., Serves C., Samuel D., Bismuth A., Mathieu D., Bismuth H. CMV hyperimmune globulin prophylaxis after liver transplantation: a prospective randomized controlled study. Transplant Proc. 1989 Feb;21(1 Pt 2):2260–2262. [PubMed] [Google Scholar]
  565. Saliba F., Eyraud D., Samuel D., David M. F., Arulnaden J. L., Dussaix E., Mathieu D., Bismuth H. Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients. Transplant Proc. 1993 Feb;25(1 Pt 2):1444–1445. [PubMed] [Google Scholar]
  566. Saliba F., Gugenheim J., Samuel D., Bismuth A., Mathieu D., Serres C., Bismuth H. Incidence of cytomegalovirus infection and effects of cytomegalovirus immune globulin prophylaxis after orthotopic liver transplantation. Transplant Proc. 1987 Oct;19(5):4081–4082. [PubMed] [Google Scholar]
  567. Salizzoni J. L., Tiruviluamala P., Reichman L. B. Liver transplantation: an unheralded probable risk for tuberculosis. Tuber Lung Dis. 1992 Aug;73(4):232–238. doi: 10.1016/0962-8479(92)90092-X. [DOI] [PubMed] [Google Scholar]
  568. Salmela K., Höckerstedt K., Lautenschlager I., Eklund B., Isoniemi H., Holmberg C., Ahonen J. Ganciclovir in the treatment of severe cytomegalovirus disease in liver transplant patients. Transplant Proc. 1990 Feb;22(1):238–240. [PubMed] [Google Scholar]
  569. Salt A., Sutehall G., Sargaison M., Woodward C., Barnes N. D., Calne R. Y., Wreghitt T. G. Viral and toxoplasma gondii infections in children after liver transplantation. J Clin Pathol. 1990 Jan;43(1):63–67. doi: 10.1136/jcp.43.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  570. Sampaio M., Ianhez L. E., Sabbaga E. Protective effect of cyclosporine in human renal posttransplant cryptococcosis. Transplant Proc. 1992 Dec;24(6):3091–3091. [PubMed] [Google Scholar]
  571. Samra Y., Shaked Y., Maier M. K. Nontyphoid salmonellosis in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis. 1986 May-Jun;8(3):431–440. doi: 10.1093/clinids/8.3.431. [DOI] [PubMed] [Google Scholar]
  572. Samuel D., Bismuth A., Serres C., Arulnaden J. L., Reynes M., Benhamou J. P., Brechot C., Bismuth H. HBV infection after liver transplantation in HBsAg positive patients: experience with long-term immunoprophylaxis. Transplant Proc. 1991 Feb;23(1 Pt 2):1492–1494. [PubMed] [Google Scholar]
  573. Sanger J. R., Stampfl D. A., Franson T. R. Recurrent granulomatous synovitis due to Mycobacterium kansasii in a renal transplant recipient. J Hand Surg Am. 1987 May;12(3):436–441. doi: 10.1016/s0363-5023(87)80019-9. [DOI] [PubMed] [Google Scholar]
  574. Santiago-Delpín E. A., Mora E., González Z. A., Morales-Otero L. A., Bermudez R. Factors in an outbreak of Pneumocystis carinii in a transplant unit. Transplant Proc. 1988 Feb;20(1 Suppl 1):462–465. [PubMed] [Google Scholar]
  575. Sartin J. S., Wilhelm M. P., Keating M. R., Batts K., Krom R. A. A case of Aspergillus fumigatus peritonitis complicating liver transplantation. Eur J Clin Microbiol Infect Dis. 1994 Jan;13(1):25–28. doi: 10.1007/BF02026119. [DOI] [PubMed] [Google Scholar]
  576. Sawyer M. D., Mayoral J. L., Gillingham K. J., Kramer M. A., Dunn D. L. Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants. Arch Surg. 1993 Feb;128(2):165–170. doi: 10.1001/archsurg.1993.01420140042007. [DOI] [PubMed] [Google Scholar]
  577. Sayage L. H., Gonwa T. A., Goldstein R. M., Husberg B. S., Klintmalm G. B. Cytomegalovirus infection in orthotopic liver transplantation. Transpl Int. 1989 Aug;2(2):96–101. doi: 10.1007/BF02459327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  578. Sayers M. H., Anderson K. C., Goodnough L. T., Kurtz S. R., Lane T. A., Pisciotto P., Silberstein L. E. Reducing the risk for transfusion-transmitted cytomegalovirus infection. Ann Intern Med. 1992 Jan 1;116(1):55–62. doi: 10.7326/0003-4819-116-1-55. [DOI] [PubMed] [Google Scholar]
  579. Schad G. A. Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients. J Infect Dis. 1986 Jan;153(1):178–178. doi: 10.1093/infdis/153.1.178. [DOI] [PubMed] [Google Scholar]
  580. Schmidt K., Burdelski M., Bernsau U., Brodehl J., Ringe B., Lauchart W., Wonigeit K., Pichlmayr R., Milbradt H. Analysis of current results of liver transplantation in children. Transplant Proc. 1987 Feb;19(1 Pt 3):2449–2450. [PubMed] [Google Scholar]
  581. Schober R., Herman M. M. Neuropathology of cardiac transplantation. Survey of 31 cases. Lancet. 1973 May 5;1(7810):962–967. doi: 10.1016/s0140-6736(73)91600-0. [DOI] [PubMed] [Google Scholar]
  582. Schröter G. P., Bakshandeh K., Husberg B. S., Well R., 3rd Coccidioidomycosis and renal transplantation. Transplantation. 1977 Jun;23(6):485–489. doi: 10.1097/00007890-197706000-00005. [DOI] [PubMed] [Google Scholar]
  583. Schröter G. P., Hoelscher M., Putnam C. W., Porter K. A., Hansbrough J. F., Starzl T. E. Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg. 1976 Dec;111(12):1337–1347. doi: 10.1001/archsurg.1976.01360300027004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  584. Schröter G. P., Hoelscher M., Putnam C. W., Porter K. A., Starzl T. E. Fungus infections after liver transplantation. Ann Surg. 1977 Jul;186(1):115–122. doi: 10.1097/00000658-197707000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  585. Schröter G. P., Temple D. R., Husberg B. S., Weil R., 3rd, Starzl T. E. Cryptococcosis after renal transplantation: report of ten cases. Surgery. 1976 Mar;79(3):268–277. [PMC free article] [PubMed] [Google Scholar]
  586. Schröter G. P., Weil R., 3rd Listeria monocytogenes infection after renal transplantation. Arch Intern Med. 1977 Oct;137(10):1395–1399. doi: 10.1001/archinte.1977.03630220037011. [DOI] [PubMed] [Google Scholar]
  587. Schumaker J. D., Band J. D., Lensmeyer G. L., Craig W. A. Thiabendazole treatment of severe strongyloidiasis in a hemodialyzed patient. Ann Intern Med. 1978 Nov;89(5 Pt 1):644–645. doi: 10.7326/0003-4819-89-5-644. [DOI] [PubMed] [Google Scholar]
  588. Schwarz A., Hoffmann F., L'age-Stehr J., Tegzess A. M., Offermann G. Human immunodeficiency virus transmission by organ donation. Outcome in cornea and kidney recipients. Transplantation. 1987 Jul;44(1):21–24. doi: 10.1097/00007890-198707000-00006. [DOI] [PubMed] [Google Scholar]
  589. Schwend M., Tiemann M., Kreipe H. H., Parwaresch M. R., Kraatz E. G., Herrmann G., Spielmann R. P., Barth J. Rapidly growing Epstein-Barr virus-associated pulmonary lymphoma after heart transplantation. Eur Respir J. 1994 Mar;7(3):612–616. doi: 10.1183/09031936.94.07030612. [DOI] [PubMed] [Google Scholar]
  590. Schäfers H. J., Cremer J., Wahlers T., Holle W., Fieguth H. G., Herrmann G., Haverich A. Pneumocystis carinii pneumonia following heart transplantation. Eur J Cardiothorac Surg. 1987;1(1):49–52. doi: 10.1016/s1010-7940(87)80014-3. [DOI] [PubMed] [Google Scholar]
  591. Scoggin C. H., Call N. B. Acute respiratory failure due to disseminated strongyloidiasis in a renal transplant recipient. Ann Intern Med. 1977 Oct;87(4):456–458. doi: 10.7326/0003-4819-87-4-456. [DOI] [PubMed] [Google Scholar]
  592. Scroggs M. W., Wolfe J. A., Bollinger R. R., Sanfilippo F. Causes of death in renal transplant recipients. A review of autopsy findings from 1966 through 1985. Arch Pathol Lab Med. 1987 Oct;111(10):983–987. [PubMed] [Google Scholar]
  593. Seale L., Jones C. J., Kathpalia S., Jackson G. G., Mozes M., Maddux M. S., Packham D. Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir. JAMA. 1985 Dec 27;254(24):3435–3438. [PubMed] [Google Scholar]
  594. Segal R., Shmueli D., Yussim A., Sandbank M., Alteras I., Shapira Z. Renal transplant incidence of superficial fungal infection as related to immunosuppressive therapy. Transplant Proc. 1989 Feb;21(1 Pt 2):2114–2116. [PubMed] [Google Scholar]
  595. Segovia J., Pulpón L. A., Crespo M. G., Daza R., Rodríguez J. C., Rubio A., Serrano S., Carreño M. C., Varela A., Arangüena R. Rhodococcus equi: first case in a heart transplant recipient. J Heart Lung Transplant. 1994 Mar-Apr;13(2):332–335. [PubMed] [Google Scholar]
  596. Seltzer J., Broaddus V. C., Jacobs R., Golden J. A. Reactivation of coccidioides infection. West J Med. 1986 Jul;145(1):96–98. [PMC free article] [PubMed] [Google Scholar]
  597. Serody J. S., Mill M. R., Detterbeck F. C., Harris D. T., Cohen M. S. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis. 1993 Jan;16(1):54–58. doi: 10.1093/clinids/16.1.54. [DOI] [PubMed] [Google Scholar]
  598. Shaariah W., Morad Z., Suleiman A. B. Cryptococcosis in renal transplant recipients. Transplant Proc. 1992 Oct;24(5):1898–1899. [PubMed] [Google Scholar]
  599. Sharples L. D., Caine N., Mullins P., Scott J. P., Solis E., English T. A., Large S. R., Schofield P. M., Wallwork J. Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease. Transplantation. 1991 Aug;52(2):244–252. doi: 10.1097/00007890-199108000-00012. [DOI] [PubMed] [Google Scholar]
  600. Shea B. F., Hoffman S., Sesin G. P., Hammer S. M. Ganciclovir hepatotoxicity. Pharmacotherapy. 1987;7(6):223–226. doi: 10.1002/j.1875-9114.1987.tb03529.x. [DOI] [PubMed] [Google Scholar]
  601. Shennib H., Massard G., Reynaud M., Noirclerc M. Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation. J Heart Lung Transplant. 1994 May-Jun;13(3):514–519. [PubMed] [Google Scholar]
  602. Shrader S. K., Watts J. C., Dancik J. A., Band J. D. Disseminated cryptococcosis presenting as cellulitis with necrotizing vasculitis. J Clin Microbiol. 1986 Nov;24(5):860–862. doi: 10.1128/jcm.24.5.860-862.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  603. Shuster E. A., Beneke J. S., Tegtmeier G. E., Pearson G. R., Gleaves C. A., Wold A. D., Smith T. F. Monoclonal antibody for rapid laboratory detection of cytomegalovirus infections: characterization and diagnostic application. Mayo Clin Proc. 1985 Sep;60(9):577–585. doi: 10.1016/s0025-6196(12)60979-3. [DOI] [PubMed] [Google Scholar]
  604. Shuttleworth D., Philpot C. M., Salaman J. R. Cutaneous fungal infection following renal transplantation: a case control study. Br J Dermatol. 1987 Nov;117(5):585–590. doi: 10.1111/j.1365-2133.1987.tb07490.x. [DOI] [PubMed] [Google Scholar]
  605. Silverman R. A., Rhodes A. R., Dennehy P. H. Disseminated intravascular coagulation and purpura fulminans in a patient with Candida sepsis. Biopsy of purpura fulminans as an aid to diagnosis of systemic Candida infection. Am J Med. 1986 Apr;80(4):679–684. doi: 10.1016/0002-9343(86)90824-7. [DOI] [PubMed] [Google Scholar]
  606. Simmons R. L., Matas A. J., Rattazzi L. C., Balfour H. H., Jr, Howard J. R., Najarian J. S. Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery. 1977 Nov;82(5):537–546. [PubMed] [Google Scholar]
  607. Simonds R. J., Holmberg S. D., Hurwitz R. L., Coleman T. R., Bottenfield S., Conley L. J., Kohlenberg S. H., Castro K. G., Dahan B. A., Schable C. A. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med. 1992 Mar 12;326(11):726–732. doi: 10.1056/NEJM199203123261102. [DOI] [PubMed] [Google Scholar]
  608. Simpson G. L., Raffin T. A., Remington J. S. Association of prior nocardiosis and subsequent occurrence of nontuberculous mycobacteriosis in a defined, immunosuppressed population. J Infect Dis. 1982 Aug;146(2):211–219. doi: 10.1093/infdis/146.2.211. [DOI] [PubMed] [Google Scholar]
  609. Sindhuphak W., MacDonald E., Head E., Hudson R. D. Exophiala jeanselmei infection in a postrenal transplant patient. J Am Acad Dermatol. 1985 Nov;13(5 Pt 2):877–881. doi: 10.1016/s0190-9622(85)70233-2. [DOI] [PubMed] [Google Scholar]
  610. Singer M. A., Hagler W. S., Grossniklaus H. E. Toxoplasma gondii retinochoroiditis after liver transplantation. Retina. 1993;13(1):40–45. doi: 10.1097/00006982-199313010-00010. [DOI] [PubMed] [Google Scholar]
  611. Singh N., Dummer J. S., Kusne S., Breinig M. K., Armstrong J. A., Makowka L., Starzl T. E., Ho M. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis. 1988 Jul;158(1):124–131. doi: 10.1093/infdis/158.1.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  612. Singh N., Gayowski T., Singh J., Yu V. L. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis. 1995 Mar;20(3):617–620. doi: 10.1093/clinids/20.3.617. [DOI] [PubMed] [Google Scholar]
  613. Singh N., Mieles L., Yu V. L., Gayowski T. Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B. Clin Infect Dis. 1993 Nov;17(5):906–908. doi: 10.1093/clinids/17.5.906. [DOI] [PubMed] [Google Scholar]
  614. Singh N., Mieles L., Yu V. L., Starzl T. E. Decreased incidence of viral infections in liver transplant recipients. Possible effects of FK506? Dig Dis Sci. 1994 Jan;39(1):15–18. doi: 10.1007/BF02090054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  615. Singh N., Yu V. L., Mieles L., Wagener M. M., Miner R. C., Gayowski T. High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial. Ann Intern Med. 1994 Mar 1;120(5):375–381. doi: 10.7326/0003-4819-120-5-199403010-00004. [DOI] [PubMed] [Google Scholar]
  616. Sinnott J. T., 4th, Emmanuel P. J. Mycobacterial infections in the transplant patient. Semin Respir Infect. 1990 Mar;5(1):65–73. [PubMed] [Google Scholar]
  617. Sinnott J. T., 4th, Holt D. A. Cryptococcal pyarthrosis complicating gouty arthritis. South Med J. 1989 Dec;82(12):1555–1556. doi: 10.1097/00007611-198912000-00024. [DOI] [PubMed] [Google Scholar]
  618. Sklarin N. T., Dutcher J. P., Wiernik P. H. Lymphomas following cardiac transplantation. Case report and review of the literature. Am J Hematol. 1991 Jun;37(2):105–111. doi: 10.1002/ajh.2830370208. [DOI] [PubMed] [Google Scholar]
  619. Smith E. J., Milligan S. L., Filo R. S. Salmonella mycotic aneurysm after renal transplantation. South Med J. 1981 Nov;74(11):1399–1401. doi: 10.1097/00007611-198111000-00027. [DOI] [PubMed] [Google Scholar]
  620. Smith S. D., Jackson R. J., Hannakan C. J., Wadowsky R. M., Tzakis A. G., Rowe M. I. Selective decontamination in pediatric liver transplants. A randomized prospective study. Transplantation. 1993 Jun;55(6):1306–1309. doi: 10.1097/00007890-199306000-00018. [DOI] [PubMed] [Google Scholar]
  621. Smith T. F., Shelley C. D. Detection of IgM antibody to cytomegalovirus and rapid diagnosis of this virus infection by the shell vial assay. J Virol Methods. 1988 Sep;21(1-4):87–96. doi: 10.1016/0166-0934(88)90055-9. [DOI] [PubMed] [Google Scholar]
  622. Smyth R. L., Higenbottam T. W., Scott J. P., Wreghitt T. G., Stewart S., Clelland C. A., McGoldrick J. P., Wallwork J. Herpes simplex virus infection in heart-lung transplant recipients. Transplantation. 1990 Apr;49(4):735–739. doi: 10.1097/00007890-199004000-00016. [DOI] [PubMed] [Google Scholar]
  623. Smyth R. L., Scott J. P., Borysiewicz L. K., Sharples L. D., Stewart S., Wreghitt T. G., Gray J. J., Higenbottam T. W., Wallwork J. Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment. J Infect Dis. 1991 Dec;164(6):1045–1050. doi: 10.1093/infdis/164.6.1045. [DOI] [PubMed] [Google Scholar]
  624. Snydman D. R. Ganciclovir therapy for cytomegalovirus disease associated with renal transplants. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S554–S562. doi: 10.1093/clinids/10.supplement_3.s554. [DOI] [PubMed] [Google Scholar]
  625. Snydman D. R., Werner B. G., Dougherty N. N., Griffith J., Rohrer R. H., Freeman R., Jenkins R., Lewis W. D., O'Rourke E. A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group. Transplant Proc. 1994 Oct;26(5 Suppl 1):23–27. [PubMed] [Google Scholar]
  626. Snydman D. R., Werner B. G., Dougherty N. N., Griffith J., Rubin R. H., Dienstag J. L., Rohrer R. H., Freeman R., Jenkins R., Lewis W. D. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1993 Nov 15;119(10):984–991. doi: 10.7326/0003-4819-119-10-199311150-00004. [DOI] [PubMed] [Google Scholar]
  627. Snydman D. R., Werner B. G., Heinze-Lacey B., Berardi V. P., Tilney N. L., Kirkman R. L., Milford E. L., Cho S. I., Bush H. L., Jr, Levey A. S. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med. 1987 Oct 22;317(17):1049–1054. doi: 10.1056/NEJM198710223171703. [DOI] [PubMed] [Google Scholar]
  628. So S., Mayo C., McCullough C., Jendrisak M., Woodle S., Marsh W., Bailey T. Cytomegalovirus prophylaxis in pediatric renal transplant recipients. Transplant Proc. 1993 Feb;25(1 Pt 2):1414–1415. [PubMed] [Google Scholar]
  629. Solary E., Rifle G., Chalopin J. M., Rifle-Mediavilla C., Rebibou J. M., Camerlynck P., Justrabo E., Cuisenier B., Caillot D., Mousson C. Disseminated aspergillosis revealed by thyroiditis in a renal allograft recipient. Transplantation. 1987 Dec;44(6):839–840. doi: 10.1097/00007890-198712000-00025. [DOI] [PubMed] [Google Scholar]
  630. Specht E. E. Candida pyarthrosis of the hip and renal homotransplant. Report of a case treated by femoral head and neck resection and 5-fluorocytosine. Clin Orthop Relat Res. 1977 Jul-Aug;(126):176–177. [PubMed] [Google Scholar]
  631. Spector S. A., Merrill R., Wolf D., Dankner W. M. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol. 1992 Sep;30(9):2359–2365. doi: 10.1128/jcm.30.9.2359-2365.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  632. Spence R. K., Dafoe D. C., Rabin G., Grossman R. A., Naji A., Barker C. F., Perloff L. J. Mycobacterial infections in renal allograft recipients. Arch Surg. 1983 Mar;118(3):356–359. doi: 10.1001/archsurg.1983.01390030086014. [DOI] [PubMed] [Google Scholar]
  633. Spencer G. D., Hackman R. C., McDonald G. B., Amos D. E., Cunningham B. A., Meyers J. D., Thomas E. D. A prospective study of unexplained nausea and vomiting after marrow transplantation. Transplantation. 1986 Dec;42(6):602–607. doi: 10.1097/00007890-198612000-00006. [DOI] [PubMed] [Google Scholar]
  634. Spieker C., Barenbrock M., Tepel M., Buchholz B., Rahn K. H., Zidek W. Pentamidine inhalation as a prophylaxis against Pneumocystis carinii pneumonia after therapy of acute renal allograft rejection with orthoclone (OKT3). Transplant Proc. 1992 Dec;24(6):2602–2603. [PubMed] [Google Scholar]
  635. Sridhar N. R., Tchervenkov J. I., Weiss M. A., Hijazi Y. M., First M. R. Disseminated histoplasmosis in a renal transplant patient: a cause of renal failure several years following transplantation. Am J Kidney Dis. 1991 Jun;17(6):719–721. doi: 10.1016/s0272-6386(12)80359-3. [DOI] [PubMed] [Google Scholar]
  636. Stamm A. M., Dismukes W. E., Simmons B. P., Cobbs C. G., Elliott A., Budrich P., Harmon J. Listeriosis in renal transplant recipients: report of an outbreak and review of 102 cases. Rev Infect Dis. 1982 May-Jun;4(3):665–682. doi: 10.1093/clinids/4.3.665. [DOI] [PubMed] [Google Scholar]
  637. Stamm A. M., Smith S. H., Kirklin J. K., McGiffin D. C. Listerial myocarditis in cardiac transplantation. Rev Infect Dis. 1990 Sep-Oct;12(5):820–823. doi: 10.1093/clinids/12.5.820. [DOI] [PubMed] [Google Scholar]
  638. Starzl T. E., Koep L., Porter K. A., Schroter G. P., Weil R., 3rd, Hartley R. B., Halgrimson C. G. Decline in survival after liver transplantation. Arch Surg. 1980 Jul;115(7):815–819. doi: 10.1001/archsurg.1980.01380070009002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  639. Starzl T., Porter K. A., Schroter G., Corman J., Groth C. G., Sharp H. L. Autopsy findings in a long-surviving liver recipient. N Engl J Med. 1973 Jul 12;289(2):82–84. doi: 10.1056/NEJM197307122890207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  640. Steffen R., Reinhartz O., Blumhardt G., Bechstein W. O., Raakow R., Langrehr J. M., Rossaint R., Slama K., Neuhaus P. Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantations. Transpl Int. 1994;7(2):101–108. doi: 10.1007/BF00336470. [DOI] [PubMed] [Google Scholar]
  641. Stein D. S., Verano A. S., Levandowski R. A. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation. Am J Gastroenterol. 1988 Jun;83(6):684–686. [PubMed] [Google Scholar]
  642. Steinhoff G., Behrend M., Wagner T. O., Höper M. H., Haverich A. Early diagnosis and effective treatment of pulmonary CMV infection after lung transplantation. J Heart Lung Transplant. 1991 Jan-Feb;10(1 Pt 1):9–14. [PubMed] [Google Scholar]
  643. Steinmuller D. R., Graneto D., Swift C., Novick A. C., Streem S. B., Cunningham R. J., Hodge E., Bretan P. Use of intravenous immunoglobulin prophylaxis for primary cytomegalovirus infection post living-related-donor renal transplantation. Transplant Proc. 1989 Feb;21(1 Pt 2):2069–2071. [PubMed] [Google Scholar]
  644. Steinmuller D. R., Novick A. C., Streem S. B., Graneto D., Swift C. Intravenous immunoglobulin infusions for the prophylaxis of secondary cytomegalovirus infection. Transplantation. 1990 Jan;49(1):68–70. doi: 10.1097/00007890-199001000-00015. [DOI] [PubMed] [Google Scholar]
  645. Stinson E. B., Bieber C. P., Griepp R. B., Clark D. A., Shumway N. E., Remington J. S. Infectious complications after cardiac transplantation in man. Ann Intern Med. 1971 Jan;74(1):22–36. doi: 10.7326/0003-4819-74-1-22. [DOI] [PubMed] [Google Scholar]
  646. Stolf N. A., Higushi L., Bocchi E., Bellotti G., Auler J. O., Uip D., Amato Neto V., Pileggi F., Jatene A. D. Heart transplantation in patients with Chagas' disease cardiomyopathy. J Heart Transplant. 1987 Sep-Oct;6(5):307–312. [PubMed] [Google Scholar]
  647. Stoutenbeek C. P., Van Saene H. K., Miranda D. R., Zandstra D. F. A new technique of infection prevention in the intensive care unit by selective decontamination of the digestive tract. Acta Anaesthesiol Belg. 1983 Sep;34(3):209–221. [PubMed] [Google Scholar]
  648. Stratta R. J. Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation. Transplant Proc. 1993 Oct;25(5 Suppl 4):15–21. [PubMed] [Google Scholar]
  649. Stratta R. J., Shaefer M. S., Cushing K. A., Markin R. S., Reed E. C., Langnas A. N., Pillen T. J., Shaw B. W., Jr A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy. Arch Surg. 1992 Jan;127(1):55–64. doi: 10.1001/archsurg.1992.01420010065009. [DOI] [PubMed] [Google Scholar]
  650. Stratta R. J., Shaefer M. S., Cushing K. A., Markin R. S., Wood R. P., Langnas A. N., Reed E. C., Woods G. L., Donovan J. P., Pillen T. J. Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients. Transplantation. 1991 Jan;51(1):90–97. doi: 10.1097/00007890-199101000-00014. [DOI] [PubMed] [Google Scholar]
  651. Stratta R. J., Shaefer M. S., Markin R. S., Wood R. P., Kennedy E. M., Langnas A. N., Reed E. C., Woods G. L., Donovan J. P., Pillen T. J. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg. 1989 Dec;124(12):1443–1450. doi: 10.1001/archsurg.1989.01410120093018. [DOI] [PubMed] [Google Scholar]
  652. Stratta R. J., Shaeffer M. S., Markin R. S., Wood R. P., Langnas A. N., Reed E. C., Donovan J. P., Woods G. L., Bradshaw K. A., Pillen T. J. Cytomegalovirus infection and disease after liver transplantation. An overview. Dig Dis Sci. 1992 May;37(5):673–688. doi: 10.1007/BF01296422. [DOI] [PubMed] [Google Scholar]
  653. Stratta R. J., Taylor R. J., Bynon J. S., Lowell J. A., Cattral M. S., Frisbie K., Miller S., Radio S. J., Brennan D. C. Viral prophylaxis in combined pancreas-kidney transplant recipients. Transplantation. 1994 Feb 27;57(4):506–512. [PubMed] [Google Scholar]
  654. Stratta R. J., Wood R. P., Langnas A. N., Duckworth R. M., Shaefer M. S., Marujo W., Pillen T. J., Markin R. S., Shaw B. W., Jr Donor selection for orthotopic liver transplantation: lack of an effect of gender or cytomegalovirus (CMV) status. Transplant Proc. 1990 Apr;22(2):410–413. [PubMed] [Google Scholar]
  655. Stratta R., Shaefer M., Markin R., Bradshaw K., Donovan J., Wood R., Langnas A., Reed E., Woods G., Zetterman R. Ganciclovir therapy for viral disease in liver transplant recipients. Transplant Proc. 1991 Jun;23(3):1968–1968. [PubMed] [Google Scholar]
  656. Studemeister A. E., Kozak K., Garrity E., Venezio F. R. Survival of a heart transplant recipient after pulmonary cavitary mucormycosis. J Heart Transplant. 1988 Mar-Apr;7(2):159–161. [PubMed] [Google Scholar]
  657. Sudduth E. J., Crumbley A. J., 3rd, Farrar W. E. Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans. Clin Infect Dis. 1992 Oct;15(4):639–644. doi: 10.1093/clind/15.4.639. [DOI] [PubMed] [Google Scholar]
  658. Sugar A. M., Restrepo A., Stevens D. A. Paracoccidioidomycosis in the immunosuppressed host: report of a case and review of the literature. Am Rev Respir Dis. 1984 Feb;129(2):340–342. [PubMed] [Google Scholar]
  659. Sughayer M., DeGirolami P. C., Khettry U., Korzeniowski D., Grumney A., Pasarell L., McGinnis M. R. Human infection caused by Exophiala pisciphila: case report and review. Rev Infect Dis. 1991 May-Jun;13(3):379–382. doi: 10.1093/clinids/13.3.379. [DOI] [PubMed] [Google Scholar]
  660. Sumrani N., Delaney V., Hong J. H., Sommer B. G. Mycobacterial avium-intracellulare infection of a renal allograft. Clin Nephrol. 1991 Jan;35(1):45–46. [PubMed] [Google Scholar]
  661. Sundberg R., Shapiro R., Darras F., Jensen C., Scantlebury V., Jordan M., McCauley J., Kusne S., Edmond M. B., Ho M. A tuberculosis outbreak in a renal transplant program. Transplant Proc. 1991 Dec;23(6):3091–3092. [PMC free article] [PubMed] [Google Scholar]
  662. Sutherland D. E., Chan F. Y., Fourcar E., Simmons P. L., Howard R. J., Najarian J. S. The bleeding cecal ulcer in transplant patients. Surgery. 1979 Sep;86(3):386–398. [PubMed] [Google Scholar]
  663. Suzuki T., Takano Y., Yamashita K., Sato K., Kakita A., Okudaira M. A possible role for Epstein-Barr virus in tumorigenesis after immunosuppression in cases of renal transplantation. J Cancer Res Clin Oncol. 1993;119(10):627–629. doi: 10.1007/BF01372727. [DOI] [PubMed] [Google Scholar]
  664. Swinnen L. J., Costanzo-Nordin M. R., Fisher S. G., O'Sullivan E. J., Johnson M. R., Heroux A. L., Dizikes G. J., Pifarre R., Fisher R. I. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med. 1990 Dec 20;323(25):1723–1728. doi: 10.1056/NEJM199012203232502. [DOI] [PubMed] [Google Scholar]
  665. Talseth T., Holdaas H., Albrechtsen D., Berg K. J., Fauchald P., Naalsund A., Nordal K. P., Skar A. G., Sødal G., Flatmark A. Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients. Transplant Proc. 1988 Jun;20(3):400–401. [PubMed] [Google Scholar]
  666. Tang C. M., Cohen J., Rees A. J., Holden D. W. Molecular epidemiological study of invasive pulmonary aspergillosis in a renal transplantation unit. Eur J Clin Microbiol Infect Dis. 1994 Apr;13(4):318–321. doi: 10.1007/BF01974610. [DOI] [PubMed] [Google Scholar]
  667. Telenti A., Smith T. F., Ludwig J., Keating M. R., Krom R. A., Wiesner R. H. Epstein-Barr virus and persistent graft dysfunction after liver transplantation. Hepatology. 1991 Aug;14(2):282–286. [PubMed] [Google Scholar]
  668. Tenschert W., Gonnermann D., Meyer-Moldenhauer W. H., Cremaschi L., Huland H. Management of cytomegalovirus infection in high-risk recipients after renal transplantation: prophylaxis by hyperimmunoglobulins or DHPG treatment? Transplant Proc. 1993 Dec;25(6):3256–3258. [PubMed] [Google Scholar]
  669. Terrault N. A., Wright T. L., Pereira B. J. Hepatitis C infection in the transplant recipient. Infect Dis Clin North Am. 1995 Dec;9(4):943–964. [PubMed] [Google Scholar]
  670. Thaler F., Gotainer B., Teodori G., Dubois C., Loirat P. Mediastinitis due to Nocardia asteroides after cardiac transplantation. Intensive Care Med. 1992;18(2):127–128. doi: 10.1007/BF01705048. [DOI] [PubMed] [Google Scholar]
  671. Thomalla J. V., Steidle C. P., Leapman S. B., Filo R. S. Ureteral obstruction of a renal allograft secondary to Candida krusei. Transplant Proc. 1988 Jun;20(3):551–554. [PubMed] [Google Scholar]
  672. Thomas D. W., Ramsahoye B., Jasani B., Lim S. H. Epstein-Barr virus in squamous cell carcinoma after renal transplantation. Transplantation. 1995 Aug 27;60(4):390–392. doi: 10.1097/00007890-199508270-00016. [DOI] [PubMed] [Google Scholar]
  673. Thomas P. A., Jr, Mozes M. F., Jonasson O. Hepatic dysfunction during isoniazid chemoprophylaxis in renal allograft recipients. Arch Surg. 1979 May;114(5):597–599. doi: 10.1001/archsurg.1979.01370290047008. [DOI] [PubMed] [Google Scholar]
  674. Thorsteinsson S. B., Musher D. M., Ortiz L. R., Wolfe K. S., Weinman E. J., Schloeder F. X. Phycomycosis in a renal transplant recipient. Tex Med. 1976 Apr;72(4):71–75. [PubMed] [Google Scholar]
  675. Tice A. D., Solomon R. J. Disseminated Mycobacterium chelonei infection: response to sulfonamides. Am Rev Respir Dis. 1979 Jul;120(1):197–201. doi: 10.1164/arrd.1979.120.1.197. [DOI] [PubMed] [Google Scholar]
  676. Tinelli M., Percivalle E., Zambelli A., Grossi P., Maccabruni A. Cytomegalovirus prophylaxis by intravenous immunoglobulins in five heart transplanted patients. Boll Ist Sieroter Milan. 1990 Jun;69(2):459–467. [PubMed] [Google Scholar]
  677. Tokunaga Y., Concepcion W., Berquist W. E., Cox K. L., Wiviott L. D., Garcia-Kennedy R., Itasaka H., Nakazato P., Esquivel C. O. Graft involvement by Legionella in a liver transplant recipient. Arch Surg. 1992 Apr;127(4):475–477. doi: 10.1001/archsurg.1992.01420040121021. [DOI] [PubMed] [Google Scholar]
  678. Tolkoff-Rubin N. E., Conti D. J., Doran M., DelVecchio A., Rubin R. H. Fluconazole in the treatment of invasive candidal and cryptococcal infections in organ transplant recipients. Pharmacotherapy. 1990;10(6 ):159S–163S. [PubMed] [Google Scholar]
  679. Tolkoff-Rubin N. E., Cosimi A. B., Russell P. S., Rubin R. H. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. Rev Infect Dis. 1982 Mar-Apr;4(2):614–618. doi: 10.1093/clinids/4.2.614. [DOI] [PubMed] [Google Scholar]
  680. Tollemar J., Ericzon B. G., Barkholt L., Andersson J., Ringdén O., Groth C. G. Risk factors for deep candida infections in liver transplant recipients. Transplant Proc. 1990 Aug;22(4):1826–1827. [PubMed] [Google Scholar]
  681. Tollemar J., Ericzon B. G., Holmberg K., Andersson J. The incidence and diagnosis of invasive fungal infections in liver transplant recipients. Transplant Proc. 1990 Feb;22(1):242–244. [PubMed] [Google Scholar]
  682. Tollemar J., Höckerstedt K., Ericzon B. G., Jalanko H., Ringdén O. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study. Transplantation. 1995 Jan 15;59(1):45–50. doi: 10.1097/00007890-199501150-00009. [DOI] [PubMed] [Google Scholar]
  683. Tomlanovich S. J., Sabatte-Caspillo J., Melzer J., Amend W., Vincenti F., Feduska N., Salvatierra O. The incidence and impact of herpes simplex virus infections in the first month following renal transplantation. Transplant Proc. 1989 Feb;21(1 Pt 2):2091–2092. [PubMed] [Google Scholar]
  684. Torre-Cisneros J., Lopez O. L., Kusne S., Martinez A. J., Starzl T. E., Simmons R. L., Martin M. CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):188–193. doi: 10.1136/jnnp.56.2.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  685. Torre-Cisneros J., Mañez R., Kusne S., Alessiani M., Martin M., Starzl T. E. The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. Transplant Proc. 1991 Dec;23(6):3040–3041. [PMC free article] [PubMed] [Google Scholar]
  686. Trulock E. P., Bolman R. M., Genton R. Pulmonary disease caused by Mycobacterium chelonae in a heart-lung transplant recipient with obliterative bronchiolitis. Am Rev Respir Dis. 1989 Sep;140(3):802–805. doi: 10.1164/ajrccm/140.3.802. [DOI] [PubMed] [Google Scholar]
  687. Tsanaclis A. M., de Morais C. F. Cerebral toxoplasmosis after renal transplantation. Case report. Pathol Res Pract. 1986 Jun;181(3):339–343. doi: 10.1016/S0344-0338(86)80113-3. [DOI] [PubMed] [Google Scholar]
  688. Tuder R. M., Renya G. S., Bensch K. Mycobacterial coronary arteritis in a heart transplant recipient. Hum Pathol. 1986 Oct;17(10):1072–1074. doi: 10.1016/s0046-8177(86)80093-4. [DOI] [PubMed] [Google Scholar]
  689. Valantine H. A., Hunt S. A., Gibbons R., Billingham M. E., Stinson E. B., Popp R. L. Increasing pericardial effusion in cardiac transplant recipients. Circulation. 1989 Mar;79(3):603–609. doi: 10.1161/01.cir.79.3.603. [DOI] [PubMed] [Google Scholar]
  690. Van Etta L. L., Peterson L. R., Gerding D. N. Acremonium falciforme (Cephalosporium falciforme) mycetoma in a renal transplant patient. Arch Dermatol. 1983 Aug;119(8):707–708. doi: 10.1001/archderm.119.8.707. [DOI] [PubMed] [Google Scholar]
  691. Van Thiel D. H., Gavaler J. S., Schade R. R., Chien M. C., Starzl T. E. Cytomegalovirus infection and gastric emptying. Transplantation. 1992 Jul;54(1):70–73. doi: 10.1097/00007890-199207000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  692. Vartivarian S. E., Coudron P. E., Markowitz S. M. Disseminated coccidioidomycosis. Unusual manifestations in a cardiac transplantation patient. Am J Med. 1987 Nov;83(5):949–952. doi: 10.1016/0002-9343(87)90657-7. [DOI] [PubMed] [Google Scholar]
  693. Vasquez E. M., Sanchez J., Pollak R., Vrahnos D., Fabrega A. J., Maddux M. S. High-dose oral acyclovir prophylaxis for primary cytomegalovirus infection in seronegative renal allograft recipients. Transplantation. 1993 Feb;55(2):448–450. doi: 10.1097/00007890-199302000-00046. [DOI] [PubMed] [Google Scholar]
  694. Venizelos P. C., Lopata M., Bardawil W. A., Sharp J. T. Respiratory failure due to Strongyloides stercoralis in a patient with a renal transplant. Chest. 1980 Jul;78(1):104–106. doi: 10.1378/chest.78.1.104. [DOI] [PubMed] [Google Scholar]
  695. Versluis D. J., Beyer W. E., Masurel N., Wenting G. J., Weimar W. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation. 1986 Oct;42(4):376–379. doi: 10.1097/00007890-198610000-00009. [DOI] [PubMed] [Google Scholar]
  696. Viviani M. A., Tortorano A. M., Langer M., Almaviva M., Negri C., Cristina S., Scoccia S., De Maria R., Fiocchi R., Ferrazzi P. Experience with itraconazole in cryptococcosis and aspergillosis. J Infect. 1989 Mar;18(2):151–165. doi: 10.1016/s0163-4453(89)91178-x. [DOI] [PubMed] [Google Scholar]
  697. Wackym P. A., Gray G. F., Jr, Richie R. E., Gregg C. R. Cutaneous chromomycosis in renal transplant recipients. Successful management in two cases. Arch Intern Med. 1985 Jun;145(6):1036–1037. [PubMed] [Google Scholar]
  698. Wade J. C., Hintz M., McGuffin R., Springmeyer S. C., Connor J. D., Meyers J. D. Treatment of cytomegalovirus pneumonia with high-dose acyclovir. Am J Med. 1982 Jul 20;73(1A):249–256. doi: 10.1016/0002-9343(82)90100-0. [DOI] [PubMed] [Google Scholar]
  699. Wade J. J., Rolando N., Hayllar K., Philpott-Howard J., Casewell M. W., Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology. 1995 May;21(5):1328–1336. doi: 10.1002/hep.1840210517. [DOI] [PubMed] [Google Scholar]
  700. Wagner D., Wagenbreth I., Stachan-Kunstyr R., Flik J. Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients. Clin Investig. 1992 Jul;70(7):585–587. doi: 10.1007/BF00184798. [DOI] [PubMed] [Google Scholar]
  701. Wagner F. M., Reichenspurner H., Uberfuhr P., Weiss M., Fingerle V., Reichart B. Toxoplasmosis after heart transplantation: diagnosis by endomyocardial biopsy. J Heart Lung Transplant. 1994 Sep-Oct;13(5):916–918. [PubMed] [Google Scholar]
  702. Wajszczuk C. P., Dummer J. S., Ho M., Van Thiel D. H., Starzl T. E., Iwatsuki S., Shaw B., Jr Fungal infections in liver transplant recipients. Transplantation. 1985 Oct;40(4):347–353. doi: 10.1097/00007890-198510000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  703. Walder B. K., Jeremy D., Charlesworth J. A., Macdonald G. J., Pussell B. A., Robertson M. R. The skin and immunosuppression. Australas J Dermatol. 1976 Dec;17(3):94–97. doi: 10.1111/j.1440-0960.1976.tb00798.x. [DOI] [PubMed] [Google Scholar]
  704. Walker D. H., Adamec T., Krigman M. Disseminated petriellidosis (allescheriosis). Arch Pathol Lab Med. 1978 Mar;102(3):158–160. [PubMed] [Google Scholar]
  705. Walker R. C., Marshall W. F., Strickler J. G., Wiesner R. H., Velosa J. A., Habermann T. M., McGregor C. G., Paya C. V. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis. 1995 May;20(5):1346–1353. doi: 10.1093/clinids/20.5.1346. [DOI] [PubMed] [Google Scholar]
  706. Walker R. C., Paya C. V., Marshall W. F., Strickler J. G., Wiesner R. H., Velosa J. A., Habermann T. M., Daly R. C., McGregor C. G. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant. 1995 Mar-Apr;14(2):214–221. [PubMed] [Google Scholar]
  707. Walker S. D., Clark R. V., King C. T., Humphries J. E., Lytle L. S., Butkus D. E. Fatal disseminated Conidiobolus coronatus infection in a renal transplant patient. Am J Clin Pathol. 1992 Dec;98(6):559–564. doi: 10.1093/ajcp/98.6.559. [DOI] [PubMed] [Google Scholar]
  708. Wallace R. J., Jr, Brown B. A., Onyi G. O. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis. 1992 Aug;166(2):405–412. doi: 10.1093/infdis/166.2.405. [DOI] [PubMed] [Google Scholar]
  709. Wallace R. J., Jr, Tanner D., Brennan P. J., Brown B. A. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med. 1993 Sep 15;119(6):482–486. doi: 10.7326/0003-4819-119-6-199309150-00006. [DOI] [PubMed] [Google Scholar]
  710. Walzer Y., Bear R. A. Ureteral obstruction of renal transplant due to ureteral candidiasis. Urology. 1983 Mar;21(3):295–297. doi: 10.1016/0090-4295(83)90090-0. [DOI] [PubMed] [Google Scholar]
  711. Waser M., Maggiorini M., Lüthy A., Laske A., von Segesser L., Mohacsi P., Opravil M., Turina M., Follath F., Gallino A. Infectious complications in 100 consecutive heart transplant recipients. Eur J Clin Microbiol Infect Dis. 1994 Jan;13(1):12–18. doi: 10.1007/BF02026117. [DOI] [PubMed] [Google Scholar]
  712. Watanabe M., Hotchi M., Nagasaki M. An autopsy case of disseminated histoplasmosis probably due to infection from a renal allograft. Acta Pathol Jpn. 1988 Jun;38(6):769–780. doi: 10.1111/j.1440-1827.1988.tb02348.x. [DOI] [PubMed] [Google Scholar]
  713. Watson A. J., Russell R. P., Cabreja R. F., Braverman R., Whelton A. Cure of cryptococcal infection during continued immunosuppressive therapy. Q J Med. 1985 May;55(217):169–172. [PubMed] [Google Scholar]
  714. Watson A. J., Whelton A., Russell R. P. Cure of cryptococcemia and preservation of graft function in a renal transplant recipient. Arch Intern Med. 1984 Sep;144(9):1877–1878. [PubMed] [Google Scholar]
  715. Watson F. S., O'Connell J. B., Amber I. J., Renlund D. G., Classen D., Johnston J. M., Smith C. B., Bristow M. R. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG). J Heart Transplant. 1988 Mar-Apr;7(2):102–105. [PubMed] [Google Scholar]
  716. Weber J., Mettang T., Staerz E., Machleidt C., Kuhlmann U. Pulmonary disease due to Mycobacterium xenopi in a renal allograft recipient: report of a case and review. Rev Infect Dis. 1989 Nov-Dec;11(6):964–969. doi: 10.1093/clinids/11.6.964. [DOI] [PubMed] [Google Scholar]
  717. Weiland D., Ferguson R. M., Peterson P. K., Snover D. C., Simmons R. L., Najarian J. S. Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg. 1983 Nov;198(5):622–629. doi: 10.1097/00000658-198311000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  718. Weimar W., Kramer P., Bijnen A. B., Jeekel J., Rothbarth P. H., Masurel N. The incidence of cytomegalo- and herpes simplex virus infections in renal allograft recipients treated with high dose recombinant leucocyte interferon: a controlled study. Scand J Urol Nephrol Suppl. 1985;92:37–39. [PubMed] [Google Scholar]
  719. Weimar W., Lameijer L. D., Edy V. G., Schellekens H. Prophylactic use of interferon in renal allograft recipients. Transplant Proc. 1979 Mar;11(1):69–70. [PubMed] [Google Scholar]
  720. Weimar W., Metselaar H. J., Balk A. H., Mochtar B., Rothbarth P. H., Jeekel J. Passive immunization to prevent cytomegalovirus disease after kidney and heart transplantation. Transplant Proc. 1990 Feb;22(1):229–232. [PubMed] [Google Scholar]
  721. Weinberg J. M. Issues in the pathophysiology of nephrotoxic renal tubular cell injury pertinent to understanding cyclosporine nephrotoxicity. Transplant Proc. 1985 Aug;17(4 Suppl 1):81–90. [PubMed] [Google Scholar]
  722. Weiss J. N., Hutchins R. K., Balogh K. Simultaneous aspergillus endophthalmitis and cytomegalovirus retinitis after kidney transplantation. Retina. 1988;8(3):193–198. doi: 10.1097/00006982-198808030-00009. [DOI] [PubMed] [Google Scholar]
  723. Weller I. V., Copland P., Gabriel R. Strongyloides stercoralis infection in renal transplant recipients. Br Med J (Clin Res Ed) 1981 Feb 14;282(6263):524–524. doi: 10.1136/bmj.282.6263.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  724. Welty F. K., McLeod G. X., Ezratty C., Healy R. W., Karchmer A. W. Pseudallescheria boydii endocarditis of the pulmonic valve in a liver transplant recipient. Clin Infect Dis. 1992 Nov;15(5):858–860. doi: 10.1093/clind/15.5.858. [DOI] [PubMed] [Google Scholar]
  725. Werner B. G., Snydman D. R., Freeman R., Rohrer R., Tilney N. L., Kirkman R. L. Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group. Transplant Proc. 1993 Feb;25(1 Pt 2):1441–1443. [PubMed] [Google Scholar]
  726. Weston M. W. Invasive pulmonary aspergillosis in the early postcardiac transplantation period. Clin Cardiol. 1990 Jun;13(6):443–446. doi: 10.1002/clc.4960130614. [DOI] [PubMed] [Google Scholar]
  727. Wheat L. J., Smith E. J., Sathapatayavongs B., Batteiger B., Filo R. S., Leapman S. B., French M. V. Histoplasmosis in renal allograft recipients. Two large urban outbreaks. Arch Intern Med. 1983 Apr;143(4):703–707. [PubMed] [Google Scholar]
  728. Wheeler J. S., Jr, Culkin D. J., O'Connell J., Winters G. Nocardia epididymo-orchitis in an immunosuppressed patient. J Urol. 1986 Dec;136(6):1314–1315. doi: 10.1016/s0022-5347(17)45327-4. [DOI] [PubMed] [Google Scholar]
  729. White F. V., Reyes J., Jaffe R., Yunis E. J. Pathology of intestinal transplantation in children. Am J Surg Pathol. 1995 Jun;19(6):687–698. doi: 10.1097/00000478-199506000-00009. [DOI] [PubMed] [Google Scholar]
  730. White J. V., Garvey G., Hardy M. A. Fatal strongyloidiasis after renal transplantation: a complication of immunosuppression. Am Surg. 1982 Jan;48(1):39–41. [PubMed] [Google Scholar]
  731. Wiesner R. H., Hermans P. E., Rakela J., Washington J. A., 2nd, Perkins J. D., DiCecco S., Krom R. Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation. 1988 Mar;45(3):570–574. doi: 10.1097/00007890-198803000-00014. [DOI] [PubMed] [Google Scholar]
  732. Wiesner R. H., Hermans P., Rakela J., Perkins J., Washington J., DiCecco S., Krom R. A. Selective bowel decontamination to prevent gram-negative bacterial and fungal infection following orthotopic liver transplantation. Transplant Proc. 1987 Feb;19(1 Pt 3):2420–2423. [PubMed] [Google Scholar]
  733. Wiesner R. H. Selective bowel decontamination for infection prophylaxis in liver transplantation patients. Transplant Proc. 1991 Jun;23(3):1927–1928. [PubMed] [Google Scholar]
  734. Wiesner R. H. The incidence of gram-negative bacterial and fungal infections in liver transplant patients treated with selective decontamination. Infection. 1990;18 (Suppl 1):S19–S21. doi: 10.1007/BF01644482. [DOI] [PubMed] [Google Scholar]
  735. Wilczek H., Kallings I., Nyström B., Hoffner S. Nosocomial Legionnaires' disease following renal transplantation. Transplantation. 1987 Jun;43(6):847–851. [PubMed] [Google Scholar]
  736. Wiles H. B., Laver J., Baum D. T-cell lymphoma in a child after heart transplantation. J Heart Lung Transplant. 1994 Nov-Dec;13(6):1019–1023. [PubMed] [Google Scholar]
  737. Wilson C. B., Siber G. R., O'Brien T. F., Morgan A. P. Phycomycotic gangrenous cellulitis. A report of two cases and a review of the literature. Arch Surg. 1976 May;111(5):532–538. doi: 10.1001/archsurg.1976.01360230032005. [DOI] [PubMed] [Google Scholar]
  738. Wilson J. P., Turner H. R., Kirchner K. A., Chapman S. W. Nocardial infections in renal transplant recipients. Medicine (Baltimore) 1989 Jan;68(1):38–57. doi: 10.1097/00005792-198901000-00003. [DOI] [PubMed] [Google Scholar]
  739. Winston D. J., Emmanouilides C., Busuttil R. W. Infections in liver transplant recipients. Clin Infect Dis. 1995 Nov;21(5):1077–1091. doi: 10.1093/clinids/21.5.1077. [DOI] [PubMed] [Google Scholar]
  740. Winston D. J., Ho W. G., Bartoni K., Holland G. N., Mitsuyasu R. T., Gale R. P., Busuttil R. W., Champlin R. E. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S547–S553. doi: 10.1093/clinids/10.supplement_3.s547. [DOI] [PubMed] [Google Scholar]
  741. Winston D. J., Wirin D., Shaked A., Busuttil R. W. Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet. 1995 Jul 8;346(8967):69–74. doi: 10.1016/s0140-6736(95)92110-9. [DOI] [PubMed] [Google Scholar]
  742. Wise K. A., Speed B. R., Ellis D. H., Andrew J. H. Two fatal infections in immunocompromised patients caused by Scedosporium inflatum. Pathology. 1993 Apr;25(2):187–189. doi: 10.3109/00313029309084797. [DOI] [PubMed] [Google Scholar]
  743. Wolfson J. S., Sober A. J., Rubin R. H. Dermatologic manifestations of infections in immunocompromised patients. Medicine (Baltimore) 1985 Mar;64(2):115–133. doi: 10.1097/00005792-198503000-00004. [DOI] [PubMed] [Google Scholar]
  744. Wolinsky E. Mycobacterial diseases other than tuberculosis. Clin Infect Dis. 1992 Jul;15(1):1–10. doi: 10.1093/clinids/15.1.1. [DOI] [PubMed] [Google Scholar]
  745. Wong S. Y., Allen D. M. Transmission of disseminated histoplasmosis via cadaveric renal transplantation: case report. Clin Infect Dis. 1992 Jan;14(1):232–234. doi: 10.1093/clinids/14.1.232. [DOI] [PubMed] [Google Scholar]
  746. Wong T., Lavaud S., Toupance O., Carquin J., Wynckel A., Melin J. P., Hanrotel C., Chanard J. Failure of acyclovir to prevent cytomegalovirus infection in renal allograft recipients. Transpl Int. 1993;6(5):285–289. doi: 10.1007/BF00336029. [DOI] [PubMed] [Google Scholar]
  747. Wood G. M., McCormack J. G., Muir D. B., Ellis D. H., Ridley M. F., Pritchard R., Harrison M. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis. 1992 May;14(5):1027–1033. doi: 10.1093/clinids/14.5.1027. [DOI] [PubMed] [Google Scholar]
  748. Woods G. L., Washington J. A., 2nd Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis. 1987 Mar-Apr;9(2):275–294. doi: 10.1093/clinids/9.2.275. [DOI] [PubMed] [Google Scholar]
  749. Wreghitt T. G., Gray J. J., Pavel P., Balfour A., Fabbri A., Sharples L. D., Wallwork J. Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients. Transpl Int. 1992 Sep;5(4):197–200. doi: 10.1007/BF00336069. [DOI] [PubMed] [Google Scholar]
  750. Wreghitt T. G., Hakim M., Gray J. J., Balfour A. H., Stovin P. G., Stewart S., Scott J., English T. A., Wallwork J. Toxoplasmosis in heart and heart and lung transplant recipients. J Clin Pathol. 1989 Feb;42(2):194–199. doi: 10.1136/jcp.42.2.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  751. Wreghitt T. G., Whipp P. J., Bagnall J. Transmission of chickenpox to two intensive care unit nurses from a liver transplant patient with zoster. J Hosp Infect. 1992 Feb;20(2):125–126. doi: 10.1016/0195-6701(92)90116-4. [DOI] [PubMed] [Google Scholar]
  752. Wright T. L., Combs C., Kim M., Ferrell L., Bacchetti P., Ascher N., Roberts J., Wilber J., Sheridan P., Urdea M. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology. 1994 Oct;20(4 Pt 1):773–779. doi: 10.1002/hep.1840200402. [DOI] [PubMed] [Google Scholar]
  753. Wright T. L. Cytomegalovirus infection and vanishing bile duct syndrome: culprit or innocent bystander? Hepatology. 1992 Aug;16(2):494–496. doi: 10.1002/hep.1840160231. [DOI] [PubMed] [Google Scholar]
  754. Wyner L. M. The evaluation and management of urinary tract infections in recipients of solid-organ transplants. Semin Urol. 1994 May;12(2):134–139. [PubMed] [Google Scholar]
  755. Yalcin S., Karpuzoglu T., Suleymanlar G., Mutlu G., Mukai T., Yamamoto T., Isegawa Y., Yamanishi K. Human herpesvirus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey. Arch Virol. 1994;136(1-2):183–190. doi: 10.1007/BF01538827. [DOI] [PubMed] [Google Scholar]
  756. Yoshino M. T., Hillman B. J., Galgiani J. N. Coccidioidomycosis in renal dialysis and transplant patients: radiologic findings in 30 patients. AJR Am J Roentgenol. 1987 Nov;149(5):989–992. doi: 10.2214/ajr.149.5.989. [DOI] [PubMed] [Google Scholar]
  757. Young C. N., Meyers A. M. Opportunistic fungal infection by Fusarium oxysporum in a renal transplant patient. Sabouraudia. 1979 Sep;17(3):219–223. [PubMed] [Google Scholar]
  758. Zainudin B. M., Kassim F., Annuar N. M., Lim C. S., Ghazali A. K., Murad Z. Disseminated histoplasmosis presenting with ileal perforation in a renal transplant recipient. J Trop Med Hyg. 1992 Aug;95(4):276–279. [PubMed] [Google Scholar]
  759. Zamora I., Simon J. M., Da Silva M. E., Piqueras A. I. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol. 1994 Apr;8(2):190–192. doi: 10.1007/BF00865476. [DOI] [PubMed] [Google Scholar]
  760. Zamora M. R., Fullerton D. A., Campbell D. N., Leone S., Diercks M. J., Fisher J. H., Badesch D. B., Grover F. L. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients. Transplant Proc. 1994 Oct;26(5 Suppl 1):49–51. [PubMed] [Google Scholar]
  761. Zeluff B. J. Fungal pneumonia in transplant recipients. Semin Respir Infect. 1990 Mar;5(1):80–89. [PubMed] [Google Scholar]
  762. Zitelli B. J., Gartner J. C., Malatack J. J., Urbach A. H., Miller J. W., Williams L., Kirkpatrick B., Breinig M. K., Ho M. Pediatric liver transplantation: patient evaluation and selection, infectious complications, and life-style after transplantation. Transplant Proc. 1987 Aug;19(4):3309–3316. [PubMed] [Google Scholar]
  763. Zucker K., Cirocco R., Roth D., Burke G., Nery J., Esquenazi V., Miller J. Prospective longitudinal assessment of hepatitis C virus infection after renal transplantation. Transplant Proc. 1995 Feb;27(1):943–944. [PubMed] [Google Scholar]
  764. Zwas S. T., Czerniak P. Head and brain scan findings in rhinocerebral mucormycosis: case report. J Nucl Med. 1975 Oct;16(10):925–927. [PubMed] [Google Scholar]
  765. al-Sulaiman M. H., Dhar J. M., al-Hasani M. K., Haleem A., al-Khader A. Tuberculous interstitial nephritis after kidney transplantation. Transplantation. 1990 Jul;50(1):162–164. doi: 10.1097/00007890-199007000-00032. [DOI] [PubMed] [Google Scholar]
  766. de Hemptinne B., Lamy M. E., Salizzoni M., Cornu C., Mostin J., Fevery J., De Groote V., Otte J. B. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine). Transplant Proc. 1988 Feb;20(1 Suppl 1):652–655. [PubMed] [Google Scholar]
  767. de Koning J., van Dorp W. T., van Es L. A., van 't Wout J. W., van der Woude F. J. Ganciclovir effectively treats cytomegalovirus disease after solid-organ transplantation, even during rejection treatment. Nephrol Dial Transplant. 1992;7(4):350–356. doi: 10.1093/oxfordjournals.ndt.a092141. [DOI] [PubMed] [Google Scholar]
  768. de la Mata M., Rufián S., Gómez F., Varo E., López-Cillero P., Costán G., Solórzano G., González R., Miño G., Pera C. Recurrent fulminant liver failure caused by hepatitis B virus after liver transplantation. J Clin Gastroenterol. 1994 Oct;19(3):238–241. doi: 10.1097/00004836-199410000-00015. [DOI] [PubMed] [Google Scholar]
  769. van Gelder T., Kroes L. C., Mulder A., Gratama J. W., Weimar W. A living-related kidney donor as the source of a nearly fatal primary Epstein-Barr virus infection following transplantation. Transplantation. 1994 Oct 15;58(7):852–855. [PubMed] [Google Scholar]
  770. van Son W. J., van den Berg A. P., The T. H., Tegzess A. M. Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation. Transplant Proc. 1993 Feb;25(1 Pt 2):1436–1438. [PubMed] [Google Scholar]
  771. van den Berg A. P., Klompmaker I. J., Haagsma E. B., Scholten-Sampson A., Bijleveld C. M., Schirm J., van der Giessen M., Slooff M. J., The T. H. Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. J Infect Dis. 1991 Aug;164(2):265–270. doi: 10.1093/infdis/164.2.265. [DOI] [PubMed] [Google Scholar]
  772. van den Berg A. P., van Son W. J., Haagsma E. B., Klompmaker I. J., Tegzess A. M., Schirm J., Dijkstra G., van der Giessen M., Slooff M. J., The T. H. Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients. Transplantation. 1993 Apr;55(4):847–851. doi: 10.1097/00007890-199304000-00031. [DOI] [PubMed] [Google Scholar]
  773. van den Elshout F. J., Huysmans F. T., Muytjens H. L., Koene R. A. Cryptococcus neoformans meningitis following renal transplantation. Neth J Med. 1987 Oct;31(3-4):183–190. [PubMed] [Google Scholar]
  774. van der Bij W., Schirm J., Torensma R., van Son W. J., Tegzess A. M., The T. H. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol. 1988 Dec;26(12):2531–2535. doi: 10.1128/jcm.26.12.2531-2535.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  775. van der Vliet J. A., Tidow G., Kootstra G., van Saene H. F., Krom R. A., Sloof M. J., Weening J. J., Tegzess A. M., Meijer S., van Boven W. P. Transplantation of contaminated organs. Br J Surg. 1980 Aug;67(8):596–598. doi: 10.1002/bjs.1800670822. [DOI] [PubMed] [Google Scholar]
  776. van der Waaij D. Colonization resistance of the digestive tract: clinical consequences and implications. J Antimicrob Chemother. 1982 Oct;10(4):263–270. doi: 10.1093/jac/10.4.263. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES